10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to

Commission file number: 001-37779

FGL HOLDINGS

(Exact name of registrant as specified in its charter)

Cayman Islands		98-1354810
(State or other jurisdiction of incorporation or organization)	4th Floor Boundary Hall, Cricket Square Grand Cayman, Cayman Islands KY1-1102	(I.R.S. Employer Identification No.)
	(Address of principal executive offices, including zip code)

(800) 445-6758

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x    or    No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes x   or   No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	x	Accelerated Filer	¨
Non-accelerated Filer	¨	Smaller reporting Company	¨
		Emerging growth company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ¨   or    No  x

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Ordinary shares, par value $.0001 per share	FG	New York Stock Exchange
Warrants to purchase ordinary shares	FG WS	New York Stock Exchange

As of April 30, 2019, there were 221,660,974 ordinary shares, $.0001 par value, issued and outstanding.

FGL HOLDINGS

TABLE OF CONTENTS

	Page
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements:	-2
Condensed Consolidated Balance Sheets as of March 31, 2019 (unaudited) and December 31, 2018	-2
Condensed Consolidated Statements of Operations (unaudited)	-3
Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)	-4
Condensed Consolidated Statements of Changes in Shareholders' Equity (unaudited)	-5
Condensed Consolidated Statements of Cash Flows (unaudited)	-6
Notes to Unaudited Condensed Consolidated Financial Statements	-7
(1) Basis of Presentation	-7
(2) Significant Accounting Policies and Practices	-7
(3) Significant Risks and Uncertainties	-11
(4) Investments	-13
(5) Derivative Financial Instruments	-22
(6) Fair Value of Financial Instruments	-26
(7) Intangibles	-38
(8) Debt	-39
(9) Equity	-40
(10) Stock Compensation	-41
(11) Income Taxes	-43
(12) Commitments and Contingencies	-44
(13) Reinsurance	-46
(14) Related Party Transactions	-47
(15) Earnings Per Share	-48
(16) Insurance Subsidiary Financial Information and Regulatory Matters	-48
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	-50
Item 3. Quantitative and Qualitative Disclosures about Market Risk	-74
Item 4. Controls and Procedures	-79
PART II. OTHER INFORMATION
Item 1. Legal Proceedings	-81
Item 1A. Risk Factors	-81
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	-81
Item 3. Defaults Upon Senior Securities	-81
Item 4. Mine Safety Disclosures	-81
Item 5. Other Information	-81
Item 6. Exhibits	-82
Signatures	-82

-1

PART I: FINANCIAL INFORMATION

Item 1. Financial Statements

FGL HOLDINGS

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions, except share data)

	March 31, 2019			December 31, 2018
	(Unaudited)
ASSETS
Investments:
Fixed maturity securities, available-for-sale, at fair value (amortized cost: March 31, 2019 - $21,908; December 31, 2018 - $22,219)	$	21,605		$	21,109
Equity securities, at fair value (cost: March 31, 2019 - $1,226; December 31, 2018 - $1,526)	1,171			1,382
Derivative investments	305			97
Mortgage loans	674			667
Other invested assets	755			662
Total investments	24,510			23,917
Cash and cash equivalents	1,357			571
Accrued investment income	238			216
Funds withheld for reinsurance receivables, at fair value	837			757
Reinsurance recoverable	3,113			3,190
Intangibles, net	1,421			1,359
Deferred tax assets, net	283			343
Goodwill	467			467
Other assets	220			125
Total assets	$	32,446		$	30,945
LIABILITIES AND SHAREHOLDERS' EQUITY
Contractholder funds	$	23,881		$	23,387
Future policy benefits, including $797 and $725 at fair value at March 31, 2019 and December 31, 2018, respectively	4,677			4,641
Funds withheld for reinsurance liabilities	653			722
Liability for policy and contract claims	70			64
Debt	541			541
Other liabilities	873			700
Total liabilities	30,695			30,055
Commitments and contingencies ("Note 12")
Shareholders' equity:
Preferred stock ($.0001 par value, 100,000,000 shares authorized, 406,510 and 399,033 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively)	—			—
Common stock ($.0001 par value, 800,000,000 shares authorized, 221,660,974 and 221,660,974 issued and outstanding at March 31, 2019 and December 31, 2018, respectively)	—			—
Additional paid-in capital	2,007			1,998
Retained earnings (Accumulated deficit)	(6		)	(167		)
Accumulated other comprehensive income (loss)	(216		)	(937		)
Treasury stock, at cost (4,328,077 shares at March 31, 2019; 600,000 shares at December 31, 2018)	(34		)	(4		)
Total shareholders' equity	1,751			890
Total liabilities and shareholders' equity	$	32,446		$	30,945

See accompanying notes to unaudited condensed consolidated financial statements.

-2

FGL HOLDINGS

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except share data)

	Three months ended
	March 31, 2019			March 31, 2018
	(Unaudited)			(Unaudited)
Revenues:
Premiums	$	16		$	18
Net investment income	289			263
Net investment gains (losses)	240			(191		)
Insurance and investment product fees and other	55			48
Total revenues	600			138
Benefits and expenses:
Benefits and other changes in policy reserves	339			(39		)
Acquisition and operating expenses, net of deferrals	44			40
Amortization of intangibles	29			27
Total benefits and expenses	412			28
Operating income	188			110
Interest expense	(8		)	(6		)
Income (loss) before income taxes	180			104
Income tax expense	(9		)	(39		)
Net income (loss)	$	171		$	65
Less Preferred stock dividend	8			7
Net income (loss) available to common shareholders	$	163		$	58
Net income (loss) per common share:
Basic	$	0.74		$	0.27
Diluted	$	0.74		$	0.27
Weighted average common shares used in computing net income per common share:
Basic	219,645,679			214,370,000
Diluted	219,681,528			214,370,000
Cash dividend per common share	$	0.01		$	—
Supplemental disclosures
Total other-than-temporary impairments	$	(2	)	$	(2	)
Portion of other-than-temporary impairments included in other comprehensive income	—			—
Net other-than-temporary impairments	(2		)	(2		)
Gains (losses) on derivatives and embedded derivatives	164			(145		)
Other investment gains (losses)	78			(44		)
Total net investment gains (losses)	$	240		$	(191	)

See accompanying notes to unaudited condensed consolidated financial statements.

-3

FGL HOLDINGS

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In millions)

	Three months ended
	March 31, 2019			March 31, 2018
	(Unaudited)			(Unaudited)
Net income (loss)	$	171		$	65
Other comprehensive income (loss):
Net change in unrealized gains/losses on investments	724			(359		)
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk	(3		)	2
Net changes to derive comprehensive income (loss) for the period	721			(357		)
Comprehensive income (loss), net of tax	$	892		$	(292	)

See accompanying notes to unaudited condensed consolidated financial statements.

-4

FGL HOLDINGS

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

(Unaudited) (In millions)

	Preferred Stock		Common Stock		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)			Accumulated Other Comprehensive Income (Loss)			Treasury Stock			Total Shareholders' Equity
Balance, December 31, 2018	$	—	$	—	$	1,998	$	(167	)	$	(937	)	$	(4	)	$	890
Treasury shares purchased	—		—		—		—			—			(30		)	(30		)
Dividends
Preferred stock (paid in kind)	—		—		8		(8		)	—			—			—
Common stock ($0.01/share)	—		—		—		(2		)	—			—			(2		)
Net income (loss)	—		—		—		171			—			—			171
Unrealized investment gains (losses), net	—		—		—		—			724			—			724
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk	—		—		—		—			(3		)	—			(3		)
Stock-based compensation	—		—		1		—			—			—			1
Balance, March 31, 2019	$	—	$	—	$	2,007	$	(6	)	$	(216	)	$	(34	)	$	1,751

	Preferred Stock		Common Stock		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)			Accumulated Other Comprehensive Income (Loss)			Treasury Stock		Total Shareholders' Equity
Balance, December 31, 2017	$	—	$	—	$	2,037	$	(149	)	$	75		$	—	$	1,963
Dividends
Preferred stock (paid in kind)	—		—		2		(7		)	—			—		(5		)
Net income (loss)	—		—		—		65			—			—		65
Unrealized investment gains (losses), net	—		—		—		—			(359		)	—		(359		)
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk	—		—		—		—			2			—		2
Cumulative effect of changes in accounting principles	—		—		—		(4		)	4			—		—
Balance, March 31, 2018	$	—	$	—	$	2,039	$	(95	)	$	(278	)	$	—	$	1,666

See accompanying notes to unaudited condensed consolidated financial statements.

-5

FGL HOLDINGS

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

	Three months ended
	March 31, 2019			March 31, 2018
	(Unaudited)			(Unaudited)
Cash flows from operating activities:
Net income (loss)	$	171		$	65
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock based compensation	1			—
Amortization	4			15
Deferred income taxes	5			12
Interest credited/index credits to contractholder account balances	308			(30		)
Net recognized losses (gains) on investments and derivatives	(240		)	191
Charges assessed to contractholders for mortality and administration	(32		)	(38		)
Intangibles, net	(90		)	(55		)
Changes in operating assets and liabilities:
Reinsurance recoverable	(16		)	(8		)
Future policy benefits	36			(40		)
Funds withheld for reinsurers	(129		)	(12		)
Collateral (returned) posted	141			(145		)
Other assets and other liabilities	(63		)	10
Net cash provided by (used in) operating activities	96			(35		)
Cash flows from investing activities:
Proceeds from available-for-sale investments sold, matured or repaid	962			3,286
Proceeds from derivatives instruments and other invested assets	44			143
Proceeds from mortgage loans	4			20
Cost of available-for-sale investments	(421		)	(3,699		)
Costs of derivatives instruments and other invested assets	(172		)	(94		)
Costs of mortgage loans	(12		)	—
Capital expenditures	(1		)	(3		)
Contingent purchase price payment	—			(30		)
Net cash provided by (used in) investing activities	404			(377		)
Cash flows from financing activities:
Treasury stock	(30		)	—
Draw on revolving credit facility	—			30
Dividends paid	(2		)	—
Contractholder account deposits	1,225			959
Contractholder account withdrawals	(907		)	(635		)
Net cash provided by (used in) financing activities	286			354
Change in cash & cash equivalents	786			(58		)
Cash & cash equivalents, beginning of period	571			1,215
Cash & cash equivalents, end of period	$	1,357		$	1,157
Supplemental disclosures of cash flow information:
Interest paid	$	—		$	2
Income taxes (refunded) paid	$	(1	)	$	(30	)
Deferred sales inducements	$	35		$	26

See accompanying notes to unaudited condensed consolidated financial statements.

-6

FGL HOLDINGS

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (In millions)

(1) Basis of Presentation

FGL Holdings (the “Company”), a Cayman Islands exempted company, markets products through its wholly-owned insurance subsidiaries, Fidelity & Guaranty Life Insurance Company (“FGL Insurance”) and Fidelity & Guaranty Life Insurance Company of New York (“FGL NY Insurance”), which together are licensed in all fifty states and the District of Columbia.

F&G Reinsurance Ltd (“F&G Re”), an exempted company incorporated in Bermuda with limited liability, provides a platform for non-affiliated international business. Front Street Re Cayman Ltd (“FSRC”), an exempted company incorporated in the Cayman Islands with limited liability, has a license to carry on business as an Unrestricted Class “B” Insurer that permits FSRC to conduct offshore direct and reinsurance business. F&G Re and FSRC (together herein referred to as the “F&G Reinsurance Companies”), are indirect wholly owned subsidiaries of FGL Holdings and parties to reinsurance transactions.

The accompanying unaudited condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and with the instructions for the Securities and Exchange Commission (“SEC”) Quarterly Report on Form 10-Q, including Article 10 of Regulation S-X, for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. Therefore, the information contained in the Notes to Consolidated Financial Statements included in the Company's 2018 Form 10-K, should be read in connection with the reading of these interim unaudited condensed consolidated financial statements.

In the opinion of management, these statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results.  Operating results for the threemonths endedMarch 31, 2019, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2019.  Amounts reclassified out of other comprehensive income are reflected in net investment gains in the unaudited Condensed Consolidated Statements of Operations.

Dollar amounts in the accompanying sections are presented in millions, unless otherwise noted.

(2) Significant Accounting Policies and Practices

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and all other entities in which the Company has a controlling financial interest and any variable interest entities ("VIEs") in which we are the primary beneficiary. All intercompany accounts and transactions have been eliminated in consolidation.

We are involved in certain entities that are considered VIEs as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support or where investors lack certain characteristics of a controlling financial interest. We assess our relationships to determine if we have the ability to direct the activities, or otherwise exert control, to evaluate if we are the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in our unaudited condensed consolidated financial statements. The Company has determined that we are not the primary beneficiary of a VIE as of March 31, 2019. See "Note 4. Investments" to the Company’s unaudited condensed consolidated financial statements for additional information on the Company’s investments in unconsolidated VIEs.

-7

Reclassifications and Retrospective Adjustments

The Company identified immaterial errors, as described below, during the period ended September 30, 2018. Management has reviewed the impact of these errors on prior periods in accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” (SAB 99) and determined none of these were material to the prior periods impacted.

Effective December 1, 2017, the Company measured the identifiable assets acquired and liabilities assumed from the Business Combination at acquisition-date fair value in accordance with ASC 805. This required significant model changes for the re-bifurcation of the host contract and embedded derivative components of the fixed income annuity ("FIA") liability. During the quarter ended September 30, 2018, the Company identified an immaterial error resulting from the model code used in the calculation of the FIA embedded derivative liability. In issuing the September 30, 2018 Form 10-Q, the Company recorded immaterial corrections to the Consolidated Statement of Operations for the three months ended March 31, 2018 by decreasing the benefits and other changes in policy reserves by $21, as well as increasing the amortization of intangibles by $4, and income tax expense by $4.

Certain prior year amounts have been reclassified or combined to conform to the current year presentation. These reclassifications and combinations had no effect on previously reported results of operations.

Adoption of New Accounting Pronouncements

Premium Amortization on Purchased Callable Debt Securities

In March 2017, the FASB issued new guidance on the amortization of callable securities (ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The ASU requires premiums paid on purchased debt securities with an explicit call option to be amortized to the earliest call date, as opposed to the maturity date (as under current GAAP). The updated guidance is applicable to instruments that are callable based on explicit, non-contingent call features that are callable at fixed prices on preset dates. The amendments in this update should be applied using the modified retrospective method through a cumulative effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted this new accounting guidance effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements.

Amendments to Lease Accounting

In February 2016, the FASB issued amended guidance (ASU 2016-02, Leases (Topic 842)), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Notable amendments in this update will:

• require entities to recognize the rights and obligations resulting from all leases or lease components of contracts, including operating leases, as lease assets and lease liabilities, with an exception allowed for leases with a term of 12 months or less

• create a distinction between finance leases and operating leases, with classification criteria substantially similar to that for distinguishing between capital leases and operating leases under previous guidance

• not retain the accounting model for leveraged leases under previous guidance for leases that commence after the effective date of ASU 2016-02

• provide additional guidance on separating the lease components from the nonlease components of a contract

• require qualitative disclosures along with specific quantitative disclosures to provide information regarding the amount, timing, and uncertainty of cash flows arising from leases

• include modifications to align lessor accounting with the changes to lessee accounting, as well as changes to the requirements of recognizing a transaction as a sale and leaseback transaction, however, these changes will have no impact on the Company's current lease arrangements

The amendments are required to be applied at the beginning of the earliest period presented using a modified retrospective approach (including several optional practical expedients related to leases commenced before the effective date). The Company has adopted this standard effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements.

-8

Future Accounting Pronouncements

Accounting pronouncements that will impact the Company in future periods have been disclosed in the Company’s 2018 Form 10-K. There have not been any additional accounting pronouncements issued during the quarter ended March 31, 2019 that are expected to impact the Company. The following two pronouncements were discussed in our 2018 Form 10-K but have been included below so as to provide an update on the Company’s status of adoption.

New Credit Loss Standard

In June 2016, the FASB issued new guidance (ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments), effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Notable amendments in this update will change the accounting for impairment of most financial assets and certain other instruments in the following ways:

• financial assets (or a group of financial assets) measured at amortized cost will be required to be presented at the net amount expected to be collected, with an allowance for credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset at purchase

• credit losses relating to AFS fixed maturity securities will be recorded through an allowance for credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for credit losses will be limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value

• the income statement will reflect the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount

• disclosures will be required to include information around how the credit loss allowance was developed, further details on information currently disclosed about credit quality of financing receivables and net investments in leases, and a rollforward of the allowance for credit losses for AFS fixed maturity securities as well as an aging analysis for securities that are past due

The amendments in this ASU may be early adopted during any interim or annual period beginning after December 15, 2018, however the Company has elected not to. The Company has identified the material asset classes impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply with the new guidance. The Company has developed a project plan to complete our adoption of this new standard, and is evaluating the impact of the new guidance on its consolidated financial statements.

Long-Duration Contracts

In August 2018, the FASB issued new guidance (ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts), effective for fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. Under this update:

• assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations

• the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income

• market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income

-9

• deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts

• deferred acquisition costs must be written off for unexpected contract terminations

• disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed

The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not currently expect to early adopt this standard. The Company has identified specific areas that will be impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply as well as the impact of the new guidance on its consolidated financial statements.

-10

(3) Significant Risks and Uncertainties

Federal Regulation

In April 2016, the Department of Labor (“DOL”) issued the “fiduciary” rule which could have had a material impact on the Company, its products, distribution, and business model. The rule provided that persons who render investment advice for a fee or other compensation with respect to an employer plan or individual retirement account ("IRA") are fiduciaries of that plan or IRA and would have expanded the definition of fiduciary under ERISA to apply to commissioned insurance agents who sell the Company’s IRA products. On June 21, 2018, the United States Court of Appeals for the Fifth Circuit formally vacated the DOL fiduciary rule in total when it issued its mandate following the court’s decision on March 15, 2018, in U.S. Chamber of Commerce v. U.S. Department of Labor, 885 F.3d 360 (5th Cir. 2018). Management will continue to monitor for potential action by state officials or the SEC to implement rules similar to the vacated DOL rule.

Use of Estimates and Assumptions

The preparation of the Company's unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used.

Concentrations of Financial Instruments

As of March 31, 2019 and December 31, 2018, the Company’s most significant investment in one industry, excluding United States ("U.S.") Government securities, was its investment securities in the Bankingindustry with a fair value of $2,348 or 10% and $2,491 or 10%, respectively, of the invested assets portfolio and an amortized cost of $2,416 and $2,691, respectively. As of March 31, 2019, the Company’s holdings in this industry include investments in 107 different issuers with the top ten investments accounting for 35% of the total holdings in this industry. As of March 31, 2019 the Company had no investments in issuers that exceeded 10% of shareholders' equity. As of December 31, 2018, the Company had 16 investments in issuers that exceeded 10% of shareholders' equity, with a total fair value of $1,634 or 7% of the invested assets portfolio: JP Morgan Chase & Co, Metropolitan Transportation Authority (NY), AT&T Inc, HSBC Holdings, Wells Fargo & Company, General Motors Co, Nationwide Mutual Insurance Company, Goldman Sachs Group Inc, United Mexican States, Energy Transfer Partners, Prudential Financial Inc, Citigroup Inc, HP Enterprise Co, Viacom Inc, Kinder Morgan Energy Partners, and Fuel Trust. The Company's largest concentration in any single issuer as of March 31, 2019 and December 31, 2018 was AT&T and JP Morgan Chase & Co, respectively, with a total fair value of $124 or 1% and $115 or 1% of the invested assets portfolio, respectively.

Concentrations of Financial and Capital Markets Risk

The Company is exposed to financial and capital markets risk, including changes in interest rates and credit spreads which can have an adverse effect on the Company’s results of operations, financial condition and liquidity. The Company expects to continue to face challenges and uncertainties that could adversely affect its results of operations and financial condition. The Company attempts to mitigate the risk, including changes in interest rates by investing in less rate-sensitive investments, including senior tranches of collateralized loan obligations, non-agency residential mortgage-backed securities, and various types of asset backed securities.

The Company’s exposure to such financial and capital markets risk relates primarily to the market price and cash flow variability associated with changes in interest rates. A rise in interest rates, in the absence of other countervailing changes, will increase the net unrealized loss position of the Company’s investment portfolio and, if long-term interest rates rise dramatically within a six to twelve month time period, certain of the Company’s products may be exposed to disintermediation risk. Disintermediation risk refers to the risk that policyholders surrender their contracts in a rising interest rate environment, requiring the Company to liquidate assets in an unrealized loss position. Management believes this risk is mitigated to some extent by surrender charge protection provided by the Company’s products.

Concentration of Reinsurance Risk

The Company has a significant concentration of reinsurance risk with third party reinsurers, Wilton Reassurance Company (“Wilton Re”) and Kubera Insurance (SAC) Ltd. acting in respect of Annuity Reinsurance Cell A1 ("Kubera") that could have a material impact on the Company’s financial position in the event that Wilton

-11

Re or Kubera fail to perform their obligations under the various reinsurance treaties. Wilton Re is a wholly-owned subsidiary of Canada Pension Plan Investment Board ("CPPIB"). CPPIB has an AAA issuer credit rating from Standard & Poor's Ratings Services ("S&P") as of March 31, 2019. Kubera is not rated, however, management has attempted to mitigate the risk of non-performance through the funds withheld arrangement. As of March 31, 2019, the net amount recoverable from Wilton Re was $1,541 and the net amount recoverable from Kubera was $681. The Company monitors both the financial condition of individual reinsurers and risk concentration arising from similar activities and economic characteristics of reinsurers to attempt to reduce the risk of default by such reinsurers. Wilton Re and Kubera are current on all amounts due as of March 31, 2019.

On March 6, 2019, Scottish Re (U.S.), Inc. (“SRUS”), a Delaware domestic life and health reinsurer of FGL Insurance, was ordered into receivership for purposes rehabilitation. As of March 31, 2019, the net amount recoverable from SRUS was $47. The financial exposure related to these ceded reserves are substantially mitigated via a reinsurance agreement whereby Wilton Re assumes treaty non-performance including credit risk for this business.

-12

(4) Investments

The Company’s fixed maturity securities investments have been designated as available-for-sale and are carried at fair value with unrealized gains and losses included in AOCI, net of associated adjustments for deferred acquisition costs ("DAC"), value of business acquired ("VOBA"), deferred sales inducements ("DSI"), unearned revenue ("UREV"), and deferred income taxes. The Company's equity securities investments are carried at fair value with unrealized gains and losses included in net income. The Company’s consolidated investments at March 31, 2019 and December 31, 2018 are summarized as follows:

	March 31, 2019
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	5,033	$	23	$	(82	)	$	4,974	$	4,974
Commercial mortgage-backed securities	2,596		60		(9		)	2,647		2,647
Corporates	10,886		60		(356		)	10,590		10,590
Hybrids	988		6		(33		)	961		961
Municipals	1,211		16		(10		)	1,217		1,217
Residential mortgage-backed securities	1,000		27		(5		)	1,022		1,022
U.S. Government	56		—		—			56		56
Foreign Governments	138		2		(2		)	138		138
Total available-for-sale securities	21,908		194		(497		)	21,605		21,605
Equity securities	1,226		3		(58		)	1,171		1,171
Derivative investments	318		74		(87		)	305		305
Commercial mortgage loans	479		—		—			485		479
Residential mortgage loans	195		—		—			199		195
Other invested assets	759		—		(4		)	744		755
Total investments	$	24,885	$	271	$	(646	)	$	24,509	$	24,510

	December 31, 2018
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	4,954	$	15	$	(137	)	$	4,832	$	4,832
Commercial mortgage-backed securities	2,568		9		(40		)	2,537		2,537
Corporates	11,213		16		(848		)	10,381		10,381
Hybrids	992		—		(91		)	901		901
Municipals	1,216		3		(32		)	1,187		1,187
Residential mortgage-backed securities	1,027		12		(8		)	1,031		1,031
U.S. Government	120		—		(1		)	119		119
Foreign Governments	129		—		(8		)	121		121
Total available-for-sale securities	22,219		55		(1,165		)	21,109		21,109
Equity securities	1,526		1		(145		)	1,382		1,382
Derivative investments	330		2		(235		)	97		97
Commercial mortgage loans	482		—		—			483		482
Residential mortgage loans	185		—		—			187		185
Other invested assets	662		—		—			651		662
Total investments	$	25,404	$	58	$	(1,545	)	$	23,909	$	23,917

-13

Included in AOCI were cumulative gross unrealized gains of $0 and gross unrealized losses of $0 related to the non-credit portion of other-than-temporary-impairments ("OTTI") on non-agency residential mortgage backed securities ("RMBS") for both March 31, 2019 and December 31, 2018.

Securities held on deposit with various state regulatory authorities had a fair value of $16,135 and $19,930 at March 31, 2019 and December 31, 2018, respectively. Under Iowa regulations, insurance companies are required to hold securities on deposit in an amount no less than the legal reserve.

At March 31, 2019 and December 31, 2018, the Company held no material investments that were non-income producing for a period greater than twelve months.

In accordance with the Company's FHLB agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to the Company for general purposes. The collateral investments had a fair value of $1,186 and $1,401 at March 31, 2019 and December 31, 2018, respectively.

The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations.

	March 31, 2019
	Amortized Cost		Fair Value
Corporates, Non-structured Hybrids, Municipal and Government securities:
Due in one year or less	$	160	$	160
Due after one year through five years	758		749
Due after five years through ten years	2,080		2,059
Due after ten years	10,281		9,994
Subtotal	13,279		12,962
Other securities which provide for periodic payments:
Asset-backed securities	5,033		4,974
Commercial mortgage-backed securities	2,596		2,647
Residential mortgage-backed securities	1,000		1,022
Subtotal	8,629		8,643
Total fixed maturity available-for-sale securities	$	21,908	$	21,605

The Company's available-for-sale securities with unrealized losses are reviewed for potential OTTI. For factors considered in evaluating whether a decline in value is other-than-temporary, please refer to “Note 2. Significant Accounting Policies and Practices" to the Company’s 2018 Form 10-K.

The Company analyzes its ability to recover the amortized cost by comparing the net present value of cash flows expected to be collected with the amortized cost of the security. Additionally, the Company considers other factors, including, but not limited to: whether the issuer is currently meeting its financial obligations and its ability to continue to meet these obligations, its existing cash available, and its access to additional available capital. For mortgage-backed and asset-backed securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions, based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. For structured securities, the payment priority within the tranche structure is also considered. For all other fixed maturity securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. If the net present value is less than the amortized cost of the investment, an OTTI is recognized.

Based on the results of our process for evaluating available-for-sale securities in unrealized loss positions for OTTI, as discussed above, the Company determined the unrealized losses as of March 31, 2019 decreased due to lower interest rates during the first quarter in conjunction with tighter credit spreads over Treasuries.

-14

The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows:

	March 31, 2019
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	2,696	$	(63	)	$	886	$	(19	)	$	3,582	$	(82	)
Commercial mortgage-backed securities	243		(4		)	250		(5		)	493		(9		)
Corporates	684		(15		)	7,227		(341		)	7,911		(356		)
Hybrids	333		(14		)	343		(19		)	676		(33		)
Municipals	45		—			482		(10		)	527		(10		)
Residential mortgage-backed securities	41		(1		)	238		(4		)	279		(5		)
U.S. Government	—		—			50		—			50		—
Foreign Government	—		—			81		(2		)	81		(2		)
Total available-for-sale securities	$	4,042	$	(97	)	$	9,557	$	(400	)	$	13,599	$	(497	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													468
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													1164
Total number of available-for-sale securities in an unrealized loss position													1,632

-15

	December 31, 2018
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	2,924	$	(116	)	$	643	$	(21	)	$	3,567	$	(137	)
Commercial mortgage-backed securities	1,466		(34		)	262		(6		)	1,728		(40		)
Corporates	8,016		(772		)	1,465		(76		)	9,481		(848		)
Hybrids	858		(90		)	7		(1		)	865		(91		)
Municipals	850		(27		)	172		(5		)	1,022		(32		)
Residential mortgage-backed securities	139		(3		)	190		(5		)	329		(8		)
U.S. Government	69		—			50		(1		)	119		(1		)
Foreign Government	47		(3		)	68		(5		)	115		(8		)
Total available-for-sale securities	$	14,369	$	(1,045	)	$	2,857	$	(120	)	$	17,226	$	(1,165	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													556
Total number of available-for-sale securities in an unrealized loss position													2,107

At March 31, 2019 and December 31, 2018, securities in an unrealized loss position were primarily concentrated in corporate debt.

At March 31, 2019 and December 31, 2018, securities with a fair value of $40 and $132, respectively, had an unrealized loss greater than 20% of amortized cost (excluding U.S. Government and U.S. Government sponsored agency securities), which were insignificant to the carrying value of all investments, respectively.

The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the threemonths endedMarch 31, 2019 and 2018, for which a portion of the OTTI was recognized in AOCI:

	Three months ended
	March 31, 2019		March 31, 2018
Beginning balance	$	—	$	—
Increases attributable to credit losses on securities:
OTTI was previously recognized	—		—
OTTI was not previously recognized	—		—
Ending balance	$	—	$	—

-16

The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the threemonths endedMarch 31, 2019 and 2018:

	Three months ended
	March 31, 2019			March 31, 2018
Credit impairment losses in operations	$	(2	)	$	(2	)
Change-of-intent losses in operations	—			—
Amortized cost	1			—
Fair value	1			—
Non-credit losses in other comprehensive income for investments which experienced OTTI	—			—

Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Corporates	(2		)	(2		)
Total	$	(2	)	$	(2	)

-17

Mortgage Loans

The Company's mortgage loans are collateralized by commercial and residential properties.

Commercial Mortgage Loans

Commercial mortgage loans ("CMLs") represented approximately 2% of the Company’s total investments as of March 31, 2019 and December 31, 2018. The Company primarily invests in mortgage loans on income producing properties including hotels, industrial properties, retail buildings, multifamily properties and office buildings. The Company diversifies its CML portfolio by geographic region and property type to attempt to reduce concentration risk. The Company continuously evaluates CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables:

	March 31, 2019				December 31, 2018
	Gross Carrying Value		% of Total		Gross Carrying Value		% of Total
Property Type:
Hotel	21		4	%	21		4	%
Industrial - General	37		8	%	37		8	%
Industrial - Warehouse	20		4	%	20		4	%
Multifamily	55		11	%	56		12	%
Office	146		31	%	147		30	%
Retail	200		42	%	201		42	%
Total commercial mortgage loans, gross of valuation allowance	$	479	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	479			$	482
U.S. Region:
East North Central	$	97	20	%	$	98	20	%
East South Central	19		4	%	19		4	%
Middle Atlantic	78		16	%	79		17	%
Mountain	65		14	%	65		13	%
New England	10		2	%	10		2	%
Pacific	115		24	%	116		24	%
South Atlantic	57		12	%	57		12	%
West North Central	13		3	%	13		3	%
West South Central	25		5	%	25		5	%
Total commercial mortgage loans, gross of valuation allowance	$	479	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	479			$	482

All of the Company's investments in CMLs had a loan-to-value ("LTV") ratio of less than 75% at March 31, 2019 and December 31, 2018, as measured at inception of the loans unless otherwise updated. As of March 31, 2019, all CMLs are current and have not experienced credit or other events which would require the recording of an impairment loss.

LTV and DSC ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. We normalize our DSC ratios to a 25-year amortization period for purposes of our general loan allowance evaluation.

-18

The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at March 31, 2019 and December 31, 2018:

	Debt-Service Coverage Ratios				Total Amount		% of Total		Estimated Fair Value		% of Total
	>1.25		1.00 - 1.25
March 31, 2019
LTV Ratios:
Less than 50%	$	299	$	6	$	305	64	%	$	309	64	%
50% to 60%	163		—		163		34	%	165		34	%
60% to 75%	11		—		11		2	%	11		2	%
Commercial mortgage loans	$	473	$	6	$	479	100	%	$	485	100	%
December 31, 2018
LTV Ratios:
Less than 50%	$	296	$	6	$	302	63	%	$	302	63	%
50% to 60%	169		—		169		35	%	170		35	%
60% to 75%	11		—		11		2	%	11		2	%
Commercial mortgage loans	$	476	$	6	$	482	100	%	$	483	100	%

(a) N/A - Current DSC ratio not available.

The Company establishes a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using DSC ratio and LTV ratio. The Company believes that the LTV ratio is an indicator of the principal recovery risk for loans that default. A higher LTV ratio will result in a higher allowance. The Company believes that the DSC ratio is an indicator of default risk on loans. A higher DSC ratio will result in a lower allowance.

The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At March 31, 2019 and December 31, 2018, the Company had no CMLs that were delinquent in principal or interest payments.

Mortgage loan workouts, refinances or restructures that are classified as troubled debt restructurings ("TDRs") are individually evaluated and measured for impairment. As of March 31, 2019 and December 31, 2018, our CML portfolio had no impairments, modifications or TDRs.

Residential Mortgage Loans

Residential mortgage loans ("RMLs") represented approximately 1% of the Company’s total investments as of March 31, 2019 and December 31, 2018. The Company's residential mortgage loans are closed end, amortizing loans. 100% of the properties are located in the United States. The Company diversifies its RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables:

	March 31, 2019
US State:	Unpaid Principal Balance		% of Total
Illinois	$	29	15	%
Florida	25		13	%
South Carolina	24		13	%
All Other States (a)	112		59	%
Total mortgage loans	$	190	100	%

(a) The individual concentration of each state is less than 9% as of March 31, 2019.

-19

	December 31, 2018
US State:	Unpaid Principal Balance		% of Total
Florida	$	25	14	%
Illinois	24		13	%
New Jersey	17		9	%
All Other States (a)	114		64	%
Total mortgage loans	$	180	100	%

(a) The individual concentration of each state is less than 9% as of December 31, 2018.

Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines non-performing residential mortgage loans as those that are 90 or more days past due and/or in nonaccrual status which is assessed monthly. The credit quality of RMLs as at March 31, 2019 and December 31, 2018, respectively, was as follows:

	March 31, 2019				December 31, 2018
Performance indicators:	Carrying Value		% of Total		Carrying Value		% of Total
Performing	$	195	100	%	$	185	100	%
Non-performing	—		—	%	—		—	%
Total residential mortgage loans, gross of valuation allowance	$	195	100	%	$	185	100	%
Allowance for loan loss	—		—	%	—		—	%
Total residential mortgage loans	$	195	100	%	$	185	100	%

Net Investment Income

The major sources of “Net investment income” on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Fixed maturity securities, available-for-sale	$	265		$	242
Equity securities	21			10
Mortgage loans	7			7
Invested cash and short-term investments	3			3
Funds withheld	8			7
Limited partnerships	8			3
Other investments	5			1
Gross investment income	317			273
Investment expense	(28		)	(10		)
Net investment income	$	289		$	263

-20

Net Investment Gains (Losses)

Details underlying “Net investment gains (losses)” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Net realized gains (losses) on fixed maturity available-for-sale securities	$	(3	)	$	(37	)
Net realized/unrealized gains (losses) on equity securities	78			(6		)
Realized gains (losses) on other invested assets	1			(3		)
Derivatives and embedded derivatives:
Realized gains (losses) on certain derivative instruments	(26		)	11
Unrealized gains (losses) on certain derivative instruments	190			(135		)
Change in fair value of reinsurance related embedded derivatives (a)	(3		)	(21		)
Change in fair value of other derivatives and embedded derivatives	3			—
Realized gains (losses) on derivatives and embedded derivatives	164			(145		)
Net investment gains (losses)	$	240		$	(191	)

(a) Change in fair value of reinsurance related embedded derivatives is due to F&G Re and FSRC unaffiliated third party business.

The proceeds from the sale of fixed-maturity available for-sale-securities and the gross gains and losses associated with those transactions were as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Proceeds	$	474		$	2,778
Gross gains	5			8
Gross losses	(10		)	(43		)

Unconsolidated Variable Interest Entities

FGL Insurance owns investments in VIEs that are not consolidated within the Company’s financial statements.  VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest.  These VIEs are not consolidated in the Company’s financial statements for the following reasons: 1)  FGL Insurance either does not control or does not have any voting rights or notice rights; 2)  the Company does not have any substantive rights to remove the investment manager; and 3)  the Company was not involved in the design of the investment.  These characteristics indicate that FGL Insurance lacks the ability to direct the activities, or otherwise exert control, of the VIEs and is not considered the primary beneficiary of them. 

The Company previously executed a commitment of $75 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, the Company does not have voting power.  The initial capital call occurred June 30, 2015, with the remaining commitment expected to fund June 2019. The Company has funded $54 as of March 31, 2019.

The Company invests in various limited partnerships as a passive investor. These investments are in corporate credit and real estate debt strategies that have a current income bias. Limited partnership interests are accounted for under the equity method and are included in “Other invested assets” on the Company’s consolidated balance sheet. The Company's maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in the Company's consolidated balance sheet in addition to any required unfunded commitments. As of March 31, 2019, the Company's maximum exposure to loss was $595 in recorded carrying value and $1,093 in unfunded commitments.

-21

(5) Derivative Financial Instruments

The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows:

	March 31, 2019		December 31, 2018
Assets:
Derivative investments:
Call options	$	304	$	97
Futures contracts	1		—
Other invested assets:
Other derivatives and embedded derivatives	17		14
	$	322	$	111

Liabilities:
Contractholder funds:
FIA embedded derivative	$	2,720	$	2,476
Other liabilities:
Preferred shares reimbursement feature embedded derivative	27		29
	$	2,747	$	2,505

The change in fair value of derivative instruments included in the accompanying unaudited Condensed Consolidated Statements of Operations is as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Revenues:
Net investment gains (losses):
Call options	$	154		$	(122	)
Futures contracts	8			(2		)
Foreign currency forward	2			—
Other derivatives and embedded derivatives	3			—
Reinsurance related embedded derivatives	(3		)	(21		)
Total net investment gains (losses)	$	164		$	(145	)
Benefits and other changes in policy reserves:
FIA embedded derivatives	$	244		$	(98	)
Acquisition and operating expenses, net of deferrals:
Preferred shares reimbursement feature embedded derivative	$	2		$	(1	)

Additional Disclosures

Other Derivatives and Embedded Derivatives

The Company holds a $35 fund-linked note issued by Nomura International Funding Pte. Ltd. The note provides for an additional payment at maturity based on the value of an embedded derivative in AnchorPath Dedicated Return Fund (the "AnchorPath Fund") of $11 which was based on the actual return of the fund. At March 31, 2019, the fair value of the fund-linked note and embedded derivative were $27 and $17, respectively. At December 31, 2018, the fair value of the fund-linked note and embedded derivative were $26 and $14, respectively. At maturity of the fund-linked note, FGL Insurance will receive the $35 face value of the note plus the value of the embedded derivative in the AnchorPath Fund. The additional payment at maturity is an embedded derivative reported in "Other invested assets", while the host is an available-for-sale security reported in "Fixed maturities, available-for-sale".

-22

Fixed Index Annuity ("FIA") Embedded Derivative and Call Options and Futures

The Company has FIA Contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, primarily the S&P 500 Index. This feature represents an embedded derivative under GAAP. The FIA embedded derivative is valued at fair value and included in the liability for contractholder funds in the accompanying Condensed Consolidated Balance Sheets with changes in fair value included as a component of “Benefits and other changes in policy reserves” in the unaudited Condensed Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments".

The Company purchases derivatives consisting of a combination of call options and futures contracts on the applicable market indices to fund the index credits due to FIA contractholders. The call options are one, two, three, and five year options purchased to match the funding requirements of the underlying policies. On the respective anniversary dates of the index policies, the index used to compute the interest credit is reset and the Company purchases new one, two, three, or five year call options to fund the next index credit. The Company manages the cost of these purchases through the terms of its FIA contracts, which permit the Company to change caps, spreads or participation rates, subject to guaranteed minimums, on each contract’s anniversary date. The change in the fair value of the call options and futures contracts is generally designed to offset the portion of the change in the fair value of the FIA embedded derivative related to index performance. The call options and futures contracts are marked to fair value with the change in fair value included as a component of “Net investment gains (losses).” The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instrument term or upon early termination and the changes in fair value of open positions.

Other market exposures are hedged periodically depending on market conditions and the Company’s risk tolerance. The Company’s FIA hedging strategy economically hedges the equity returns and exposes the Company to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. The Company uses a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. The Company intends to continue to adjust the hedging strategy as market conditions and the Company’s risk tolerance change.

Preferred Equity Remarketing Reimbursement Embedded Derivative Liability

On November 30, 2017 the Company issued 275,000 Series A cumulative preferred shares and 100,000 Series B cumulative preferred shares (together the “Preferred Shares”). The Preferred Shares do not have a maturity date and are non-callable for the first five years.From and after November 30, 2022, the original holders of the Preferred Shares may request and thus require, the Company (subject to customary blackout provisions) to remarket the Preferred Shares on their existing terms. If the remarketing is successful and the original holders elect to sell their preferred shares at the remarketed price and proceeds from such sale are less than the outstanding balance of the applicable shares (including dividends paid in kind and accumulated but unpaid dividends), the Company will be required to reimburse the sellers, up to a maximum of 10% of the par value of the originally issued preferred shares (including dividends paid in kind and accumulated but unpaid dividends) with such amount payable either in cash, ordinary shares, or any combination thereof, at the Company's option (the “Reimbursement Feature”). The Reimbursement Feature represents an embedded derivative that is not clearly and closely related to the preferred stock host and must be bifurcated. The Reimbursement Feature liability is held at fair value within “Other liabilities” in the accompanying Condensed Consolidated Balance Sheets using a Black Derman Toy model incorporating among other things the paid in kind dividend coupon rate and the Company’s call option. Changes in fair value of this derivative are recognized within “Acquisition and operating expenses, net of deferrals” in the accompanying unaudited Condensed Consolidated Statements of Operations.

-23

Credit Risk

The Company is exposed to credit loss in the event of non-performance by its counterparties on the call options and reflects assumptions regarding this non-performance risk in the fair value of the call options. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. The Company maintains a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement.

Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table:

		March 31, 2019
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	3,496	$	70	$	25	$	45
Deutsche Bank	A-/A3/BBB+	1,151		14		14		—
Morgan Stanley	*/A1/A+	1,657		25		24		1
Barclay's Bank	A+/A2/A	2,752		79		61		18
Canadian Imperial Bank of Commerce	*/Aa2/A+	1,430		41		29		12
Wells Fargo	A+/A2/A-	2,034		58		56		2
Goldman Sachs	A/A3/BBB+	1,030		17		16		1
Total		$	13,550	$	304	$	225	$	79

		December 31, 2018
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	3,952	$	25	$	—	$	25
Deutsche Bank	A-/A3/BBB+	1,327		5		6		(1		)
Morgan Stanley	*/A1/A+	1,648		9		6		3
Barclay's Bank	A+/A2/A	2,205		27		20		7
Canadian Imperial Bank of Commerce	*/Aa2/A+	1,716		11		8		3
Wells Fargo	A+/A2/A-	1,635		17		16		1
Goldman Sachs	A/A3/BBB+	647		3		3		—
Total		$	13,130	$	97	$	59	$	38

(a) An * represents credit ratings that were not available.

-24

Collateral Agreements

The Company is required to maintain minimum ratings as a matter of routine practice as part of its over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, the Company has agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open option contracts between the parties, at which time any amounts payable by the Company or the counterparty would be dependent on the market value of the underlying option contracts. The Company's current rating doesn't allow any counterparty the right to terminate ISDA agreements. In certain transactions, the Company and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. For all counterparties, except one, this threshold is set to zero. As of March 31, 2019 and December 31, 2018, counterparties posted $225 and $59 of collateral, respectively, of which $200 and $59 is included in "Cash and cash equivalents" with an associated payable for this collateral included in "Other liabilities" on the Condensed Consolidated Balance Sheets. The remaining $25 and $0 of non-cash collateral was held by a third-party custodian and may not be sold or re-pledged, except in the event of default, and, therefore, is not included in the Company's Condensed Consolidated Balance Sheets at March 31, 2019 and December 31, 2018, respectively. This collateral generally consists of U.S. treasury bonds and mortgage-backed securities. Accordingly, the maximum amount of loss due to credit risk that the Company would incur if parties to the call options failed completely to perform according to the terms of the contracts was $79 and $38 at March 31, 2019 and December 31, 2018, respectively.

The Company is required to pay counterparties the effective federal funds rate each day for cash collateral posted to FGL for daily mark to market margin changes.  The Company reinvests derivative cash collateral to reduce the interest cost. Cash collateral is invested in short term Treasury securities and A1/P1 commercial paper which are included in "Cash and cash equivalents" in the accompanying Condensed Consolidated Balance Sheets.

The Company held 774 and 664 futures contracts at March 31, 2019 and December 31, 2018, respectively. The fair value of the futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements). The Company provides cash collateral to the counterparties for the initial and variation margin on the futures contracts which is included in "Cash and cash equivalents" in the accompanying Condensed Consolidated Balance Sheets. The amount of cash collateral held by the counterparties for such contracts was $4 and $3 at March 31, 2019 and December 31, 2018, respectively.

-25

(6) Fair Value of Financial Instruments

The Company’s measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or non-performance risk, which may include the Company’s own credit risk. The Company’s estimate of an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market for that asset or liability in the absence of a principal market as opposed to the price that would be paid to acquire the asset or assume a liability (“entry price”). The Company categorizes financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is defined as follows:

Level 1 - Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date.

Level 2 - Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads, and yield curves.

Level 3 - Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.

When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. In addition to the unobservable inputs, Level 3 fair value investments may include observable components, which are components that are actively quoted or can be validated to market-based sources.

-26

The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows:

	March 31, 2019
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	1,357	$	—	$	—	$	1,357	$	1,357
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,466		508		4,974		4,974
Commercial mortgage-backed securities	—		2,579		68		2,647		2,647
Corporates	—		9,381		1,209		10,590		10,590
Hybrids	277		674		10		961		961
Municipals	—		1,179		38		1,217		1,217
Residential mortgage-backed securities	—		403		619		1,022		1,022
U.S. Government	51		5		—		56		56
Foreign Governments	—		122		16		138		138
Equity securities	441		657		20		1,118		1,118
Derivative investments	1		304		—		305		305
Other invested assets	—		—		41		41		41
Funds withheld for reinsurance receivables, at fair value	161		664		7		832		832
Total financial assets at fair value	$	2,288	$	20,434	$	2,536	$	25,258	$	25,258
Liabilities
Derivatives:
FIA embedded derivatives, included in contractholder funds	—		—		2,720		2,720		2,720
Preferred shares reimbursement feature embedded derivative	—		—		27		27		27
Fair value of future policy benefits	—		—		797		797		797
Total financial liabilities at fair value	$	—	$	—	$	3,544	$	3,544	$	3,544

-27

	December 31, 2018
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	571	$	—	$	—	$	571	$	571
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,388		444		4,832		4,832
Commercial mortgage-backed securities	—		2,470		67		2,537		2,537
Corporates	—		9,150		1,231		10,381		10,381
Hybrids	265		626		10		901		901
Municipals	—		1,150		37		1,187		1,187
Residential mortgage-backed securities	—		417		614		1,031		1,031
U.S. Government	114		5		—		119		119
Foreign Governments	—		105		16		121		121
Equity securities	454		874		4		1,332		1,332
Derivative investments	—		97		—		97		97
Other invested assets	—		—		39		39		39
Funds withheld for reinsurance receivables, at fair value	169		576		4		749		749
Total financial assets at fair value	$	1,573	$	19,858	$	2,466	$	23,897	$	23,897
Liabilities
Derivatives:
FIA embedded derivatives, included in contractholder funds	$	—	$	—	$	2,476	$	2,476	$	2,476
Preferred shares reimbursement feature embedded derivative	—		—		29		29		29
Fair value of future policy benefits	—		—		725		725		725
Total financial liabilities at fair value	$	—	$	—	$	3,230	$	3,230	$	3,230

Valuation Methodologies

Fixed Maturity Securities & Equity Securities

The Company measures the fair value of its securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity or equity security, and the Company will then consistently apply the valuation methodology to measure the security’s fair value. The Company's fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services, independent broker quotations, or pricing matrices. The Company uses observable and unobservable inputs in its valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met.

For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant unobservable input used in the fair value measurement of equity securities for which the market approach valuation technique is employed is yield for comparable securities. Increases or decreases in the yields would result in lower or higher, respectively, fair value measurements. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. Management believes the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices. The Company has an equity investment in a private business development company which is not traded on an exchange or valued by other sources such as analytics or brokers. The Company based the fair value of this investment on an estimated net asset value provided by the investee. Management did not make any adjustments to this valuation.

The fair value of the Company's investment in mutual funds is based on the net asset value published by the respective mutual fund and represents the value the Company would have received if it withdrew its investment on the balance sheet date.

-28

The Company did not adjust prices received from third parties as of March 31, 2019 or December 31, 2018. However, the Company does analyze the third-party valuation methodologies and related inputs to perform assessments to determine the appropriate level within the fair value hierarchy.

Derivative Financial Instruments

The fair value of call option assets is based upon valuation pricing models, which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the options, entered into offsetting positions, or exercised the options. Fair values for these instruments are determined internally, based on valuation pricing models which use market-observable inputs, including interest rates, yield curve volatilities, and other factors.

The fair value of futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements) which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the futures contract or entered into offsetting positions. These contracts are classified as Level 1.

The fair value measurement of the FIA embedded derivatives included in contractholder funds is determined through a combination of market observable information and significant unobservable inputs. The market observable inputs are the market value of option and interest swap rates. The significant unobservable inputs are the mortality multiplier, surrender rates, non-performance spread and option costs. The mortality multiplier at March 31, 2019 and December 31, 2018 was applied to the Annuity 2000 mortality tables. Significant increases or decreases in the market value of an option in isolation would result in a higher or lower, respectively, fair value measurement. Significant increases or decreases in interest swap rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher fair value measurement, respectively. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input.

The fair value of the Reimbursement Feature is determined using a Black Derman Toy model, incorporating the paid in kind dividend coupon, the Company's redemption option and the preferred shareholder's remarketing feature. The remarketing feature allows the shareholder to put the preferred shares to the Company for a value of par after five years and, if after a successful remarketing event the amount is less than 90% par, up to a maximum of 10% of liquidation price defined. Fair value of this derivative decreased $2 during the threemonths endedMarch 31, 2019, due to changes in the credit spread.

Other Invested Assets

Fair value of the AnchorPath embedded derivative is based on an unobservable input, the net asset value of the AnchorPath fund at the balance sheet date.  The embedded derivative is similar to a call option on the net asset value of the AnchorPath fund with a strike price of zero since FGL Insurance will not be required to make any additional payments at maturity of the fund-linked note in order to receive the net asset value of the AnchorPath fund on the maturity date.  A Black-Scholes model determines the net asset value of the AnchorPath fund as the fair value of the call option regardless of the values used for the other inputs to the option pricing model.  The net asset value of the AnchorPath fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black-Scholes model is the value of the AnchorPath fund. As the value of the AnchorPath fund increases or decreases, the fair value of the embedded derivative will increase or decrease.

FSRC and F&G Re Funds Withheld for Reinsurance Receivables and Future Policy Benefits

FSRC and F&G Re elected to apply the Fair Value Option to account for its funds withheld receivables and future policy benefits liability related to its assumed reinsurance. FSRC and F&G Re measures the fair value of the Funds Withheld for Reinsurance Receivables based on the fair values of the securities in the underlying funds withheld portfolio held by the cedant. FSRC and F&G Re use a discounted cash flows approach to measure the fair value of the Future Policy Benefits Reserve. The cash flows associated with future policy premiums and benefits are generated using best estimate assumptions (plus a risk margin, where applicable) and are consistent with market prices, where available. Risk margins are typically applied to non-observable, non-hedgeable market inputs such as long term volatility, mortality, morbidity, lapse, etc.

The significant unobservable inputs used in the fair value measurement of the FSRC and F&G Re future policy benefit liability are undiscounted cash flows, non-performance risk spread and risk margin to reflect uncertainty.  Undiscounted cash flows used in our March 31, 2019 discounted cash flow model equaled $1,152. 

-29

Increases or decreases in non-performance risk spread and risk margin to reflect uncertainty would result in a lower or higher fair value measurement, respectively. 

Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of March 31, 2019 and December 31, 2018, are as follows:

	Fair Value at		Valuation Technique	Unobservable Input(s)	Range (Weighted average)
	March 31, 2019				March 31, 2019
Assets
Asset-backed securities	$	489	Broker-quoted	Offered quotes	97.50% - 105.17% (100.84%)
Asset-backed securities	19		Third-Party Valuation	Offered quotes	0.00% - 98.30% (28.44%)
Commercial mortgage-backed securities	43		Broker-quoted	Offered quotes	81.01% - 100.14% (87.90%)
Commercial mortgage-backed securities	25		Matrix Pricing	Quoted prices	121.01% - 121.01% (121.01%)
Corporates	731		Broker-quoted	Offered quotes	54.00% - 107.83% (99.49%)
Corporates	478		Matrix Pricing	Quoted prices	95.94% - 117.55% (101.67%)
Hybrids	10		Matrix Pricing	Quoted prices	98.84% - 98.84% (98.84%)
Municipals	38		Broker-quoted	Offered quotes	114.61% - 114.61% (114.61%)
Residential mortgage-backed securities	619		Broker-quoted	Offered quotes	92.52% - 103.81% (103.34%)
Foreign governments	16		Broker-quoted	Offered quotes	101.38% - 103.55% (102.06%)
Equity securities	16		Broker-quoted	Offered quotes	100.00%
Equity securities (Salus preferred equity)	4		Income-Approach	Yield	7.18%
Other Invested Assets:
Available-for-sale embedded derivative (AnchorPath)	16		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit Linked Note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables at fair value	6		Matrix pricing	Quoted prices	100.00%
Funds withheld for reinsurance receivables at fair value	1		Loan recovery value	Recovery rate	14.00%
Total	$	2,536
Liabilities
Future policy benefits	$	797	Discounted cash flow	Market value of option	0.88% - 6.95% (1.90%)
				Mortality multiplier	90.00% - 100.00% (100.00%)
				Surrender rates	0.65% - 40.00% (4.63%)
				Partial withdrawals	0.00% - 2.50% (0.93%)
				Non-performance spread	0.00% - 0.10% (0.03%)
				Option cost	1.14% - 4.58% (1.72%)
				Risk margin to reflect uncertainty	0.35% - 0.62% (0.44%)
				Morbidity risk margin	0.00% - 2.00% (0.17%)
Derivatives:
FIA embedded derivatives included in contractholder funds	2,720		Discounted cash flow	Market value of option	0.00% - 32.37% (2.23%)
				SWAP rates	2.29% - 2.41% (2.34%)

-30

				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.86%)
				Partial withdrawals	1.00% - 2.50% (2.00%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.18% - 16.61% (2.16%)
Preferred shares reimbursement feature embedded derivative	27		Black Derman Toy model	Credit Spread	4.50%
				Yield Volatility	20.00%
Total liabilities at fair value	$	3,544

-31

	Fair Value at		Valuation Technique	Unobservable Input(s)	Range (Weighted average)
	December 31, 2018				December 31, 2018
Assets
Asset-backed securities	$	405	Broker-quoted	Offered quotes	97.00% - 102.00% (99.77%)
Asset-backed securities	24		Matrix Pricing	Quoted prices	96.07% - 96.07% (96.07%)
Asset-backed securities	15		Third-Party Valuation	Offered quotes	0.00% - 99.29% (23.05%)
Commercial mortgage-backed securities	43		Broker-quoted	Offered quotes	77.12% - 100.08% (85.46%)
Commercial mortgage-backed securities	24		Matrix Pricing	Quoted prices	117.72% - 117.72% (117.72%)
Corporates	577		Broker-quoted	Offered quotes	74.63% - 104.62% (97.80%)
Corporates	654		Matrix Pricing	Quoted prices	91.74% - 113.25% (98.86%)
Hybrids	10		Matrix Pricing	Quoted prices	96.60% - 96.60% (96.60%)
Municipals	37		Broker-quoted	Offered quotes	111.23% - 111.23% (111.23%)
Residential mortgage-backed securities	614		Broker-quoted	Offered quotes	89.80% - 100.99% (100.73%)
Foreign governments	16		Broker-quoted	Offered quotes	98.38% - 99.01% (98.58%)
Equity securities (Salus preferred equity)	4		Income-Approach	Yield	7.15%
Other Invested Assets:
Available-for-sale embedded derivative (AnchorPath)	14		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit Linked Note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables, at fair value	4		Matrix pricing	Calculated prices	100.00%
Total	$	2,466
Liabilities
Future policy benefits	$	725	Discounted cash flow	Non-Performance risk spread	0.00% - 0.22% (0.18%)
				Risk margin to reflect uncertainty	0.35% - 0.71% (0.68%)
Derivatives:
FIA embedded derivatives included in contractholder funds	2,476		Discounted cash flow	Market value of option	0.00% - 31.06% (0.94%)
				SWAP rates	2.57% - 2.71% (2.63%)
				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.90%)
				Partial withdrawals	1.00% - 2.50% (2.00%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.11% - 16.61% (2.18%)
Preferred shares reimbursement feature embedded derivative	29		Black Derman Toy model	Credit Spread	5.14%
				Yield Volatility	20.00%
Total liabilities at fair value	$	3,230

Changes in unrealized losses (gains), net in the Company’s FIA embedded derivatives are included in "Benefits and other changes in policy reserves" in the unaudited Condensed Consolidated Statements of Operations.

-32

The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the threemonths endedMarch 31, 2019 and 2018, respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.

	Three months ended March 31, 2019
	Balance at Beginning of Period		Total Gains (Losses)					Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	444	$	—		$	5	$	114	$	—		$	(31	)	$	(24	)	$	508
Commercial mortgage-backed securities	67		—			2		—		—			(1		)	—			68
Corporates	1,231		(1		)	24		—		(21		)	(35		)	11			1,209
Hybrids	10		—			—		—		—			—			—			10
Municipals	37		—			1		—		—			—			—			38
Residential mortgage-backed securities	614		—			16		7		—			(18		)	—			619
Foreign Governments	16		—			—		—		—			—			—			16
Equity securities	4		—			1		—		—			—			15			20
Other invested assets:
Available-for-sale embedded derivative	14		2			—		—		—			—			—			16
Credit linked note	25		—			—		—		—			—			—			25
Funds withheld for reinsurance receivables at fair value	4		—			—		5		—			—			(2		)	7
Total assets at Level 3 fair value	$	2,466	$	1		$	49	$	126	$	(21	)	$	(85	)	$	—		$	2,536
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,476	$	244		$	—	$	—	$	—		$	—		$	—		$	2,720
Future policy benefits	725		29			—		—		—			43			—			797
Preferred shares reimbursement feature embedded derivative	29		(2		)	—		—		—			—			—			27
Total liabilities at Level 3 fair value	$	3,230	$	271		$	—	$	—	$	—		$	43		$	—		$	3,544

(a) The net transfers out of Level 3 during the three months ended March 31, 2019 were exclusively to Level 2.

-33

	Three months ended March 31, 2018
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales		Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	412	$	—		$	(2	)	$	28	$	—	$	(6	)	$	(131	)	$	301
Commercial mortgage-backed securities	49		—			(1		)	—		—		(6		)	—			42
Corporates	1,169		—			(20		)	100		—		(34		)	—			1,215
Hybrids	10		—			—			—		—		—			—			10
Municipals	38		—			(1		)	—		—		—			—			37
Residential mortgage-backed securities	66		—			—			—		—		(1		)	—			65
Foreign Governments	17		—			—			—		—		—			—			17
Equity securities	3		1			—			—		—		—			—			4
Other invested assets:
Available-for-sale embedded derivative	17		—			—			—		—		—			—			17
Funds withheld for reinsurance receivables, at fair value	4		—			—			2		—		—			—			6
Total assets at Level 3 fair value	$	1,785	$	1		$	(24	)	$	130	$	—	$	(47	)	$	(131	)	$	1,714
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,277	$	(98	)	$	—		$	—	$	—	$	—		$	—		$	2,179
Future policy benefits	728		(20		)	—			—		—		4			—			712
Preferred shares reimbursements feature embedded derivative	23		1			—			—		—		—			—			24
Total liabilities at Level 3 fair value	$	3,028	$	(117	)	$	—		$	—	$	—	$	4		$	—		$	2,915

(a) The net transfers out of Level 3 during the three months ended March 31, 2018 were exclusively to Level 2.

-34

Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value

The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments.

Mortgage Loans

The fair value of mortgage loans is established using a discounted cash flow method based on credit rating, maturity and future income. This yield-based approach is sourced from our third-party vendor. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt service coverage, loan-to-value, quality of tenancy, borrower, and payment record. In the event of an impairment, the carrying value is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price, or the fair value of the collateral if the loan is collateral-dependent. The inputs used to measure the fair value of our mortgage loans are classified as Level 3 within the fair value hierarchy.

Policy Loans (included within Other Invested Assets)

Fair values for policy loans are estimated from a discounted cash flow analysis, using interest rates currently being offered for loans with similar credit risk.  Loans with similar characteristics are aggregated for purposes of the calculations.

Investment Contracts

Investment contracts include deferred annuities, FIAs, indexed universal life policies ("IULs") and immediate annuities. The fair value of deferred annuity, FIA, and IUL contracts is based on their cash surrender value (i.e. the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of immediate annuities contracts is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. At March 31, 2019 and December 31, 2018, this resulted in lower fair value reserves relative to the carrying value. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value.

Debt

The fair value of debt is based on quoted market prices. The inputs used to measure the fair value of our outstanding debt are classified as Level 2 within the fair value hierarchy. Our revolving credit facility debt is classified as Level 3 within the fair value hierarchy, and the estimated fair value reflects the carrying value as the revolver has no maturity date.

-35

The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Condensed Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described.

	March 31, 2019
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	56	$	—	$	56	$	56
Commercial mortgage loans	—		—		485		485		479
Residential mortgage loans	—		—		199		199		195
Policy loans, included in other invested assets	—		—		12		12		23
Affiliated other invested assets	—		—		40		40		40
Funds withheld for reinsurance receivables, at fair value	—		—		5		5		5
Total	$	—	$	56	$	741	$	797	$	798
Liabilities
Investment contracts, included in contractholder funds	—		—		18,355		18,355		21,161
Debt	—		543		—		543		541
Total	$	—	$	543	$	18,355	$	18,898	$	21,702

	December 31, 2018
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	52	$	—	$	52	$	52
Commercial mortgage loans	—		—		483		483		482
Residential mortgage loans	—		—		187		187		185
Policy loans, included in other invested assets	—		—		11		11		22
Affiliated other invested assets	—		—		39		39		39
Funds withheld for reinsurance receivables, at fair value	—		—		8		8		8
Total	$	—	$	52	$	728	$	780	$	788
Liabilities
Investment contracts, included in contractholder funds	$	—	$	—	$	18,358	$	18,358	$	20,911
Debt	—		520		—		520		541
Total	$	—	$	520	$	18,358	$	18,878	$	21,452

The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments are measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices” to the Company's 2018 Form 10-K.

	Carrying Value After Measurement
	March 31, 2019		December 31, 2018
Equity securities	$	53	$	50
Limited partnership investment, included in other invested assets	595		510

For investments for which NAV is used as a practical expedient for fair value, the Company does not have any significant restrictions in their ability to liquidate their positions in these investments, other than obtaining

-36

general partner approval, nor does the Company believe it is probable a price less than NAV would be received in the event of a liquidation.

The Company reviews the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3, or between other levels, at the beginning fair value for the reporting period in which the changes occur. The transfers into and out of Level 3 were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value.

The Company’s assessment resulted in gross transfers into and gross transfers out of certain fair value levels by asset class for the threemonths endedMarch 31, 2019 and 2018, are as follows:

	Transfers Between Fair Value Levels
	Level 1				Level 2				Level 3
	In		Out		In		Out		In		Out
Three months ended March 31, 2019
Asset-backed securities	$	—	$	—	$	24	$	—	$	—	$	24
Corporates	—		—		—		11		11		—
Equity securities	5		17		2		5		15		—
Funds withheld for reinsurance receivables	—		—		2		—		—		2
Total transfers	$	5	$	17	$	28	$	16	$	26	$	26
Three months ended March 31, 2018
Asset-backed securities	$	—	$	—	$	131	$	—	$	—	$	131
Hybrids	15		—		—		15		—		—
Total transfers	$	15	$	—	$	131	$	15	$	—	$	131

-37

(7) Intangibles

A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows:

	VOBA			DAC			DSI			Total
Balance at December 31, 2018	$	866		$	344		$	149		$	1,359
Deferrals	—			91			35			126
Amortization	(31		)	(3		)	(2		)	(36		)
Interest	4			2			1			7
Unlocking	—			—			—			—
Adjustment for net unrealized investment (gains) losses	(35		)	—			—			(35		)
Balance at March 31, 2019	$	804		$	434		$	183		$	1,421

	VOBA			DAC			DSI			Total
Balance at December 31, 2017	$	821		$	22		$	10		$	853
Deferrals	—			59			26			85
Amortization	(30		)	(1		)	(1		)	(32		)
Interest	5			—			—			5
Unlocking	—			—			—			—
Adjustment for net unrealized investment (gains) losses	38			4			1			43
Balance at March 31, 2018	$	834		$	84		$	36		$	954

Amortization of VOBA, DAC, and DSI is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 0.05% to 4.01%. The adjustment for unrealized net investment losses (gains) represents the amount of VOBA, DAC, and DSI that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the unaudited Condensed Consolidated Statements of Operations. As of March 31, 2019 and 2018, the VOBA balances included cumulative adjustments for net unrealized investment (gains) losses of $40 and $22, respectively, the DAC balances included cumulative adjustments for net unrealized investment (gains) losses of $5 and $0, respectively, and the DSI balance included net unrealized investment (gains) losses of $2 and $2, respectively.

Estimated amortization expense for VOBA in future fiscal periods is as follows:

	Estimated Amortization Expense
Fiscal Year
2019	48
2020	83
2021	89
2022	84
2023	75
Thereafter	385

The Company had an unearned revenue liability balance of $(39) as of March 31, 2019, including deferrals of $(9), amortization of $2, unlocking of $0, and adjustment for net unrealized investment gains (losses) of $9.

-38

Definite and Indefinite Lived Intangible Assets

Amortizable intangible assets as of March 31, 2019 consist of the following:

	Cost		Accumulated amortization		Net carrying amount		Weighted average useful life (years)
Trade marks / trade names	$	16	$	2	$	14	10
State insurance licenses	6		N/A		6		Indefinite
Total					$	20

(8) Debt

The carrying amount of the Company's outstanding debt as of March 31, 2019 and December 31, 2018 is as follows:

	March 31, 2019		December 31, 2018
Debt	$	541	$	541

As of March 31, 2019 and December 31, 2018, the company had not drawn on the revolver, which would have carried interest rates equal to 5.25% and 5.27%, respectively, had we drawn on the revolver. As of March 31, 2019 and December 31, 2018, the amount available to be drawn on the revolver was $250.

The interest expense and amortization of debt issuance costs for the threemonths endedMarch 31, 2019 and 2018, respectively, were as follows:

	Three months ended
	March 31, 2019		March 31, 2018
	Interest Expense	Amortization	Interest Expense	Amortization
Debt	8	—	5	—
Revolving credit facility	—	—	1	—

-39

(9) Equity

Share Repurchases

On December 19, 2018, the Company's Board of Directors authorized a share repurchase program of up to $150 of the Company's outstanding common stock. This program will expire on December 15, 2020, and may be modified at any time. Under the share repurchase program, the Company may repurchase shares from time to time in open market transactions or through privately negotiated transactions in accordance with applicable federal securities laws. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934. The extent to which the Company repurchases its shares, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other considerations, as determined by the Company.

During the three months ended March 31, 2019, the Company repurchased 3,728 thousand shares for a total cost of $30. As of March 31, 2019, the Company had repurchased a total of 4,328 thousand shares for a total cost of $34.

Dividends

The Company declared the following cash dividend to its common shareholders during the threemonths endedMarch 31, 2019.

Date Declared	Date Paid	Date Shareholders of record	Shareholders of record (in thousands)	Cash Dividend declared (per share)	Total cash paid
February 27, 2019	April 1, 2019	March 18, 2019	221,661	$0.01	$2

On May 7, 2019, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend will be paid on June 10, 2019 to shareholders of record as of the close of business on May 28, 2019.

The Company did not declare a cash dividend to its common shareholders during the threemonths endedMarch 31, 2018.

The Company declared the following dividends to its preferred shareholders during the threemonths endedMarch 31, 2019:

Type of Preferred Share	Date Declared	Date Paid	Date Shareholders of record	Shares outstanding at date of record (in thousands)	Method of Payment	Total cash paid	Total shares paid in kind (in thousands)
Series A Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	298	Paid in kind	$—	6
Series B Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	108	Paid in kind	$—	2

The Company declared the following dividends to its preferred shareholders during the threemonths endedMarch 31, 2018:

Type of Preferred Share	Date Declared	Date Paid	Date Shareholders of record	Shares outstanding at date of record (in thousands)	Method of Payment	Total cash paid	Total shares paid in kind (in thousands)
Series A Preferred Shares	March 29, 2018	April 1, 2018	March 15, 2018	277	Paid in kind	$—	5
Series B Preferred Shares	March 29, 2018	April 1, 2018	March 15, 2018	101	Paid in kind	$—	1

-40

(10) Stock Compensation

On August 8, 2017, the Company adopted a stock-based incentive plan (the “FGL Incentive Plan”) that permits the granting of awards in the form of qualified stock options, non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, unrestricted stock, performance-based awards, dividend equivalents, cash awards and any combination of the foregoing. The Company’s Compensation Committee is authorized to grant up to 15,006 thousand equity awards under the Incentive Plan. At March 31, 2019, 5,588 thousand equity awards are available for future issuance.

FGL Incentive Plan

On February 26, 2019 FGL granted 1,699 thousand stock options to a certain officer of the Company. The following table summarizes the vesting conditions for these options:

Vesting mechanism	Vest Dates	Number of options subject to these vesting conditions
Service	Each March 15 from 2020 through 2023; subject to continued service	485
Service and return on equity performance	March 15 2020, 2021 and 2022 subject to continued service and targeted return on equity	607
Service and stock price performance	Each March 15 from 2019 through 2023; subject to continued service and target stock price goals being achieved	607

The total fair value of the options granted on February 26, 2019 was $3. The fair value of the awards is expensed over the service period, which generally corresponds to the vesting period.

At March 31, 2019, the intrinsic value of stock options outstanding or expected to vest was $76. At March 31, 2019, the weighted average remaining contractual term of stock options outstanding, exercisable and vested or expected to vest was 7 years, 6 years and 7 years, respectively. At March 31, 2019 there were 485 options that were exercisable.

A summary of the Company’s outstanding stock options as of March 31, 2019, and related activity during the threemonths endedMarch 31, 2019, is as follows (share amount in thousands):

Stock Option Awards	Options		Weighted Average Exercise Price
Stock options outstanding at December 31, 2018	13,007		$	9.68
Granted	1,699		10.00
Exercised	—		—
Forfeited or expired	(1,869	)	(10.00		)
Stock options outstanding at March 31, 2019	12,837		9.67
Exercisable at March 31, 2019	485		10.00
Vested or projected to vest at March 31, 2019	12,837		9.67

-41

To value the options granted with service and return on equity performance vesting conditions, we used a Black Scholes valuation model. To value the options granted with stock price market performance vesting conditions, we used a Monte Carlo simulation. The following inputs and assumptions were used in the determination of the grant date fair values of the February 26, 2019 grants for each.

	Black-Scholes Model		Monte Carlo Model
	Serviced based	ROE Performance based	Stock Price Performance based	Source of input/ assumption
Weighted average fair value per options granted	$1.68	$1.74	$1.26	N/A
Risk-free interest rate	2.48%	2.50%	2.54%	US Treasury Curve
Assumed dividend yield	0.49%	0.49%	0.49%	Internal projection
Expected option term	5.75 years	6.0 years	N/A	Internal model
Contractual term	N/A	N/A	7.0 years	N/A
Volatility	26.00%	26.00%	26.00%	Predecessor and peer group experience
Early exercise multiple	N/A	N/A	2.8	Hull White model
Cost of equity	N/A	N/A	10.50%	Capital asset pricing model - 20 year risk free rate

The Company granted 147 thousand restricted shares to directors in the threemonths endedMarch 31, 2019. These shares will vest on December 31, 2019. The total fair value of the restricted shares granted in the threemonths endedMarch 31, 2019 was $1.

A summary of the Company’s nonvested restricted shares outstanding as of March 31, 2019, and related activity during the threemonths ended, is as follows (share amount in thousands):

Restricted Stock Awards	Shares	Weighted Average Grant Date Fair Value
Restricted shares outstanding at December 31, 2018	—	$	—
Granted	147	6.82
Vested	—	—
Forfeited or expired	—	—
Vested or expected to vest at March 31, 2019	147	6.82

Management Incentive Plan

In the threemonths endedMarch 31, 2019, the Company granted 424 thousand phantom units to members of management under a management incentive plan (the "Management Incentive Plan"). The total fair value of the restricted shares granted in the threemonths endedMarch 31, 2019 was $4.

One half of the phantom units vest in three equal installments on each March 15^th from 2020 to 2022, subject to awardees continued service with the Company. The other half will begin vesting on March 15, 2021 and cliff vest on March 15, 2022 based on continued service and attainment of a performance metric: adjusted operating income return on equity.

At March 31, 2019, the liability for phantom units of $1 was based on the number of units granted, the elapsed portion of the service period and the fair value of the Company’s common stock on that date which was $7.87.

-42

A summary of the Management Incentive Plan nonvested phantom units outstanding as of March 31, 2019, and related activity during the threemonths ended, is as follows (share amount in thousands):

Phantom units	Shares		Weighted Average Grant Date Fair Value
Phantom units outstanding at December 31, 2018	356		$	8.95
Granted	424		8.64
Vested	(59	)	10.00
Forfeited or expired	(10	)	8.96
Phantom units outstanding at March 31, 2019	711		9.19

The Company recognized total stock compensation expense related to the FGL Incentive Plan and Management Incentive Plan is as follows:

	Three months ended
	March 31, 2019
FGL Incentive Plan
Stock options	$	1
Restricted shares	—
	1
Management Incentive Plan
Phantom units	—
	—
Total stock compensation expense	1
Related tax benefit	—
Net stock compensation expense	$	1

The stock compensation expense is included in "Acquisition and operating expenses, net of deferrals" in the unaudited Condensed Consolidated Statements of Operations.

Total compensation expense related to the FGL Incentive Plan and Management Incentive Plan not yet recognized as of March 31, 2019 and the weighted-average period over which this expense will be recognized are as follows:

	Unrecognized Compensation Expense		Weighted Average Recognition Period in Years
FGL Incentive Plan
Stock options	$	18	3
Restricted shares	1		1
	19
Management Incentive Plan
Phantom units	3		3
	3
Total unrecognized stock compensation expense	$	22	3

(11) Income Taxes

The Company is a Cayman-domiciled corporation that has operations in Bermuda and the U.S. Neither the Cayman Islands nor Bermuda impose a corporate income tax. The Company’s U.S. non-life subsidiaries file a consolidated non-life U.S. Federal income tax return. The Company’s US life insurance subsidiaries file a separate life consolidated U.S. Federal income tax return. The life insurance companies will be eligible to join in a consolidated filing with the U.S. non-life companies in 2022.

-43

The provision for income taxes represents federal income taxes. The effective tax rate for the threemonths endedMarch 31, 2019 was 5%. The effective tax rate for the threemonths endedMarch 31, 2018 was 38%. The effective tax rate on pre-tax income for the current threemonths endedMarch 31, 2019 differs from the U.S Federal statutory rate for 2019 of 21% primarily due to two factors. First, in 2018, a partial valuation allowance was established against the US Life companies' unrealized loss deferred tax assets because there were not sufficient sources of income to recover those assets. During the first quarter of 2019, the unrealized loss position recovered enough that the valuation allowance was no longer needed and it was released. Secondly, the Company had substantial income in jurisdictions that do not impose an income tax. The effective tax rate on pre-tax income for the threemonths endedMarch 31, 2018 differed from the U.S. Federal statutory rate for 2018 of 21% primarily due to the impact of an intended tax election. During the first quarter of 2018, there was uncertainty surrounding the impact of the Base-Erosion and Anti-Abuse Tax ("BEAT") that was enacted as part of the Tax Cut and Jobs Act and how it would impact the reinsurance agreement between F&G Life Re and FGL Insurance. As a result of the uncertainty, F&G Life Re intended to make an election under IRC Code Section 953(d) for the 2018 tax year to be treated as if it were a US taxpayer for the year.  As such, an opening balance sheet deferred tax liability was set up resulting in a discrete expense being recorded in the first quarter of 2018 that increased the first quarter effective rate. Based on clarifying guidance, the Company ultimately decided not to make that election in the fourth quarter of 2018.

As of March 31, 2019, the Company had a partial valuation allowance of $33 against its gross deferred tax assets of $316. The valuation allowance is an offset to the non-life companies deferred tax assets and FSRC deferred tax assets. The non-life insurance company subsidiaries have a history of losses and insufficient sources of future income that would allow for recognition of any of their deferred tax assets. FSRC is in a cumulative loss position and does not have a sufficient track record of earnings to recognize any portion of its deferred tax assets

The valuation allowance is reviewed quarterly and will be maintained until there is sufficient positive evidence to support a release. At each reporting date, management considers new evidence, both positive and negative, that could impact the future realization of deferred tax assets. Management will consider a release of the valuation allowance once there is sufficient positive evidence that it is more likely than not that the deferred tax assets will be realized. Any release of the valuation allowance will be recorded as a tax benefit increasing net income or other comprehensive income.

All other deferred tax assets are more likely than not to be realized based on expectations as to our future taxable income and considering all other available evidence, both positive and negative.

(12) Commitments and Contingencies

Commitments

The Company has unfunded investment commitments as of March 31, 2019 based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. A summary of unfunded commitments by invested asset class are included below:

	March 31, 2019
Asset Type
Other invested assets	$	1,093
Equity securities	21
Fixed maturity securities, available-for-sale	39
Other assets	5
Total	$	1,158

As of March 31, 2019, the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information.

-44

Lease Commitments

The Company leases office space under non-cancelable operating leases that expire in May 2021. Rent expense and minimum rental commitments under non-cancelable leases are immaterial.

Contingencies

Regulatory and Litigation Matters

The Company is involved in various pending or threatened legal proceedings, including purported class actions, arising in the ordinary course of business. In some instances, these proceedings include claims for unspecified or substantial punitive damages and similar types of relief in addition to amounts for alleged contractual liability or requests for equitable relief. In the opinion of the Company's management and in light of existing insurance and other potential indemnification, reinsurance and established accruals, such litigation is not expected to have a material adverse effect on the Company's financial position, although it is possible that the results of operations and cash flows could be materially affected by an unfavorable outcome in any one period.

The Company is assessed amounts by state guaranty funds to cover losses to policyholders of insolvent or rehabilitated insurance companies. Those mandatory assessments may be partially recovered through a reduction in future premium taxes in certain states. At March 31, 2019, the Company has accrued $2 for guaranty fund assessments that is expected to be offset by estimated future premium tax deductions of $2.

The Company has received inquiries from a number of state regulatory authorities regarding our use of the U.S. Social Security Administration’s Death Master File (“Death Master File”) and compliance with state claims practices regulations and unclaimed property or escheatment laws. We have established procedures to periodically compare our in-force life insurance and annuity policies against the Death Master File or similar databases; investigate any identified potential matches to confirm the death of the insured; and determine whether benefits are due and attempt to locate the beneficiaries of any benefits due or, if no beneficiary can be located, escheat the benefit to the state as unclaimed property. We believe we have established sufficient reserves with respect to these matters; however, it is possible that third parties could dispute these amounts and additional payments or additional unreported claims or liabilities could be identified which could be significant and could have a material adverse effect on our results of operations.

On June 30, 2017, a putative class action complaint was filed against FGL Insurance, FGL, and FS Holdco II Ltd in the United States District Court for the District of Maryland, captioned Brokerage Insurance Partners v. Fidelity & Guaranty Life Insurance Company, Fidelity & Guaranty Life, FS Holdco II Ltd, and John Doe, No. 17-cv-1815. The complaint alleges that FGL Insurance breached the terms of its agency agreement with Brokerage Insurance Partners (“BIP”) and other agents by changing certain compensation terms. The complaint asserts, among other causes of action, breach of contract, defamation, tortious interference with contract, negligent misrepresentation, and violation of the Racketeer Influenced and Corrupt Organizations Act (“RICO”).  The complaint seeks to certify a class composed of all persons who entered into an agreement with FGL Insurance to sell life insurance and who sold at least one life insurance policy between January 1, 2015 and January 1, 2017.  The complaint seeks unspecified compensatory, consequential, and punitive damages in an amount not presently determinable, among other forms of relief.

On September 1, 2017, FGL Insurance filed a counterclaim against BIP and John and Jane Does 1-10, asserting, among other causes of action, breach of contract, fraud, civil conspiracy and violations of RICO. On September 22, 2017, Plaintiff filed an Amended Complaint, and on October 16, 2017, FGL Insurance filed an Amended Counterclaim against BIP, Agent Does 1-10, and Other Person Does 1-10. The parties also filed cross-Motions to Dismiss in Part.

On August 17, 2018, the Court in the BIP Litigation denied all pending Motions to Dismiss filed by all parties without prejudice, pending a decision as to whether the BIP Litigation will be consolidated into related litigation, captioned Fidelity & Guaranty Life Insurance Company v. Network Partners, et al., Case No. 17-cv-1508. On August 31, 2018, FGL Insurance filed its Answer to BIP’s Amended Complaint. Also on that date, FGL Insurance filed its Answer to Amended Complaint, Affirmative Defenses, and Counterclaim, Filed Pursuant to Fed. R. Civ. P. 12(a)(4)(A). As of March 31, 2019, BIP has not filed any paper or pleading in response to the Court’s August 17, 2018 Order or to FGL Insurance’s filing. BIP's response date has been adjourned to May 15, 2019.

As of the date of this report, the Company does not have sufficient information to determine whether it has exposure to any losses that would be either probable or reasonably estimable. 

-45

(13) Reinsurance

The Company reinsures portions of its policy risks with other insurance companies. The use of indemnity reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding the Company's retention limit is reinsured. The Company primarily seeks reinsurance coverage in order to limit its exposure to mortality losses and enhance capital management. The Company follows reinsurance accounting when there is adequate risk transfer. Otherwise, the deposit method of accounting is followed. The Company also assumes policy risks from other insurance companies.

The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the threemonths endedMarch 31, 2019 and 2018 were as follows:

	Three months ended
	March 31, 2019				March 31, 2018
	Net Premiums Earned		Net Benefits Incurred		Net Premiums Earned		Net Benefits Incurred
Direct	57		372		60		41
Assumed	—		20		—		(21	)
Ceded	(41	)	(53	)	(42	)	(59	)
Net	16		339		18		(39	)

Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. The Company did not write off any significant reinsurance balances during the threemonths endedMarch 31, 2019 and 2018. The Company did not commute any ceded reinsurance treaties during the threemonths endedMarch 31, 2019 or 2018.

No policies issued by the Company have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance.

The Company has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues.

Effective January 1, 2017, FGL Insurance entered into an indemnity reinsurance agreement with Hannover Re, a third party reinsurer, to reinsure an inforce block of its FIA and fixed deferred annuity contracts with  GMWB and Guaranteed Minimum Death Benefit (“GMDB”) guarantees. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of the net retention of guarantee payments in excess of account value for GMWB and GMDB guarantees. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. Effective July 1, 2017, FGL Insurance extended this agreement to include new business issued during 2017. Effective January 1, 2018 FGL Insurance extended this agreement to include new business issued during 2018, and extended the recapture period from 8 to 12 years. Effective January 1, 2019, FGL Insurance extended this agreement to include new business issued during 2019. FGL Insurance incurred risk charge fees of $4 during the threemonths endedMarch 31, 2019, in relation to this reinsurance agreement.

Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $758 of certain MYGA and deferred annuity GAAP reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes a 40%, 45%, and 63% quota share percentage of these annuity plans for issue years 2013, 2001 through 2012, and 2000 and prior, respectively.

Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $4 billion of certain FIA statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes an 80% and 90% quota share percentage of these annuity plans for issue years 2013 through 2014, and 2007 and prior, respectively. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk.

-46

F&G Reinsurance Companies

FSRC, an affiliate of FGL Insurance, has entered into various reinsurance agreements on a funds withheld basis, meaning that funds are withheld by the ceding company from the coinsurance premium owed to FSRC as collateral for FSRC's payment obligations. Accordingly, the collateral assets remain under the ultimate ownership of the ceding company. FSRC manages the assets supporting the reserves assumed in accordance with the internal investment policy of the ceding companies and applicable law. At March 31, 2019, FSRC had $286 of funds withheld receivables and $270 of insurance reserves related to these reinsurance treaties.

F&G Re, an affiliate of FGL Insurance, has entered into two reinsurance agreements on a funds withheld basis with unaffiliated parties. At March 31, 2019, F&G Re had $551 of funds withheld receivables and $527 of insurance reserves related to these reinsurance treaties.

See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts in "Note 2. Significant Accounting Policies and Practices" within the Company's 2018 Form 10-K.

(14) Related Party Transactions

Affiliated Investments

The Company, and certain subsidiaries of the Company, entered into investment management agreements with Blackstone ISG-I Advisors LLC ("BISGA"), a wholly-owned subsidiary of The Blackstone Group LP ("Blackstone") on December 1, 2017. Pursuant to the terms of the investment management agreements, BISGA may delegate certain of its investment management services to sub-managers and any fees or other remuneration payable to such sub-managers is payable by the Company out of the assets managed by such sub-managers. BISGA has delegated certain investment management services to its affiliates, Blackstone Real Estate Special Situations Advisors L.L.C. (“BRESSA”) and GSO Capital Advisors II LLC (“GSO Capital Advisors II”), pursuant to sub-management agreements executed between BISGA and each of BRESSA and GSO Capital Advisors. As of March 31, 2019 and December 31, 2018, the Company has a net liability of $25 and $20, respectively, for the services consumed under the investment management agreements and related sub-management agreements, partially offset by fees received and expense reimbursements from BISGA.

During the threemonths endedMarch 31, 2019, the Company received expense reimbursements from BISGA for the services consumed under these agreements. Fees received for these types of services are $2 for the threemonths endedMarch 31, 2019.

The Company holds certain fixed income security interests, limited partnerships and bank loans issued by portfolio companies that are affiliates of Blackstone Tactical Opportunities, an affiliate of Blackstone Tactical Opportunities LR Associates-B (Cayman) Ltd (the “Blackstone Fixed Income Securities”) both on a direct and indirect basis.  Indirect investments include an investment made in an affiliates’ asset backed fund while direct investments are an investment in affiliates' equity or debt securities.  As of March 31, 2019 and December 31, 2018, the Company held $1,549 and $1,461 in affiliated investments, respectively, which includes foreign exchange unrealized loss of $(4) and $(2), respectively. As of March 31, 2019 and December 31, 2018, the Company had unfunded commitments relating to affiliated investments of $971 and $990, respectively.

The Company purchased $12 and $185 of residential loans from Finance of America Holdings LLC, a Blackstone affiliate, during the three months ended March 31, 2019 and on December 17, 2018, respectively. 

On December 1, 2017, the Company executed an agreement with Blackstone Tactical Opportunities Advisors LLC ("BTO Advisors") and Fidelity National Financial, Inc. ("FNF"), to provide the Company transactional and operational services and advice through December 31, 2018. The agreement was amended on November 2, 2018 to provide services through June 30, 2019. The Company will pay fees to BTO Advisors (or its designee(s)), and to FNF in consideration for such services in cash, ordinary shares or warrants exercisable for ordinary shares of the Company. As of March 31, 2019, no such services have been provided.

The Company paid-in-kind dividends on preferred shares held by GSO Capital Partners, an indirect wholly owned subsidiary of The Blackstone Group LP, of 6 thousand shares for the threemonths endedMarch 31, 2019.

The Company had no gross realized gains or realized impairment losses on related party investments during the threemonths endedMarch 31, 2019 and 2018.

-47

(15) Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands):

	Three months ended
	March 31, 2019		March 31, 2018
Net income (loss)	$	171	$	65
Less Preferred stock dividend	8		7
Net income (loss) available to common shares	163		58
Weighted-average common shares outstanding - basic	219,646		214,370
Dilutive effect of unvested restricted stock	36		—
Weighted-average shares outstanding - diluted	219,682		214,370
Net income (loss) per common share:
Basic	$	0.74	$	0.27
Diluted	$	0.74	$	0.27

The number of shares of common stock outstanding used in calculating the weighted average thereof reflects the actual number of FGL Holdings shares of common stock outstanding, excluding unvested restricted stock and shares held in treasury.

The calculation of diluted earnings per share for the threemonths endedMarch 31, 2019 excludes the incremental effect of 6 million weighted average common stock warrants outstanding due to their anti-dilutive effect. This calculation also excludes the potential dilutive effect of the 406 thousand preferred stock shares outstanding as of March 31, 2019 as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met. The calculation of diluted earnings per share for the threemonths endedMarch 31, 2019 excludes the incremental effect related to certain outstanding stock options due to their anti-dilutive effect. The number of weighted average equivalent shares excluded is 1,737 thousand shares for the threemonths endedMarch 31, 2019.

The calculation of diluted earnings per share for the threemonths endedMarch 31, 2018 excludes the potential dilutive effective of the 377 thousand preferred stock shares outstanding as of March 31, 2018 as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met.

(16) Insurance Subsidiary Financial Information and Regulatory Matters

The Company’s U.S. insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect DAC, DSI and VOBA, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items.

FSRC (Cayman), F&G Re (Bermuda), and F&G Life Re (Bermuda) file financial statements with their respective regulators that are based on U.S. GAAP.

FGL Insurance applies Iowa-prescribed accounting practices that permit Iowa-domiciled insurers to report equity call options used to economically hedge FIA index credits at amortized cost for statutory accounting purposes and to calculate FIA statutory reserves such that index credit returns will be included in the reserve only after crediting to the annuity contract. This resulted in a $48 decrease and $30 increase to statutory capital and surplus at March 31, 2019 and December 31, 2018, respectively.

-48

FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset which increased Raven Re’s statutory capital and surplus by $100 and $110 at March 31, 2019 and December 31, 2018, respectively.

Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance which increased Raven Re’s statutory capital and surplus by $1 and $0 at March 31, 2019 and December 31, 2018, respectively. Without such permitted statutory accounting practices Raven Re’s statutory capital and (deficit) surplus would be $(4) and $(16) as of March 31, 2019 and December 31, 2018, respectively, and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by NAIC 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent. FGL Insurance’s statutory carrying value of Raven Re at March 31, 2019 and December 31, 2018 was $97 and $94, respectively.

As of March 31, 2019, FGL NY Insurance did not follow any prescribed or permitted statutory accounting practices that differ from the NAIC's statutory accounting practices.

The prescribed and permitted statutory accounting practices have no impact on the Company’s unaudited condensed consolidated financial statements which are prepared in accordance with GAAP.

-49

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Special Note Regarding Forward-Looking Statements

This quarterly report includes forward-looking statements. Some of the forward-looking statements can be identified by the use of terms such as “believes”, “expects”, “may”, “will”, “should”, “could”, “seeks”, “intends”, “plans”, “estimates”, “anticipates” or other comparable terms. However, not all forward-looking statements contain these identifying words. These forward-looking statements include all matters that are not related to present facts or current conditions or that are not historical facts. They appear in a number of places throughout this report and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our consolidated results of operations, financial condition, liquidity, prospects and growth strategies and the industries in which we operate and including, without limitation, statements relating to our future performance.

Forward-looking statements are subject to known and unknown risks and uncertainties, many of which are beyond our control. We caution you that forward-looking statements are not guarantees of future performance and that our actual consolidated results of operations, financial condition and liquidity, and industry development may differ materially from those made in or suggested by the forward-looking statements contained in this report. In addition, even if our consolidated results of operations, financial condition and liquidity, and industry development are consistent with the forward-looking statements contained in this report, those results or developments may not be indicative of results or developments in subsequent periods. A number of important factors could cause actual results to differ materially from those contained in or implied by the forward-looking statements, including the risks and uncertainties discussed in “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2018 (“2018 Form 10-K”), which can be found at the U.S. Securities & Exchange Commission's ("SEC's") website, www.sec.gov. Factors that could cause actual results to differ from those reflected in forward-looking statements relating to our operations and business include:

• general economic conditions and other factors, including prevailing interest and unemployment rate levels and stock and credit market performance;

• concentration in certain states for distribution of our products;

• the impact of interest rate fluctuations;

• equity market volatility;

• credit market volatility or disruption;

• the impact of credit risk of our counterparties;

• volatility or decline in the market price of our ordinary shares could impair our ability to raise necessary capital;

• changes in our assumptions and estimates regarding the amortization of our deferred acquisition costs, deferred sales inducements and value of business acquired balances;

• changes in our methodologies, estimates and assumptions regarding our valuation of investments and the determinations of the amounts of allowances and impairments;

• changes in our valuation allowance against our deferred tax assets, and restrictions on our ability to fully utilize such assets;

• the accuracy of management’s reserving assumptions;

• regulatory changes or actions, including those relating to regulation of financial services affecting (among other things) underwriting of insurance products and regulation of the sale, underwriting and pricing of products and minimum capitalization and statutory reserve requirements for insurance companies, or the ability of our insurance subsidiaries to make cash distributions to us (including dividends or payments on surplus notes those subsidiaries issue to us);

• the ability to maintain or obtain approval of Iowa Insurance Division ("IID") and other regulatory authorities as required for our operations and those of our insurance subsidiaries

• the impact of the "fiduciary" rule proposals on the Company, its products, distribution and business model;

• changes in the federal income tax laws and regulations which may affect the relative income tax advantages of our products;

• changes in tax laws which affect us and/or our shareholders;

• potential adverse tax consequences if we are treated as a passive foreign investment company;

• the impact on our business of new accounting rules or changes to existing accounting rules;

• our potential need and our insurance subsidiaries’ potential need for additional capital to maintain our and their financial strength and credit ratings and meet other requirements and obligations;

• our ability to successfully acquire new companies or businesses and integrate such acquisitions into our existing framework;

-50

• the impact of potential litigation, including class action litigation;

• our ability to protect our intellectual property;

• our ability to maintain effective internal controls over financial reporting;

• the impact of restrictions in the Company's debt instruments on its ability to operate its business, finance its capital needs or pursue or expand its business strategies;

• our ability and our insurance subsidiaries’ ability to maintain or improve financial strength ratings;

• the continued availability of capital required for our insurance subsidiaries to grow;

• the performance of third parties including third party administrators, independent distributors, underwriters, actuarial consultants and other outsourcing relationships;

• the loss of key personnel;

• interruption or other operational failures in telecommunication, information technology and other operational systems, or a failure to maintain the security, integrity, confidentiality or privacy of sensitive data residing on such systems;

• our exposure to unidentified or unanticipated risk not adequately addressed by our risk management policies and procedures;

• the impact on our business of natural and man-made catastrophes, pandemics, and malicious and terrorist acts;

• our ability to compete in a highly competitive industry;

• our ability to attract and retain national marketing organizations and independent agents;

• our subsidiaries’ ability to pay dividends to us; and

• the other factors discussed in “Risk Factors” of our 2018 Form 10-K.

You should read this report completely and with the understanding that actual future results may be materially different from expectations. All forward-looking statements made in this report are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this report and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments. Comparisons of results for current and any prior periods are not intended to express any future trends, or indications of future performance, unless expressed as such, and should only be viewed as historical data.

Introduction

Management's discussion and analysis reviews our unaudited condensed consolidated financial position at March 31, 2019 (unaudited) and December 31, 2018, and the unaudited consolidated results of operations for the threemonths endedMarch 31, 2019 and 2018 and where appropriate, factors that may affect future financial performance. This analysis should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto appearing elsewhere in this Form 10-Q and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" of FGL Holdings (“FGL Holdings,” “we,” “us,” “our” and, collectively with its subsidiaries, the “Company”), which was included with our audited consolidated financial statements for the year ended December 31, 2018 included within the Company’s 2018 Form 10-K. Certain statements we make under this Item 2 constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. See "Special Note Regarding Forward-Looking Statements" in this report. You should consider our forward-looking statements in light of our unaudited condensed consolidated financial statements, related notes, and other financial information appearing elsewhere in this report, and our filings with the SEC, including our 2018 Form 10-K, which can be found at the SEC website, www.sec.gov.

Basis of Presentation

Our unaudited condensed consolidated financial statements included elsewhere in the Quarterly Report are presented: (i) as of March 31, 2019 and December 31, 2018; and (ii) for the threemonths endedMarch 31, 2019 and 2018. In this Management’s Discussion and Analysis of Financial Condition and Results of Operations, we discuss the threemonths endedMarch 31, 2019 results compared to the threemonths endedMarch 31, 2018 results. We believe this discussion provides helpful information with respect to performance of our business during those respective periods.

-51

Overview

We provide our principal life and annuity products through our insurance subsidiaries - Fidelity & Guaranty Life Insurance Company ("FGL Insurance") and Fidelity & Guaranty Life Insurance Company of New York ("FGL NY Insurance"). Our customers range across a variety of age groups and are concentrated in the middle-income market. Our fixed indexed annuities (“FIAs”) provide for pre-retirement wealth accumulation and post-retirement income management. Our universal life products ("IUL") provide wealth protection and transfer opportunities. Life and annuity products are primarily distributed through Independent Marketing Organizations ("IMOs") and independent insurance agents.

In setting the features and pricing of new FIA products relative to our targeted net margin, we take into account our expectations regarding (1) net investment spread, which is the difference between the net investment income we earn and the sum of the interest credited to policyholders and the cost of hedging our risk on the policies; (2) fees, including surrender charges and rider fees, partly offset by vesting bonuses that we pay our policyholders; and (3) a number of related expenses, including benefits and changes in reserves, acquisition costs, and general and administrative expenses.

F&G Reinsurance Ltd (“F&G Re”), an exempted company incorporated in Bermuda with limited liability, provides a platform for non-affiliated international business. Front Street Re Cayman Ltd (“FSRC”), an exempted company incorporated in the Cayman Islands with limited liability, has a license to carry on business as an Unrestricted Class “B” Insurer that permits FSRC to conduct offshore direct and reinsurance business. F&G Re and FSRC (together herein referred to as the “F&G Reinsurance Companies”), are indirect wholly owned subsidiaries of FGL Holdings and parties to reinsurance transactions.

Trends and Uncertainties

The following factors represent some of the key trends and uncertainties that have influenced the development of our business and our historical financial performance and that we believe will continue to influence our business and financial performance in the future.

Market Conditions

Market volatility has affected and may continue to affect our business and financial performance in varying ways. Volatility can pressure sales and reduce demand as consumers hesitate to make financial decisions. To enhance the attractiveness and profitability of our products and services, we continually monitor the behavior of our customers, as evidenced by annuitization rates and lapse rates, which vary in response to changes in market conditions.

Interest Rate Environment

Some of our products include guaranteed minimum crediting rates, most notably our fixed rate annuities. As of March 31, 2019, the Company's reserves, net of reinsurance, and average crediting rate on our fixed rate annuities were $4 billion and 3%, respectively. We are required to pay the guaranteed minimum crediting rates even if earnings on our investment portfolio decline, which would negatively impact earnings. In addition, we expect more policyholders to hold policies with comparatively high guaranteed rates for a longer period in a low interest rate environment. Conversely, a rise in average yield on our investment portfolio would increase earnings if the average interest rate we pay on our products does not rise correspondingly. Similarly, we expect that policyholders would be less likely to hold policies with existing guarantees as interest rates rise and the relative value of other new business offerings are increased, which would negatively impact our earnings and cash flows.

See “Item 3. Quantitative and Qualitative Disclosures about Market Risk” for a more detailed discussion of interest rate risk.

Aging of the U.S. Population

We believe that the aging of the U.S. population will increase the demand for our products. As the “baby boomer” generation prepares for retirement, we believe that demand for retirement savings, growth, and income products will grow. The impact of this growth may be offset to some extent by asset outflows as an increasing percentage of the population begins withdrawing assets to convert their savings into income.

-52

Industry Factors and Trends Affecting Our Results of Operations

Demographics and macroeconomic factors are increasing the demand for our FIA and IUL products, for which demand is large and growing. Over 10,000 people will turn 65 each day in the United States over the next 15 years, and according to the U.S. Census Bureau, the proportion of the U.S. population over the age of 65 is expected to grow from 15% in 2015 to 20% in 2030.

We operate in the sector of the insurance industry that focuses on the needs of middle-income Americans. The underserved middle-income market represents a major growth opportunity for the Company. As a tool for addressing the unmet need for retirement planning, we believe that many middle-income Americans have grown to appreciate the “sleep at night protection” that annuities such as our FIA products afford. Accordingly, the FIA market grew from nearly $12 billion of sales in 2002 to $68 billion of sales in 2018. Additionally, this market demand has positively impacted the IUL market as it has expanded from $100 million of annual premiums in 2002 to $2 billion of annual premiums in 2018.

Competition

Please refer to section titled "Competition" in Part I Item 1. Business in our 2018 Form 10-K for discussion on our competition.

Annuity and Life Sales

We regularly monitor and report the production volume metric titled “Sales”. Sales are not derived from any specific GAAP income statement accounts or line items and should not be viewed as a substitute for any financial measure determined in accordance with GAAP. Annuity and IUL sales are recorded as deposit liabilities (i.e. contractholder funds) within the Company's unaudited condensed consolidated financial statements in accordance with GAAP. Management believes that presentation of sales, as measured for management purposes, enhances the understanding of our business and helps depict longer term trends that may not be apparent in the results of operations due to the timing of sales and revenue recognition. Sales of annuities and IULs for the quarter ended March 31 were as follows:

	Annuity Sales				IUL Sales
(dollars in millions)	2019		2018		2019		2018
First Quarter	$	1,053	$	778	$	8	$	6

Key Components of Our Historical Results of Operations

Under U.S. GAAP, premium collections for fixed indexed annuities, fixed rate annuities, and immediate annuities without life contingency are reported in the financial statements as deposit liabilities (i.e., contractholder funds) instead of as sales or revenues. Similarly, cash payments to customers are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities are net investment income, surrender and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Components of expenses for products accounted for as deposit liabilities are interest-sensitive and index product benefits (primarily interest credited to account balances or the cost of providing index credits to the policyholder), amortization of deferred acquisition cost (“DAC”), deferred sales inducements (“DSI”), and value of business acquired (“VOBA”), other operating costs and expenses, and income taxes.

Through our insurance subsidiaries, we issue a broad portfolio of deferred annuities (fixed indexed and fixed rate annuities) and immediate annuities. A deferred annuity is a type of contract that accumulates value on a tax deferred basis and typically begins making specified periodic or lump sum payments a certain number of years after the contract has been issued. An immediate annuity is a type of contract that begins making specified payments within one annuity period (e.g., one month or one year) and typically makes payments of principal and interest earnings over a period of time.

The Company hedges certain portions of its exposure to product related equity market risk by entering into derivative transactions. We purchase derivatives consisting predominantly of call options and, to a lesser degree, futures contracts on the equity indices underlying the applicable policy. These derivatives are used to offset the statutory reserve impact of the index credits due to policyholders under the FIA contracts. The majority of all such call options are one-year options purchased to match the funding requirements underlying the FIA contracts. We attempt to manage the cost of these purchases through the terms of our FIA contracts, which permit us to change

-53

caps, spread, or participation rates, subject to certain guaranteed minimums that must be maintained. The call options and futures contracts are marked to fair value with the change in fair value included as a component of net investment gains (losses). The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instruments’ terms or upon early termination and the changes in fair value of open positions.

Earnings from products accounted for as deposit liabilities are primarily generated from the excess of net investment income earned over the sum of interest credited to policyholders and the cost of hedging our risk on FIA policies, known as the net investment spread. With respect to FIAs, the cost of hedging our risk includes the expenses incurred to fund the index credits. Proceeds received upon expiration or early termination of call options purchased to fund annual index credits are recorded as part of the change in fair value of derivatives, and are largely offset by an expense for index credits earned on annuity contractholder fund balances.

Our profitability depends in large part upon the amount of assets under management (“AUM”), the net investment spreads earned on our AUM, our ability to manage our operating expenses and the costs of acquiring new business (principally commissions to agents and bonuses credited to policyholders). As we grow AUM, earnings generally increase. AUM increases when cash inflows, which include sales, exceed cash outflows. Managing net investment spreads involves the ability to maximize returns on our AUM and minimize risks such as interest rate changes and defaults or impairment of investments. It also includes our ability to manage interest rates credited to policyholders and costs of the options and futures purchased to fund the annual index credits on the FIAs or IULs. We analyze returns on average assets under management ("AAUM") pre- and post-DAC, DSI and VOBA as well as pre- and post-tax to measure our profitability in terms of growth and improved earnings.

Non-GAAP Financial Measures

Management believes that certain non-GAAP financial measures may be useful in certain instances to provide additional meaningful comparisons between current results and results in prior operating periods. Our non-GAAP measures may not be comparable to similarly titled measures of other organizations because other organizations may not calculate such non-GAAP measures in the same manner as we do. Reconciliations of such measures to the most comparable GAAP measures are included herein.

Adjusted Operating Income ("AOI") is a non-GAAP economic measure we use to evaluate financial performance each period. AOI is calculated by adjusting net income (loss) to eliminate:

(i) the impact of net investment gains/losses, including other than temporary impairment ("OTTI") losses recognized in operations, but excluding gains and losses on derivatives hedging our indexed annuity policies,

(ii) the impacts related to changes in the fair values of FIA related derivatives and embedded derivatives, net of hedging cost, and the fair value accounting impacts of assumed reinsurance by our international subsidiaries,

(iii) the tax effect of affiliated reinsurance embedded derivative,

(iv) the effect of change in fair value of the reinsurance related embedded derivative,

(v) the effect of integration, merger related & other non-operating items,

(vi) impact of extinguishment of debt, and

(vii) net impact from Tax Cuts and Jobs Act.

Adjustments to AOI are net of the corresponding impact on amortization of intangibles, as appropriate. The income tax impact related to these adjustments is measured using an effective tax rate, as appropriate by tax jurisdiction. While these adjustments are an integral part of the overall performance of the Company, market conditions and/or the non-operating nature of these items can overshadow the underlying performance of the core business. Accordingly, Management considers this to be a useful measure internally and to investors and analysts in analyzing the trends of our operations.

Beginning with the quarter ended December 31, 2018, the Company updated its AOI definition to remove the incremental change due to the impact of the fair value accounting election for international subsidiaries. Management believes this revision will enhance the understanding of our business as the Company executes its growth strategy through international third party assumed business and is more relevant to investors as the impact of fair value accounting election can create an increases/decreases in the assumed liabilities that does not match

-54

the increase/decrease of the corresponding assets. This change will be applied on a prospective basis as the Company executes its growth strategy through international third party assumed reinsurance.

AOI should not be used as a substitute for net income. However, we believe the adjustments made to net income in order to derive AOI provide an understanding of our overall results of operations. For example, we could have strong operating results in a given period, yet report net income that is materially less, if during such period the fair value of our derivative assets hedging the FIA index credit obligations decreased due to general equity market conditions but the embedded derivative liability related to the index credit obligation did not decrease in the same proportion as the derivative assets because of non-equity market factors such as interest rate movements. Similarly, we could also have poor operating results in a given period yet show net income that is materially greater, if during such period the fair value of the derivative assets increases but the embedded derivative liability did not increase in the same proportion as the derivative assets. We hedge our FIA index credits with a combination of static and dynamic strategies, which can result in earnings volatility, the effects of which are generally likely to reverse over time. Our management and board of directors review AOI and net income as part of their examination of our overall financial results. However, these examples illustrate the significant impact derivative and embedded derivative movements can have on our net income. Accordingly, our management and board of directors perform a review and analysis of these items, as part of their review of our hedging results each period.

The adjustments to net income are net of intangibles amortization, as appropriate. Amounts attributable to the fair value accounting for derivatives hedging the FIA index credits and the related embedded derivative liability fluctuate from period to period based upon changes in the fair values of call options purchased to fund the annual index credits for FIAs, changes in the interest rates used to discount the embedded derivative liability, and the fair value assumptions reflected in the embedded derivative liability. The accounting standards for fair value measurement require the discount rates used in the calculation of the embedded derivative liability to be based on risk-free interest rates as of the reporting date. The impact of the change in fair values of FIA-related derivatives, embedded derivatives and hedging costs has been removed from net income in calculating AOI.

AAUM is a non-GAAP measure we use to assess the rate of return on assets available for reinvestment. AAUM is calculated as the sum of (i) total invested assets at amortized cost, excluding derivatives; (ii) related party loans and investments; (iii) accrued investment income; (iv) funds withheld at fair value; (v) the net payable/receivable for the purchase/sale of investments and (iv) cash and cash equivalents, excluding derivative collateral, at the beginning of the period and the end of each month in the period, divided by the total number of months in the period plus one. Management considers this to be a useful measure internally and to investors and analysts when assessing the rate of return on assets available for reinvestment.

Critical Accounting Policies and Estimates

The preparation of the Company’s unaudited condensed consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of certain assets, liabilities, revenues, expenses and related disclosures regarding contingencies and commitments. Actual results could differ from these estimates. During the threemonths endedMarch 31, 2019, the Company did not make any material changes in its critical accounting policies as previously disclosed in Management’s Discussion and Analysis in the Company’s 2018 Form 10-K as filed with the SEC.

Recent Accounting Pronouncements

Please refer to "Note 2. Significant Accounting Policies and Practices" to our unaudited condensed consolidated financial statements for disclosure of recent accounting pronouncements.

-55

Results of Operations

(All amounts presented in millions unless otherwise noted)

The following table sets forth the consolidated results of operations for the periods presented:

	Three months ended
	March 31, 2019			March 31, 2018			Increase/ (Decrease)
Revenues:
Premiums	$	16		$	18		$	(2	)
Net investment income	289			263			26
Net investment gains (losses)	240			(191		)	431
Insurance and investment product fees and other	55			48			7
Total revenues	600			138			462
Benefits and expenses:
Benefits and other changes in policy reserves	339			(39		)	378
Acquisition and operating expenses, net of deferrals	44			40			4
Amortization of intangibles	29			27			2
Total benefits and expenses	412			28			384
Operating income	188			110			78
Interest expense	(8		)	(6		)	(2		)
Income (loss) before income taxes	180			104			76
Income tax expense	(9		)	(39		)	30
Net income (loss)	$	171		$	65		$	106
Less Preferred stock dividend	8			7			1
Net income (loss) available to common shareholders	$	163		$	58		$	105

The following table summarizes sales by product type for the periods presented:

	Three months ended
	March 31, 2019		March 31, 2018		Increase/ (Decrease)
Fixed index annuities ("FIA")	$	668	$	436	$	232
Fixed rate annuities ("MYGA")	280		142		138
Institutional spread based	105		200		(95		)
Total annuity	$	1,053	$	778	$	275
Index universal life ("IUL")	$	8	$	6	$	2
Flow reinsurance	$	60	$	33	$	27

• FIA sales during the threemonths endedMarch 31, 2019 and 2018 reflect continued strong and productive collaboration with our distribution partners, primarily Independent Marketing Organizations, as well as the overall growth of the FIA market.

• MYGA volume and funding agreements are viewed as opportunistic and therefore these volumes will fluctuate from period to period.

• Institutional spread based products in threemonths endedMarch 31, 2019 and 2018 reflect funding agreements with Federal Home Loan Bank, under an investment strategy that is subject to fluctuation period to period.

• The increased flow reinsurance sales in the threemonths endedMarch 31, 2019 compared to 2018 reflect the on-boarding of a new flow reinsurance partner effective January 1, 2019.

-56

Revenues

Premiums

Premiums primarily reflect insurance premiums for traditional life insurance products which are recognized as revenue when due from the policyholder. FGL Insurance has ceded the majority of its traditional life business to unaffiliated third party reinsurers. While the base contract has been reinsured, we continue to retain the return of premium rider. The traditional life insurance premiums are primarily related to the return of premium riders on traditional life contracts. The following table summarizes the change in premiums for the periods presented:

	Three months ended
	March 31, 2019		March 31, 2018		Increase/ (Decrease)
Traditional life insurance	$	8	$	9	$	(1	)
Life-contingent immediate annuity	8		9		(1		)
Premiums	$	16	$	18	$	(2	)

• Premiums for the threemonths endedMarch 31, 2019 reflects a decrease compared to the three months ended March 31, 3018 primarily due to lower renewals and return of premium block maturing.

• Immediate annuity premiums for the threemonths endedMarch 31, 2019 reflects a decrease as a result of policyholder behavior for annuitizations.

Net investment income

Below is a summary of net investment income ("NII") for the periods presented:

	Three months ended
	March 31, 2019			March 31, 2018			Increase/ (Decrease)
Fixed maturity securities, available-for-sale	$	265		$	242		$	23
Equity securities	21			10			11
Mortgage loans	7			7			—
Invested cash and short-term investments	3			3			—
Funds withheld	8			7			1
Limited partnerships	8			3			5
Other investments	5			1			4
Gross investment income	317			273			44
Investment expense	(28		)	(10		)	(18		)
Net investment income	$	289		$	263		$	26

Our net investment spread and AAUM for the period is summarized as follows (annualized):

	Three months ended
	March 31, 2019			March 31, 2018			Increase/ (Decrease)
Yield on AAUM (at amortized cost)	4.47		%	4.21		%	0.26		%
Less: Interest credited and option cost	(2.30		)%	(2.33		)%	0.03		%
Net investment spread	2.17		%	1.88		%	0.29		%
AAUM	$	25,862		$	24,967		$	895

• The increases in AAUM from March 31, 2018 to March 31, 2019 were primarily influenced by $1.9 billion net new business asset flows, partially offset by a decrease as the result of FGL Insurance's reinsurance agreement with Kubera Insurance (SAC) Ltd. acting in respect of Annuity Reinsurance Cell A1 ("Kubera"), effective December 31, 2018.

-57

• The 10% increase in NII from the three months ended March 31, 2018 to the three months ended March 31, 2019 was primarily due to $19 from the portfolio reposition lift, $18 from invested asset growth, and $15 lower premium amortization, partially offset by $18 of higher planned investment expense and $8 decrease related to the Kubera reinsurance cession.

Net investment gains (losses)

Below is a summary of the major components included in net investment gains (losses) for the periods presented:

	Three months ended
	March 31, 2019			March 31, 2018			Increase/ (Decrease)
Net realized and unrealized gains (losses) on fixed maturity available-for-sale securities, equity securities and other invested assets	$	76		$	(46	)	$	122
Net realized and unrealized gains (losses) on certain derivatives instruments	164			(124		)	288
Change in fair value of reinsurance related embedded derivatives	(3		)	(21		)	18
Change in fair value of other derivatives and embedded derivatives	3			—			3
Net investment gains (losses)	$	240		$	(191	)	$	431

• For the three months ended March 31, 2019, net realized gains on available-for-sale securities, equity securities and other invested assets includes $77 in the unrealized gains (losses) on equity securities, reflecting market movements during the period, and $2 of credit related impairments.

• The fair value of reinsurance related embedded derivative is based on the change in fair value of the underlying assets held in the funds withheld ("FWH") portfolio.

• See the table below for primary drivers of gains (losses) on certain derivatives.

We utilize a combination of static (call options) and dynamic (long futures contracts) instruments in our hedging strategy. A substantial portion of the call options and futures contracts are based upon the S&P 500 Index with the remainder based upon other equity, bond and gold market indices.

The components of the realized and unrealized gains (losses) on certain derivative instruments hedging our indexed annuity and universal life products are summarized in the table below for the periods presented:

	Three months ended
	March 31, 2019			March 31, 2018			Increase/ (Decrease)
Call Options:
Gains (losses) on option expiration	$	(33	)	$	5		$	(38	)
Change in unrealized gains (losses)	188			(127		)	315
Futures contracts:
Gains (losses) on futures contracts expiration	7			6			1
Change in unrealized gains (losses)	2			(8		)	10
Total net change in fair value	$	164		$	(124	)	$	288
Annual Point-to-Point Change in S&P 500 Index during the period	9		%	12		%	(3		)%

• Realized gains and losses on certain derivative instruments are directly correlated to the performances of the indices upon which the call options and futures contracts are based and the value of the derivatives at the time of expiration compared to the value at the time of purchase. Additionally, the fair value of call options are primarily driven by the underlying performance of the S&P 500 Index during each respective year relative to the S&P Index on the policyholder buy dates.

• The net change in fair value of the call options and futures contracts for the threemonths endedMarch 31, 2019 and 2018 were primarily driven by movements in the S&P 500 Index relative to the policyholder buy dates.

-58

The average index credits to policyholders are as follows for the periods presented:

	Three months ended
	March 31, 2019		March 31, 2018		Increase/ (Decrease)
Average Crediting Rate	1	%	5	%	(4	)%
S&P 500 Index:
Point-to-point strategy	2	%	4	%	(2	)%
Monthly average strategy	1	%	4	%	(3	)%
Monthly point-to-point strategy	—	%	7	%	(7	)%
3 year high water mark	17	%	7	%	10	%

• Actual amounts credited to contractholder fund balances may differ from the index appreciation due to contractual features in the FIA contracts (caps, spreads and participation rates) which allow the Company to manage the cost of the options purchased to fund the annual index credits.

• The credits for the three months ended March 31, 2019 and 2018 were based on comparing the S&P 500 Index on each issue date in these respective periods to the same issue date in the respective prior year periods. Due to volatility in the S&P 500 Index, policyholders with anniversaries during the threemonths endedMarch 31, 2019, on average, received less credits.

Insurance and investment product fees and other

Insurance and investment product fees and other consists primarily of the cost of insurance on IUL policies, policy rider fees primarily on FIA policies and surrender charges assessed against policy withdrawals in excess of the policyholder's allowable penalty-free amounts (up to 10% of the prior year's value, subject to certain limitations). Below is a summary of the major components included in Insurance and investment product fees and other for the periods presented:

	Three months ended
	March 31, 2019		March 31, 2018		Increase/ (Decrease)
Surrender charges	$	8	$	14	$	(6	)
Cost of insurance fees and other income	47		34		13
Total insurance and investment product fees and other	$	55	$	48	$	7

• Cost of insurance fees and other income increased year over year primarily as the result of the amortization of the deferred reinsurance gain established at the inception of FGL Insurance's reinsurance agreement with Kubera, effective December 31, 2018.

• Surrender charges were higher in the prior year quarter, primarily due to more universal life policy surrenders.

-59

Benefits and expenses

Benefits and other changes in policy reserves

Below is a summary of the major components included in Benefits and other changes in policy reserves for the periods presented:

	Three months ended
	March 31, 2019			March 31, 2018			Increase/ (Decrease)
FIA embedded derivative impact	152			(263		)	415
Index credits, interest credited & bonuses	91			207			(116		)
Annuity payments	34			38			(4		)
Other policy benefits and reserve movements	(6		)	(7		)	1
Change in fair value of reserve liabilities held at fair value	68			(14		)	82
Total benefits and other changes in policy reserves	$	339		$	(39	)	$	378

• The FIA market value option liability increased quarter over quarter, driven by the changes in the equity markets and risk free rates during the current quarter, in conjunction with premium growth arising from the quarterly sales result. The movements in risk free rates increased the FAS 133 reserves by approximately $58 during the three months ended March 31, 2019 as compared to an decrease of $97 for the corresponding period in 2018, with the remaining impacts from changes in the equity markets. The change in equity market also impacts the market value of the derivative assets hedging our FIA policies. See table in the net investment gains/losses discussion above for summary and discussion of net unrealized gains (losses) on certain derivative instruments.

• The quarter over quarter decreases in index credits, interest credited & bonuses were primarily due to lower index credits on FIA policies, reflecting market movement during the respective periods.

• The change in the fair value of reserve liabilities held at fair value represents FSRC's and F&G Re's third-party business.

Acquisition and operating expenses, net of deferrals

Below is a summary of acquisition and operating expenses, net of deferrals for the periods presented:

	Three months ended
	March 31, 2019			March 31, 2018			Increase/ (Decrease)
General expenses	$	31		$	35		$	(4	)
Acquisition expenses	103			54			49
Deferred acquisition costs	(90		)	(49		)	(41		)
Total acquisition and operating expenses, net of deferrals	$	44		$	40		$	4

• The increase in acquisition and operating expenses, net of deferrals, during the quarter ended March 31, 2019 compared to the prior year quarter ended March 31, 2018 reflects higher commissions net of deferrals driven by higher sales, partially offset by a decrease in general expenses related to the mark-to-market movement in the preferred equity remarketing reimbursement embedded derivative liability.

Amortization of intangibles

Below is a summary of the major components included in amortization of intangibles for the periods presented:

	Three months ended
	March 31, 2019			March 31, 2018			Increase/ (Decrease)
Amortization	$	36		$	32		$	4
Interest	(7		)	(5		)	(2		)
Unlocking	—			—			—
Total amortization of intangibles	$	29		$	27		$	2

-60

• Amortization of intangibles is based on historical, current and future expected gross margins (pre-tax operating income before amortization). The quarter over quarter increase in total net amortization was primarily due to higher actual gross profits ("AGPs"). AGPs were driven primarily by higher net investment gains, partially offset by higher change in reserves in the threemonths endedMarch 31, 2019 compared to the threemonths endedMarch 31, 2018.

Other items affecting net income

Interest expense

Below is a summary of the interest expense on our debt and revolving credit facility and amortization of debt issuance costs for the periods presented:

	Three months ended
	March 31, 2019		March 31, 2018		Increase/ (Decrease)
Debt	$	8	$	5	$	3
Revolving credit facility	—		1		(1		)
Total interest expense	$	8	$	6	$	2

• The threemonths endedMarch 31, 2019 reflects increased debt interest expense incurred on the $550 5.50% Senior Notes as compared to the historical $300 6.375% Senior Notes.

Income tax expense

Below is a summary of the major components included in income tax expense for the periods presented:

	Three months ended
	March 31, 2019			March 31, 2018			Increase/ (Decrease)
Income before taxes	$	180		$	104		$	76
Income tax before valuation allowance	30			34			(4		)
Change in valuation allowance	(21		)	5			(26		)
Income tax	$	9		$	39		$	(30	)
Effective rate	5		%	38		%	(33		)%

• Income tax expense for the three months ended March 31, 2019 was $9, net of a valuation allowance release of $21, compared to income tax expense of $39 for the three months ended March 31, 2018, inclusive of a valuation allowance expense of $5. The decrease in income tax expense of $30 quarter over quarter was primarily due to the valuation allowance release on the partial recovery of the unrealized loss position for the US life companies, as well as higher international income in zero tax jurisdictions for the three months ended March 31, 2019. For the three months ended March 31, 2018 there was a $15 expense related to F&G Life Re. For further details, refer to "Note 11. Income Taxes".

-61

AOI

The table below shows the adjustments made to reconcile net income to our AOI for the periods presented:

	Three months ended
	March 31, 2019			March 31, 2018			Increase/ (Decrease)
Net income (loss)	$	171		$	65		$	106
Adjustments to arrive at AOI:
Effect of investment losses (gains), net of offsets (a)	(70		)	39			(109		)
Impacts related to changes in the fair values of FIA related derivatives and embedded derivatives, net of hedging cost, and the fair value accounting impacts of assumed reinsurance by our international subsidiaries (a) (b)	(17		)	(63		)	46
Effect of change in fair value of reinsurance related embedded derivative, net of offsets (a)	19			—			19
Effects of integration, merger related & other non-operating items	(3		)	8			(11		)
Tax effect of affiliated reinsurance embedded derivative	—			15			(15		)
Tax impact of adjusting items	(10		)	4			(14		)
AOI	$	90		$	68		$	22

(a) Amounts are net of offsets related to value of business acquired ("VOBA"), deferred acquisition cost ("DAC"), deferred sale inducement ("DSI"), unearned revenue ("UREV") amortization and cost of reinsurance intangible, as applicable.

(b) The updated definition removes the fair value impacts of assumed reinsurance by our international subsidiaries for periods after September 30, 2018.

• AOI increased $22 from $68 in the three months ended March 31, 2018 to $90 for the three months ended March 31, 2019. The current quarter results included $14 net favorable actual to expected mortality within the single premium immediate annuity ("SPIA") product line, and $5 bond prepay income and other, partially offset by $2 project costs. Comparatively, the three months ended March 31, 2018 AOI included $8 net favorable actual to expected mortality within the SPIA product line and other annuity reserve movements.

-62

Investment Portfolio

(All dollar amounts presented in millions unless otherwise noted)

The types of assets in which we may invest are influenced by various state laws, which prescribe qualified investment assets applicable to insurance companies. Within the parameters of these laws, we invest in assets giving consideration to four primary investment objectives: (i) maintain robust absolute returns; (ii) provide reliable yield and investment income; (iii) preserve capital and (iv) provide liquidity to meet policyholder and other corporate obligations.

Our investment portfolio is designed to contribute stable earnings and balance risk across diverse asset classes and is primarily invested in high quality fixed income securities.

As of March 31, 2019 and December 31, 2018, the fair value of our investment portfolio was approximately $25 billion and $24 billion, respectively, and was divided among the following asset class and sectors:

	March 31, 2019				December 31, 2018
	Fair Value		Percent		Fair Value		Percent
Fixed maturity securities, available for sale:
United States Government full faith and credit	$	56	—	%	$	119	—	%
United States Government sponsored entities	104		—	%	106		—	%
United States municipalities, states and territories	1,217		5	%	1,187		5	%
Foreign Governments	138		1	%	121		1	%
Corporate securities:
Finance, insurance and real estate	4,003		16	%	4,113		17	%
Manufacturing, construction and mining	619		3	%	574		2	%
Utilities, energy and related sectors	2,322		9	%	2,281		10	%
Wholesale/retail trade	1,431		6	%	1,376		6	%
Services, media and other	2,215		9	%	2,037		9	%
Hybrid securities	961		4	%	901		4	%
Non-agency residential mortgage-backed securities	918		4	%	925		4	%
Commercial mortgage-backed securities	2,647		11	%	2,537		10	%
Asset-backed securities	4,974		20	%	4,832		20	%
Total fixed maturity available for sale securities	21,605		88	%	21,109		88	%
Equity securities (a)	1,171		5	%	1,382		6	%
Commercial mortgage loans	485		2	%	483		2	%
Residential mortgage loans	199		1	%	187		1	%
Other (primarily derivatives and limited partnerships)	1,049		4	%	748		3	%
Short term investments	—		—	%	—		—	%
Total investments	$	24,509	100	%	$	23,909	100	%

(a) Includes investment grade non-redeemable preferred stocks ($1,001 and $1,208, respectively).

Insurance statutes regulate the type of investments that our life insurance subsidiaries are permitted to make and limit the amount of funds that may be used for any one type of investment. In light of these statutes and regulations, and our business and investment strategy, we generally seek to invest in (i) corporate securities rated investment grade by established nationally recognized statistical rating organizations (each, an “NRSRO”), (ii) U.S. Government and government-sponsored agency securities, or (iii) securities of comparable investment quality, if not rated.

-63

As of March 31, 2019 and December 31, 2018, our fixed maturity available-for-sale ("AFS") securities portfolio was approximately $22 billion and $21 billion, respectively. The following table summarizes the credit quality, by Nationally Recognized Statistical Ratings Organization ("NRSRO") rating, of our fixed income portfolio:

	March 31, 2019				December 31, 2018
Rating	Fair Value		Percent		Fair Value		Percent
AAA	$	741	3	%	$	627	3	%
AA	1,476		7	%	1,415		7	%
A	5,599		26	%	5,354		25	%
BBB	8,242		38	%	8,328		39	%
Not rated (c)	3,733		17	%	3,612		17	%
Total investment grade	19,791		91	%	19,336		91	%
BB (a)	1,311		6	%	1,307		6	%
B and below (b)	384		2	%	351		2	%
Not rated (c)	119		1	%	115		1	%
Total below investment grade	1,814		9	%	1,773		9	%
Total	$	21,605	100	%	$	21,109	100	%

(a) Includes $16 and $17 at March 31, 2019 and December 31, 2018, respectively, of non-agency residential mortgage-backed securities ("RMBS") that carry a National Association of Insurance Commissioners ("NAIC") 1 designation.

(b) Includes $166 and $175 at March 31, 2019 and December 31, 2018, respectively, of non-agency RMBS that carry a NAIC 1 designation.

(c) Securities denoted as not-rated by an NRSRO were classified as investment or non-investment grade according to the securities' respective NAIC designation.

The NAIC’s Securities Valuation Office ("SVO") is responsible for the day-to-day credit quality assessment and valuation of securities owned by state regulated insurance companies. Insurance companies report ownership of securities to the SVO when such securities are eligible for regulatory filings. The SVO conducts credit analysis on these securities for the purpose of assigning an NAIC designation or unit price. Typically, if a security has been rated by an NRSRO, the SVO utilizes that rating and assigns an NAIC designation based upon the following system:

NAIC Designation	NRSRO Equivalent Rating
1	AAA/AA/A
2	BBB
3	BB
4	B
5	CCC and lower
6	In or near default

The NAIC has adopted revised designation methodologies for non-agency RMBS, including RMBS backed by subprime mortgage loans and for commercial mortgage-backed securities ("CMBS"). The NAIC’s objective with the revised designation methodologies for these structured securities was to increase accuracy in assessing expected losses and to use the improved assessment to determine a more appropriate capital requirement for such structured securities. The NAIC designations for structured securities, including subprime and Alternative A-paper ("Alt-A") RMBS, are based upon a comparison of the bond’s amortized cost to the NAIC’s loss expectation for each security. Securities where modeling does not generate an expected loss in all scenarios are given the highest designation of NAIC 1. A large percentage of our RMBS securities carry a NAIC 1 designation while the NRSRO rating indicates below investment grade. The revised methodologies reduce regulatory reliance on rating agencies and allow for greater regulatory input into the assumptions used to estimate expected losses from such structured securities. In the tables below, we present the rating of structured securities based on ratings from the revised NAIC rating methodologies described above (which in some cases do not correspond to rating agency designations). All NAIC designations (e.g., NAIC 1-6) are based on the revised NAIC methodologies.

-64

The tables below present our fixed maturity securities by NAIC designation as of March 31, 2019 and December 31, 2018:

	March 31, 2019
NAIC Designation	Amortized Cost		Fair Value		Percent of Total Fair Value
1	$	11,302	$	11,297	52	%
2	9,240		8,998		42	%
3	1,066		1,017		5	%
4	191		183		1	%
5	73		72		—	%
6	36		38		—	%
Total	$	21,908	$	21,605	100	%
	December 31, 2018
NAIC Designation	Amortized Cost		Fair Value		Percent of Total Fair Value
1	$	11,245	$	10,928	52	%
2	9,677		9,003		43	%
3	1,064		967		4	%
4	155		139		1	%
5	71		65		—	%
6	7		7		—	%
Total	$	22,219	$	21,109	100	%

-65

Investment Industry Concentration

The tables below present the top ten industry categories of our fixed maturity and equity securities and FHLB common stock, including the fair value and percent of total fixed maturity and equity securities and FHLB common stock fair value as of March 31, 2019 and December 31, 2018:

	March 31, 2019
Top 10 Industry Concentration	Fair Value		Percent of Total Fair Value
ABS collateralized loan obligation ("CLO")	$	3,418	15	%
Banking	2,348		10	%
Whole loan collateralized mortgage obligation ("CMO")	2,332		10	%
ABS Other	1,553		7	%
Life insurance	1,407		6	%
Municipal	1,216		5	%
Electric	952		4	%
CMBS	870		4	%
Pipelines	820		4	%
Technology	571		3	%
Total	$	15,487	68	%

	December 31, 2018
Top 10 Industry Concentration	Fair Value		Percent of Total Fair Value
ABS collateralized loan obligation ("CLO")	$	3,283	15	%
Banking	2,491		11	%
Whole loan collateralized mortgage obligation ("CMO")	2,234		10	%
ABS Other	1,545		7	%
Life insurance	1,376		6	%
Municipal	1,187		5	%
Electric	939		4	%
CMBS	874		4	%
Pipelines	812		4	%
Property and casualty insurance	542		2	%
Total	$	15,283	68	%

-66

The amortized cost and fair value of fixed maturity AFS securities by contractual maturities as of March 31, 2019 and December 31, 2018, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations.

	March 31, 2019				December 31, 2018
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Corporate, Non-structured Hybrids, Municipal and Government securities:
Due in one year or less	$	160	$	160	$	191	$	191
Due after one year through five years	758		749		817		794
Due after five years through ten years	2,080		2,059		2,219		2,137
Due after ten years	10,281		9,994		10,443		9,587
Subtotal	$	13,279	$	12,962	$	13,670	$	12,709
Other securities which provide for periodic payments:
Asset-backed securities	$	5,033	$	4,974	$	4,954	$	4,832
Commercial-mortgage-backed securities	2,596		2,647		2,568		2,537
Residential mortgage-backed securities	1,000		1,022		1,027		1,031
Subtotal	$	8,629	$	8,643	$	8,549	$	8,400
Total fixed maturity available-for-sale securities	$	21,908	$	21,605	$	22,219	$	21,109

Non-Agency RMBS Exposure

Our investment in non-agency RMBS securities is predicated on the conservative and adequate cushion between purchase price and NAIC 1 rating, general lack of sensitivity to interest rates, positive convexity to prepayment rates and correlation between the price of the securities and the unfolding recovery of the housing market.

The fair value of our investments in subprime and Alt-A RMBS securities was $100 and $161 as of March 31, 2019, respectively, and $104 and $163 as of December 31, 2018, respectively.

-67

The following tables summarize our exposure to subprime and Alt-A RMBS by credit quality using NAIC designations, NRSRO ratings and vintage year as of March 31, 2019 and December 31, 2018:

	March 31, 2019				December 31, 2018
NAIC Designation:	Fair Value		Percent of Total		Fair Value		Percent of Total
1	$	237	91	%	$	245	92	%
2	12		5	%	18		7	%
3	9		3	%	—		—	%
4	2		1	%	4		1	%
5	1		—	%	—		—	%
6	—		—	%	—		—	%
Total	$	261	100	%	$	267	100	%
NRSRO:
AAA	$	1	—	%	$	1	—	%
AA	10		4	%	11		4	%
A	24		9	%	25		9	%
BBB	8		3	%	8		3	%
Not rated - Above investment grade (a)	47		18	%	46		17	%
BB and below	171		66	%	176		66	%
Total	$	261	100	%	$	267	100	%
Vintage:
2017	$	12	5	%	$	12	4	%
2016	15		6	%	15		6	%
2007	50		19	%	51		19	%
2006	62		24	%	63		24	%
2005 and prior	122		46	%	126		47	%
Total	$	261	100	%	$	267	100	%

(a) Securities denoted as not-rated by an NRSRO were classified as investment or non-investment grade according to the securities' respective NAIC designation.

ABS Exposure

As of March 31, 2019 and December 31, 2018, our ABS exposure was largely composed of CLOs, which comprised 69% and 68%, respectively, of all ABS holdings. These exposures are generally senior tranches of CLOs which have leveraged loans as their underlying collateral. The remainder of our ABS exposure was largely diversified by underlying collateral and issuer type, including automobile and home equity receivables.

As of March 31, 2019, the non-CLO exposure represents 31% of total ABS assets, or 6% of total invested assets and the CLO and non-CLO positions were trading at a net unrealized gain (loss) position of $(73) and $14, respectively. As of December 31, 2018, the non-CLO exposure represented 32% of total ABS assets, or 6% of total invested assets and the CLO and non-CLO positions were trading at a net unrealized gain (loss) position of $(128) and $6, respectively. The following table summarize our ABS exposure.

	March 31, 2019				December 31, 2018
Asset Class	Fair Value		Percent		Fair Value		Percent
ABS CLO	$	3,418	69	%	$	3,283	68	%
ABS auto	—		—	%	1		—	%
ABS credit card	3		—	%	3		—	%
ABS other	1,553		31	%	1,545		32	%
Total ABS	$	4,974	100	%	$	4,832	100	%

-68

Commercial Mortgage Loans

We rate all CMLs to quantify the level of risk. We place those loans with higher risk on a watch list and closely monitor them for collateral deficiency or other credit events that may lead to a potential loss of principal and/or interest. If we determine the value of any CML to be impaired (i.e., when it is probable that we will be unable to collect on amounts due according to the contractual terms of the loan agreement), the carrying value of the CML is reduced to either the present value of expected cash flows from the loan, discounted at the loan’s effective interest rate, or fair value of the collateral. For those mortgage loans that are determined to require foreclosure, the carrying value is reduced to the fair value of the underlying collateral, net of estimated costs to obtain and sell at the point of foreclosure. The carrying value of the impaired loans is reduced by establishing a specific write-down recorded in "Net realized capital gains (losses)" in the unaudited Condensed Consolidated Statements of Operations.

Loan-to-value (“LTV”) and debt service coverage (“DSC”) ratios are utilized as part of the review process described above. As of March 31, 2019, our mortgage loans on real estate portfolio had a weighted average DSC ratio of 2.3 times, and a weighted average LTV ratio of 46%. See "Note 4. Investments" to our unaudited condensed consolidated financial statements for additional information regarding our LTV and DSC ratios.

-69

Unrealized Losses

The amortized cost and fair value of the fixed maturity securities and the equity securities that were in an unrealized loss position as of March 31, 2019 and December 31, 2018 were as follows:

	March 31, 2019
	Number of securities		Amortized Cost		Unrealized Losses			Fair Value
Fixed maturity securities, available for sale:
United States Government full faith and credit	$	7	$	50	$	—		$	50
United States Government sponsored agencies	64		84		—			84
United States municipalities, states and territories	49		537		(10		)	527
Foreign Governments	8		83		(2		)	81
Corporate securities:
Finance, insurance and real estate	252		3,125		(107		)	3,018
Manufacturing, construction and mining	76		543		(28		)	515
Utilities, energy and related sectors	172		1,716		(71		)	1,645
Wholesale/retail trade	181		1,281		(91		)	1,190
Services, media and other	192		1,602		(59		)	1,543
Hybrid securities	47		709		(33		)	676
Non-agency residential mortgage backed securities	93		200		(5		)	195
Commercial mortgage backed securities	67		502		(9		)	493
Asset backed securities	424		3,664		(82		)	3,582
Total fixed maturity available for sale securities	1,632		14,096		(497		)	13,599
Equity securities	80		1,141		(58		)	1,083
Total investments	$	1,712	$	15,237	$	(555	)	$	14,682

	December 31, 2018
	Number of securities		Amortized Cost		Unrealized Losses			Fair Value
Fixed maturity securities, available for sale:
United States Government full faith and credit	$	15	$	120	$	(1	)	$	119
United States Government sponsored agencies	72		88		(2		)	86
United States municipalities, states and territories	103		1,054		(32		)	1,022
Foreign Governments	16		123		(8		)	115
Corporate securities:
Finance, insurance and real estate	300		3,721		(230		)	3,491
Manufacturing, construction and mining	86		613		(57		)	556
Utilities, energy and related sectors	237		2,347		(222		)	2,125
Wholesale/retail trade	211		1,469		(144		)	1,325
Services, media and other	266		2,179		(195		)	1,984
Hybrid securities	67		956		(91		)	865
Non-agency residential mortgage backed securities	110		249		(6		)	243
Commercial mortgage backed securities	205		1,768		(40		)	1,728
Asset backed securities	419		3,704		(137		)	3,567
Total fixed maturity available for sale securities	2,107		18,391		(1,165		)	17,226
Equity securities	95		1,523		(145		)	1,378
Total investments	$	2,202	$	19,914	$	(1,310	)	$	18,604

The gross unrealized loss position on the available-for-sale fixed and equity portfolio was $555 and $1,310 as of March 31, 2019 and December 31, 2018, respectively. Most components of the portfolio exhibited price appreciation as interest rates and credit spreads tightened during the period. The total book value of all securities in an unrealized loss position was $15,237 and $19,914 as of March 31, 2019 and December 31, 2018, respectively. The total book value of all securities in an unrealized loss position decreased 23% from December 31, 2018 to March 31, 2019. The average market value/book value of corporate bonds in an unrealized loss position was 96%

-70

and 92% as of March 31, 2019 and December 31, 2018, respectively. In aggregate, corporate bonds represented 64% and 65% of the total unrealized loss position as of March 31, 2019 and December 31, 2018, respectively.

Our municipal bond exposure is a combination of general obligation bonds (fair value of $227 and an amortized cost of $226 as of March 31, 2019) and special revenue bonds (fair value of $990 and amortized cost of $985 as of March 31, 2019).

Across all municipal bonds, the largest issuer represented 10% of the category, less than 1% of the entire portfolio and is rated NAIC 1. Our focus within municipal bonds is on NAIC 1 rated instruments, and 92% of our municipal bond exposure is rated NAIC 1.

The amortized cost and fair value of fixed maturity securities and equity securities (excluding U.S. Government and U.S. Government-sponsored agency securities) in an unrealized loss position greater than 20% and the number of months in an unrealized loss position with fixed maturity investment grade securities (NRSRO rating of BBB/Baa or higher) as of March 31, 2019 and December 31, 2018, were as follows:

	March 31, 2019
	Number of securities	Amortized Cost		Fair Value		Gross Unrealized Losses
Investment grade:
Less than six months	1	$	5	$	4	$	(1	)
Six months or more and less than twelve months	1	3		2		(1		)
Twelve months or greater	3	35		27		(8		)
Total investment grade	5	43		33		(10		)
Below investment grade:
Less than six months	2	1		1		—
Six months or more and less than twelve months	1	—		—		—
Twelve months or greater	3	8		6		(2		)
Total below investment grade	6	9		7		(2		)
Total	11	$	52	$	40	$	(12	)

	December 31, 2018
	Number of securities	Amortized Cost		Fair Value		Gross Unrealized Losses
Investment grade:
Less than six months	3	$	23	$	18	$	(5	)
Six months or more and less than twelve months	10	72		55		(17		)
Twelve months or greater	4	25		19		(6		)
Total investment grade	17	120		92		(28		)
Below investment grade:
Less than six months	3	11		9		(2		)
Six months or more and less than twelve months	9	31		22		(9		)
Twelve months or greater	5	12		9		(3		)
Total below investment grade	17	54		40		(14		)
Total	34	$	174	$	132	$	(42	)

-71

OTTI and Watch List

At March 31, 2019 and December 31, 2018, our watch list included 11 and 34 securities, respectively, in an unrealized loss position with an amortized cost of $52 and $174, unrealized losses of $12 and $42, and a fair value of $40 and $132, respectively. As part of the cash flow testing analysis, we evaluated each of these securities to assess the following:

•whether the issuer is currently meeting its financial obligations

•its ability to continue to meet these obligations

•its existing cash available

•its access to additional available capital

•any expense management actions the issuer has taken; and

•whether the issuer has the ability and willingness to sell non-core assets to generate liquidity

Based on our analysis, these securities demonstrated that the March 31, 2019 and December 31, 2018 carrying values were fully recoverable.

There were 3 and 4 structured securities with a fair value of $6 and $6 on the watch list to which we had potential credit exposure as of March 31, 2019 and December 31, 2018, respectively. Our analysis of these structured securities, which included cash flow testing results, demonstrated the March 31, 2019 and December 31, 2018 values were fully recoverable.

Exposure to Sovereign Debt

Our investment portfolio had no direct exposure to European sovereign debt as of March 31, 2019 and December 31, 2018.

As of March 31, 2019 and December 31, 2018 the Company also had no material exposure risk related to financial investments in Puerto Rico.

Net Investment Income and Net Investment Gains (Losses)

For discussion regarding our net investment income and net investment gains (losses) refer to "Note 4. Investments" to our unaudited condensed consolidated financial statements.

Available-For-Sale Securities

For additional information regarding our AFS securities, including the amortized cost, gross unrealized gains (losses), and fair value as well as the amortized cost and fair value of fixed maturity AFS securities by contractual maturities, as of March 31, 2019, refer to "Note 4. Investments", to our unaudited condensed consolidated financial statements.

Concentrations of Financial Instruments

For detail regarding our concentration of financial instruments refer to "Note 3. Significant Risks and Uncertainties" to our unaudited condensed consolidated financial statements.

Derivatives

We are exposed to credit loss in the event of nonperformance by our counterparties on call options. We attempt to reduce this credit risk by purchasing such options from large, well-established financial institutions.

We also hold cash and cash equivalents received from counterparties for call option collateral, as well as U.S. Government securities pledged as call option collateral, if our counterparty’s net exposures exceed pre-determined thresholds.

The Company is required to pay counterparties the effective federal funds rate each day for cash collateral posted to FGL for daily mark to market margin changes. The Company reduces the negative interest cost associated with cash collateral posted from counterparties under various ISDA agreements by reinvesting derivative cash collateral. This program permits collateral cash received to be invested in short term Treasury securities and commercial paper rated A1/P1 which are included in "Cash and cash equivalents" in the accompanying unaudited Condensed Consolidated Balance Sheets.

See "Note 5. Derivative Financial Instruments" to our unaudited condensed consolidated financial statements for additional information regarding our derivatives and our exposure to credit loss on call options.

-72

Liquidity and Capital Resources

Liquidity and Cash Flow

Liquidity refers to the ability of an enterprise to generate adequate amounts of cash from its normal operations to meet cash requirements with a prudent margin of safety. Our principal sources of cash flow from operating activities are insurance premiums, and fees and investment income, however, sources of cash flows from investing activities also result from maturities and sales of invested assets. Our operating activities provided (used) cash of $96 in the threemonths endedMarch 31, 2019 and $(35) in the threemonths endedMarch 31, 2018, respectively. When considering our liquidity and cash flow, it is important to distinguish between the needs of our insurance subsidiaries and the needs of the holding company, FGL Holdings. As a holding company with no operations of its own, FGL Holdings derives its cash primarily from its insurance subsidiaries and CF Bermuda Holdings Limited, a Bermuda exempted limited liability company and a wholly owned direct subsidiary of the Company ("CF Bermuda"), a downstream holding company that provides additional sources of liquidity.  Dividends from our insurance subsidiaries flow through CF Bermuda to FGL Holdings.

The sources of liquidity of the holding company are principally comprised of dividends from subsidiaries, bank lines of credit (at FGLH level) and the ability to raise long-term public financing under an SEC-filed registration statement or private placement offering. These sources of liquidity and cash flow support the general corporate needs of the holding company, interest and debt service, funding acquisitions and investment in core businesses.

Our cash flows associated with collateral received from and posted with counterparties change as the market value of the underlying derivative contract changes. As the value of a derivative asset declines (or increases), the collateral required to be posted by our counterparties would also decline (or increase). Likewise, when the value of a derivative liability declines (or increases), the collateral we are required to post to our counterparties would also decline (or increase).

Discussion of Consolidated Cash Flows

Presented below is a table that summarizes the cash provided or used in our activities and the amount of the respective increases or decreases in cash provided or used from those activities for the threemonths endedMarch 31, 2019 and 2018:

(dollars in millions)	Three months ended
	March 31, 2019		March 31, 2018
Cash provided by (used in):
Operating activities	$	96	$	(35	)
Investing activities	404		(377		)
Financing activities	286		354
Net increase (decrease) in cash and cash equivalents	$	786	$	(58	)

Operating Activities

Cash provided by (used in) operating activities totaled $96 and $(35) for the threemonths endedMarch 31, 2019 and 2018, respectively, which were principally due to a $286 increase in cash and short-term collateral from derivative counterparties, partially offset by a $41 increase in deferred acquisition costs and deferred sales inducements, and a $29 decrease in income tax refunds received.

Investing Activities

Cash provided by (used in) investing activities was $404 and $(377) for the threemonths endedMarch 31, 2019 and 2018, respectively, due to the purchases of fixed maturity securities and other investments, and the cash proceeds from sales, maturities and repayments.

-73

Financing Activities

Cash provided by financing activities was $286 and $354 for the Company in the threemonths endedMarch 31, 2019 and 2018, respectively, which were primarily related to the issuance of investment contracts and pending new production, including annuity and universal life insurance contracts, net of redemptions and benefit payments.

On April 20, 2018, the FGLH completed a debt offering of $550 aggregate principal amount of 5.50% senior notes due 2025 (the “5.50% Senior Notes”). Please refer to the Company's 2018 Form 10-K for further discussion.

The Indenture contains covenants that restrict the CF Bermuda’s and its restricted subsidiaries’ ability to, among other things, pay dividends on or make other distributions in respect of equity interests or make other restricted payments, make certain investments, incur or guarantee additional indebtedness, create liens on certain assets to secure debt, sell certain assets, consummate certain mergers or consolidations or sell all or substantially all assets, or enter into transactions with affiliates.

Off-Balance Sheet Arrangements

Throughout our history, we have entered into indemnifications in the ordinary course of business with our customers, suppliers, service providers, business partners and in certain instances, when we sold businesses. Additionally, we have indemnified our directors and officers who are, or were, serving at our request in such capacities. Although the specific terms or number of such arrangements is not precisely known due to the extensive history of our past operations, costs incurred to settle claims related to these indemnifications have not been material to our financial statements. We have no reason to believe that future costs to settle claims related to our former operations will have a material impact on our financial position, results of operations or cash flows.

On November 30, 2017, FGLH and CF Bermuda, together as borrowers and each as a borrower, entered into the Credit Agreement with certain financial institutions party thereto, as lenders, and Royal Bank of Canada, as administrative agent and letter of credit issuer, which provides for a $250 senior unsecured revolving credit facility with a maturity of three years. As of March 31, 2019, the total drawn on the revolver was $0. Please refer to the Company's 2018 Form 10-K for further discussion.

The Company has unfunded investment commitments as of March 31, 2019 based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. Please refer to "Note 4. Investments" and "Note 12. Commitments and Contingencies" to our unaudited condensed consolidated financial statements for additional details on unfunded investment commitments.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market Risk Factors

Market risk is the risk of the loss of fair value resulting from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates, commodity prices and equity prices. Market risk is directly influenced by the volatility and liquidity in the markets in which the related underlying financial instruments are traded. We have significant holdings in financial instruments and are naturally exposed to a variety of market risks. We are primarily exposed to interest rate risk, credit risk and equity price risk and have some exposure to counterparty risk, which affect the fair value of financial instruments subject to market risk.

Enterprise Risk Management

For information about our enterprise risk management see "Part II - Item 7A. Quantitative and Qualitative Disclosures about Market Risk" included in our 2018 Form 10-K.

Interest Rate Risk

Interest rate risk is our primary market risk exposure. We define interest rate risk as the risk of an economic loss due to adverse changes in interest rates. This risk arises from our holdings in interest sensitive assets and liabilities, primarily as a result of investing life insurance premiums and fixed annuity deposits received in interest-sensitive assets and carrying these funds as interest-sensitive liabilities. Substantial and sustained increases or decreases in market interest rates can affect the profitability of the insurance products and the fair value of our investments, as the majority of our insurance liabilities are backed by fixed maturity securities.

-74

The profitability of most of our products depends on the spreads between interest yield on investments and rates credited on insurance liabilities. We have the ability to adjust the rates credited, primarily caps and credit rates, on the majority of the annuity liabilities at least annually, subject to minimum guaranteed values. In addition, the majority of the annuity products have surrender and withdrawal penalty provisions designed to encourage persistency and to help ensure targeted spreads are earned. However, competitive factors, including the impact of the level of surrenders and withdrawals, may limit our ability to adjust or maintain crediting rates at the levels necessary to avoid a narrowing of spreads under certain market conditions.

In order to meet our policy and contractual obligations, we must earn a sufficient return on our invested assets. Significant changes in interest rates exposes us to the risk of not earning the anticipated spreads between the interest rate earned on our investments and the credited interest rates paid on outstanding policies and contracts. Both rising and declining interest rates can negatively affect interest earnings, spread income and the attractiveness of certain of our products.

During periods of increasing interest rates, we may offer higher crediting rates on interest-sensitive products, such as IUL insurance and fixed annuities, and we may increase crediting rates on in-force products to keep these products competitive. A rise in interest rates, in the absence of other countervailing changes, will result in a decline in the market value of our investment portfolio.

As part of our asset liability management (“ALM”) program, we have made a significant effort to identify the assets appropriate to different product lines and ensure investing strategies match the profile of these liabilities. Our ALM strategy is designed to align the expected cash flows from the investment portfolio with the expected liability cash flows. As such, a major component of our effort to manage interest rate risk has been to structure the investment portfolio with cash flow characteristics that are consistent with the cash flow characteristics of the insurance liabilities. We use actuarial models to simulate the cash flows expected from the existing business under various interest rate scenarios. These simulations enable us to measure the potential gain or loss in the fair value of interest rate-sensitive financial instruments, to evaluate the adequacy of expected cash flows from assets to meet the expected cash requirements of the liabilities and to determine if it is necessary to lengthen or shorten the average life and duration of our investment portfolio. Duration measures the price sensitivity of a security to a small change in interest rates. When the durations of assets and liabilities are similar, exposure to interest rate risk is minimized because a change in the value of assets could be expected to be largely offset by a change in the value of liabilities.

The duration of the investment portfolio, excluding cash and cash equivalents, derivatives, policy loans, and common stocks as of March 31, 2019, is summarized as follows:

(Dollars in millions)
Duration	Amortized Cost		% of Total
0-4	$	8,975	37	%
5-9	7,074		29	%
10-14	6,693		27	%
15-19	1,801		7	%
20-25	32		—	%
Total	$	24,575	100	%

Credit Risk and Counterparty Risk

We are exposed to the risk that a counterparty will default on its contractual obligation resulting in financial loss. The major source of credit risk arises predominantly in our insurance operations’ portfolios of debt and similar securities. The fair value of our fixed maturity portfolio totaled $22 billion and $21 billion at March 31, 2019 and December 31, 2018, respectively. Our credit risk materializes primarily as impairment losses. We are exposed to occasional cyclical economic downturns, during which impairment losses may be significantly higher than the long-term historical average. This is offset by years where we expect the actual impairment losses to be substantially lower than the long-term average. Credit risk in the portfolio can also materialize as increased capital requirements as assets migrate into lower credit qualities over time. The effect of rating migration on our capital requirements is also dependent on the economic cycle and increased asset impairment levels may go hand in hand with increased asset related capital requirements.

-75

We attempt to manage the risk of default and rating migration by applying disciplined credit evaluation and underwriting standards and limiting allocations to lower quality, higher risk investments. In addition, we diversify our exposure by issuer and country, using rating based issuer and country limits. We also set investment constraints that limit our exposure by industry segment. To limit the impact that credit risk can have on earnings and capital adequacy levels, we have portfolio-level credit risk constraints in place. Limit compliance is monitored on a monthly or, in some cases, daily basis.

In connection with the use of call options, we are exposed to counterparty credit risk-the risk that a counterparty fails to perform under the terms of the derivative contract. We have adopted a policy of only dealing with credit worthy counterparties and obtaining sufficient collateral where appropriate, as a means of attempting to mitigate the financial loss from defaults. The exposure and credit rating of the counterparties are continuously monitored and the aggregate value of transactions concluded is spread amongst different approved counterparties to limit the concentration in one counterparty. Our policy allows for the purchase of derivative instruments from counterparties and/or clearinghouses that meet the required qualifications under the Iowa Code. The Company reviews the ratings of all the counterparties periodically. Collateral support documents are negotiated to further reduce the exposure when deemed necessary. See "Note 5. Derivative Financial Instruments" to our unaudited condensed consolidated financial statements for additional information regarding our exposure to credit loss.

-76

We also have credit risk related to the ability of reinsurance counterparties to honor their obligations to pay the contract amounts under various agreements. To minimize the risk of credit loss on such contracts, we diversify our exposures among many reinsurers and limit the amount of exposure to each based on credit rating. We also generally limit our selection of counterparties with which we do new transactions to those with an “A-” credit rating or above and/or that are appropriately collateralized and provide credit for reinsurance. When exceptions are made to that principle, we ensure that we obtain collateral to mitigate our risk of loss. The following table presents our reinsurance recoverable balances and financial strength ratings for our five largest reinsurance recoverable balances as of March 31, 2019:

(Dollars in millions)		Financial Strength Rating
Parent Company/Principal Reinsurers	Reinsurance Recoverable	AM Best	S&P	Moody's
Wilton Re	$1,541	A+	Not Rated	Not Rated
Kubera Insurance (SAC) Ltd	681	Not Rated	Not Rated	Not Rated
Security Life of Denver	162	A	A	A2
Hannover Re	130	A+	AA-	Not Rated
London Life	108	A+	Not Rated	Not Rated

In the normal course of business, certain reinsurance recoverables are subject to reviews by the reinsurers. We are not aware of any material disputes arising from these reviews or other communications with the counterparties as of March 31, 2019 that would require an allowance for uncollectible amounts.

Through FSRC and F&G Re, the Company is exposed to insurance counterparty risk, which is the potential for FSRC and F&G Re to incur losses due to a client or partner becoming distressed or insolvent. This includes run-on-the-bank risk and collection risk. The run-on-the-bank risk is that a client’s in force block incurs substantial surrenders and/or lapses due to credit impairment, reputation damage or other market changes affecting the counterparty. Substantially higher than expected surrenders and/or lapses could result in inadequate in force business to recover cash paid out for acquisition costs. The collection risk for clients includes their inability to satisfy a reinsurance agreement because the right of offset is disallowed by the receivership court; the reinsurance contract is rejected by the receiver, resulting in a premature termination of the contract; and/or the security supporting the transaction becomes unavailable to FSRC and F&G Re.

FSRC and F&G Re are exposed to the risk that a counterparty will default on its contractual obligation resulting in financial loss. The major source of credit risk arises predominantly in FSRC and F&G Re’s funds withheld receivables portfolio that consists primarily of debt and equity securities. FSRC and F&G Re’s credit risk materializes primarily as impairment losses. FSRC and F&G Re are exposed to occasional cyclical economic downturns, during which impairment losses may be significantly higher than the long-term historical average. This is offset by years where FSRC and F&G Re expect the actual impairment losses to be substantially lower than the long-term average. Credit risk in the portfolio can also materialize as increased capital requirements as assets migrate into lower credit qualities over time. The effect of rating migration on FSRC and F&G Re’s capital requirements is also dependent on the economic cycle and increased asset impairment levels may go hand in hand with increased asset related capital requirements.

FSRC and F&G Re assume reinsurance business from counterparties that seek to manage the risk of default and rating migration by applying credit evaluation and underwriting standards and limiting allocations to lower quality, higher risk investments. In addition, FSRC and F&G Re’s reinsurance counterparties diversify their exposure by issuer and country, using rating based issuer and country limits and set investment constraints that limit its exposure by industry segment. To limit the impact that credit risk can have on earnings and capital adequacy levels, FSRC and F&G Re have portfolio-level credit risk constraints in place. Limit compliance is monitored on a daily or, in some cases, monthly basis.

-77

Equity Price Risk

We are primarily exposed to equity price risk through certain insurance products, specifically those products with GMWB. We offer a variety of FIA contracts with crediting strategies linked to the performance of indices such as the S&P 500 Index, Dow Jones Industrials or the NASDAQ 100 Index. The estimated cost of providing GMWB incorporates various assumptions about the overall performance of equity markets over certain time periods. Periods of significant and sustained downturns in equity markets, increased equity volatility or reduced interest rates could result in an increase in the valuation of the future policy benefit or policyholder account balance liabilities associated with such products, resulting in a reduction in our net income (loss). The rate of amortization of intangibles related to FIA products and the cost of providing GMWB could also increase if equity market performance is worse than assumed.

To economically hedge the equity returns on these products, we purchase derivatives to hedge the FIA equity exposure. The primary way we hedge FIA equity exposure is to purchase over the counter equity index call options from broker-dealer derivative counterparties approved by the Company. The second way to hedge FIA equity exposure is by purchasing exchange traded equity index futures contracts. Our hedging strategy enables us to reduce our overall hedging costs and achieve a high correlation of returns on the call options purchased relative to the index credits earned by the FIA contractholders. The majority of the call options are one-year options purchased to match the funding requirements underlying the FIA contracts. These hedge programs are limited to the current policy term of the FIA contracts, based on current participation rates. Future returns, which may be reflected in FIA contracts’ credited rates beyond the current policy term, are not hedged. We attempt to manage the costs of these purchases through the terms of our FIA contracts, which permit us to change caps or participation rates, subject to certain guaranteed minimums that must be maintained.

The derivatives are used to fund the FIA contract index credits and the cost of the call options purchased is treated as a component of spread earnings. While the FIA hedging program does not explicitly hedge GAAP income volatility, the FIA hedging program tends to mitigate a significant portion of the GAAP reserve changes associated with movements in the equity market and risk-free rates. This is due to the fact that a key component in the calculation of GAAP reserves is the market valuation of the current term embedded derivative. Due to the alignment of the embedded derivative reserve component with hedging of this same embedded derivative, there should be a reasonable match between changes in this component of the reserve and changes in the assets backing this component of the reserve. However, there may be an interim mismatch due to the fact that the hedges which are put in place are only intended to cover exposures expected to remain until the end of an indexing term. To the extent index credits earned by the contractholder exceed the proceeds from option expirations and futures income, we incur a raw hedging loss.

See "Note 5. Derivative Financial Instruments" to our unaudited condensed consolidated financial statements for additional details on the derivatives portfolio.

Fair value changes associated with these investments are intended to, but do not always, substantially offset the increase or decrease in the amounts added to policyholder account balances for index products. When index credits to policyholders exceed option proceeds received at expiration related to such credits, any shortfall is funded by our net investment spread earnings and futures income. For the threemonths endedMarch 31, 2019 and 2018, the annual index credits to policyholders on their anniversaries were $24 and $131, respectively. Proceeds received at expiration on options related to such credits were $23 and $131, respectively.

Other market exposures are hedged periodically depending on market conditions and our risk tolerance. The FIA hedging strategy economically hedges the equity returns and exposes us to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. We use a variety of techniques including direct estimation of market sensitivities and value-at-risk to monitor this risk daily. We intend to continue to adjust the hedging strategy as market conditions and risk tolerance change.

-78

Sensitivity Analysis

The analysis below is hypothetical and should not be considered a projection of future risks. Earnings projections are before tax and non-controlling interest.

Interest Rate Risk

We assess interest rate exposures for financial assets, liabilities and derivatives using hypothetical test scenarios that assume either increasing or decreasing 100 basis point parallel shifts in the yield curve, reflecting changes in either credit spreads or risk-free rates.

If interest rates were to increase 100 basis points from levels at March 31, 2019, the estimated fair value of our fixed maturity securities would decrease by approximately $1,530. The impact on shareholders’ equity of such decrease, net of income taxes (assumes a 21% tax rate) and intangibles adjustments, and the change in reinsurance related derivative would be a decrease of $1,161 in AOCI and a decrease of $1,121 in total shareholders’ equity. If interest rates were to decrease by 100 basis points from levels at March 31, 2019, the estimated impact on the FIA embedded derivative liability of such a decrease would be an increase of $250.

The actuarial models used to estimate the impact of a one percentage point change in market interest rates incorporate numerous assumptions, require significant estimates and assume an immediate and parallel change in interest rates without any management of the investment portfolio in reaction to such change. Consequently, potential changes in value of financial instruments indicated by these simulations will likely be different from the actual changes experienced under given interest rate scenarios, and the differences may be material. Because we actively manage our investments and liabilities, the net exposure to interest rates can vary over time. However, any such decreases in the fair value of fixed maturity securities, unless related to credit concerns of the issuer requiring recognition of an OTTI, would generally be realized only if we were required to sell such securities at losses prior to their maturity to meet liquidity needs. Our liquidity needs are managed using the surrender and withdrawal provisions of the annuity contracts and through other means.

Equity Price Risk

Assuming all other factors are constant, we estimate that a decline in equity market prices of 10% would cause the market value of our equity investments to decrease by approximately $117, our call option investments to decrease by approximately $14 based on equity positions and our FIA embedded derivative liability to decrease by approximately $24 as of March 31, 2019. Due to the adoption of ASU 2016-01 in 2018, the 10% decline in market value of our equity securities would affect current earnings. These scenarios consider only the direct effect on fair value of declines in equity market levels and not changes in asset-based fees recognized as revenue, or changes in our estimates of total gross profits used as a basis for amortizing intangibles.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

An evaluation was performed under the supervision and participation of the Company’s management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this report. Based on that evaluation, the Company’s management, including the CEO and CFO, concluded that, as of March 31, 2019, the Company’s disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to the Company’s management, including the Company’s CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Notwithstanding the foregoing, there can be no assurance that the Company’s disclosure controls and procedures will detect or uncover all failures of persons within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.

-79

Changes in Internal Control Over Financial Reporting

An evaluation was performed under the supervision of the Company's management, including the CEO and CFO, of whether any change in the Company's internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) occurred during the quarter ended March 31, 2019.

Based on that evaluation, the Company’s management, including the CEO and CFO, concluded that no change in the Company’s internal control over financial reporting occurred during the quarter ended March 31, 2019 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Limitations on the Effectiveness of Controls

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

-80

PART II

Item 1. Legal Proceedings

See "Note 12. Commitments and Contingencies" to our unaudited condensed consolidated financial statements.

Item 1A. Risk Factors

A detailed discussion of our risk factors can be found in our 2018 Form 10-K, which can be found at the SEC's website www.sec.gov. There have been no material changes to the risk factors disclosed in our 2018 Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities by the Issuer

On December 19, 2018, the Company's board of directors authorized a share repurchase program of up to $150 of the Company's outstanding common stock. This program will expire on December 15, 2020, and may be modified at any time. Under the share repurchase program, the Company may repurchase shares from time to time in open market transactions or through privately negotiated transactions in accordance with applicable federal securities laws. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934. The extent to which the Company repurchases its shares, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other considerations, as determined by the Company.

The following table provides information about our repurchases of our ordinary shares during the quarter ended March 31, 2019.

	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Approximate dollar value of shares that may yet be purchased under the plans or programs (1)
Period
January 1 to January 31, 2019	1,051,347	$	7.12	1,051,347	$	138
February 1 to February 28, 2019	20,652	7.49		20,652	138
March 1 to March 31, 2019	2,656,078	8.35		2,656,078	116
Total	3,728,077	$	8.00	3,728,077	$	116

(1) On December 19, 2018, the Company’s board of directors authorized and the Company announced a share repurchase program of up to $150 million of the Company’s outstanding ordinary shares. This repurchase program will expire on December 15, 2020, and may be modified at any time.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

-81

Item 6. Exhibits

The following is a list of exhibits filed or incorporated by reference as a part of this Quarterly Report on Form 10-Q.

Exhibit No.	Description of Exhibits
10.1	Employment Agreement between FGL Holdings and Christopher Blunt, dated as of February 6, 2019 (incorporated by reference to Exhibit 10.69 to the Registrant’s Annual Report on Form 10-K filed with the SEC on March 1, 2019 (File No. 001-37779)).
31.1 *	Certification of Chief Executive Officer, pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 *	Certification of Chief Financial Officer, pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 *	Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 *	Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS *	XBRL Instance Document.
101.SCH *	XBRL Taxonomy Extension Schema.
101.CAL *	XBRL Taxonomy Extension Calculation Linkbase.
101.DEF *	XBRL Taxonomy Definition Linkbase.
101.LAB *	XBRL Taxonomy Extension Label Linkbase.
101.PRE *	XBRL Taxonomy Extension Presentation Linkbase.

* Filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		FGL HOLDINGS (Registrant)
Date:	May 7, 2019	By:	/s/ Dennis R. Vigneau
			Chief Financial Officer
			(on behalf of the Registrant and as Principal Financial Officer)

-82

EX-31.1

Exhibit 31.1

CERTIFICATION OF CEO PURSUANT TO RULE 13a-14(a) or 15d-14(a) OF THE SECURITIES

EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Christopher O. Blunt, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2019 of FGL Holdings;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 7, 2019

/s/ CHRISTOPHER O. BLUNT

Christopher O. Blunt

President & Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF CFO PURSUANT TO RULE 13a-14(a) or 15d-14(a) OF THE SECURITIES

EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Dennis R. Vigneau, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2019 of FGL Holdings;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 7, 2019

/s/ DENNIS R. VIGNEAU

Dennis R. Vigneau

Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of FGL Holdings (the “Company”) on Form 10-Q for the quarter ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher O. Blunt, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ CHRISTOPHER O. BLUNT

Christopher O. Blunt

President & Chief Executive Officer

May 7, 2019

This Certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

EX-32.2

Exhibit 32.2

CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of FGL Holdings (the “Company”) on Form 10-Q for the quarter ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dennis R. Vigneau, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ DENNIS R. VIGNEAU

Dennis R. Vigneau

Chief Financial Officer

May 7, 2019

This Certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	Apr. 30, 2019
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Trading Symbol	FG
Entity Registrant Name	FGL Holdings
Entity Central Index Key	0001668428
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		221,660,974

XML

Investments - Proceeds From The Sale of Fixed-maturity available for-sale-securities - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule of Available-for-sale Securities [Line Items]
Document Period End Date	Mar. 31, 2019
Available-for-sale Securities
Schedule of Available-for-sale Securities [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:	$ 962	$ 3,286
Available-for-sale Securities | Total fixed maturities
Schedule of Available-for-sale Securities [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:	474
Gain on sale of investments	5
Loss on Sale of Investments	$ 10
Predecessor | Available-for-sale Securities | Total fixed maturities
Schedule of Available-for-sale Securities [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:		2,778
Gain on sale of investments		8
Loss on Sale of Investments		$ 43

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Investments:
Fixed maturity securities, available-for-sale, at fair value (amortized cost: March 31, 2019 - $21,908; December 31, 2018 - $22,219)	$ 21,605	$ 21,109
Equity securities, at fair value (cost: March 31, 2019 - $1,226; December 31, 2018 - $1,526)	1,171	1,382
Derivative investments	305	97
Mortgage loans	674	667
Other invested assets	755	662
Total investments	24,510	23,917
Cash and cash equivalents	1,357	571
Accrued investment income	238	216
Funds withheld for reinsurance receivables, at fair value	837	757
Reinsurance recoverable	3,113	3,190
Intangibles, net	1,421	1,359
Deferred tax assets, net	283	343
Goodwill	467	467
Other assets	220	125
Total assets	32,446	30,945
LIABILITIES AND SHAREHOLDERS' EQUITY
Contractholder funds	23,881	23,387
Future policy benefits, including $797 and $725 at fair value at March 31, 2019 and December 31, 2018, respectively	4,677	4,641
Funds Held under Reinsurance Agreements, Liability	653	722
Liability for policy and contract claims	70	64
Debt	541	541
Other liabilities	873	700
Total liabilities	30,695	30,055
Commitments and contingencies (Note 12)
Shareholders' equity:
Preferred stock ($.0001 par value, 100,000,000 shares authorized, 406,510 and 399,033 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively)	0	0
Common stock ($.0001 par value, 800,000,000 shares authorized, 221,660,974 and 221,660,974 issued and outstanding at March 31, 2019 and December 31, 2018, respectively)	0	0
Additional paid-in capital	2,007	1,998
Retained earnings (Accumulated deficit)	(6)	(167)
Accumulated other comprehensive income (loss)	(216)	(937)
Treasury Stock, Value	34	4
Total shareholders' equity	1,751	890
Total liabilities and shareholders' equity	$ 32,446	$ 30,945

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Fixed maturity securities, available-for-sale, at fair value (amortized cost)	$ 21,908	$ 22,219
Equity securities, available-for-sale, at fair value (amortized cost)	1,226	1,526
Future policy benefits. at fair value	$ 797	$ 725
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred Stock, shares issued (in shares)	406,510	399,033
Preferred Stock, shares outstanding (in shares)	406,510	399,033
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	800,000,000	800,000,000
Common stock, shares issued (in shares)	211,660,974	211,660,974
Common stock, shares outstanding (in shares)	211,660,974	211,660,974
Treasury Stock, shares (in shares)	0	0

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues:
Premiums	$ 16
Net investment income	289
Net investment gains (losses)	240	$ (191)
Insurance and investment product fees and other	55
Total revenues	600
Benefits and expenses:
Benefits and other changes in policy reserves	339
Acquisition and operating expenses, net of deferrals	44
Amortization of intangibles	29
Total benefits and expenses	412
Operating income	188
Interest expense	(8)
Income (loss) before income taxes	180
Income tax expense	(9)
Net income (loss)	171	65
Less Preferred stock dividend	8	7
Net income (loss) available to common shareholders	$ 163	$ 58
Net income per common share
Basic (in USD per share)	$ 0.74
Diluted (in USD per share)	$ 0.74
Weighted average common shares used in computing net income per common share:
Basic (in shares)	219,645,679
Diluted (in shares)	219,681,528
Cash dividend per common share (in dollars per share)	$ 0.01	$ 0.000
Total other-than-temporary impairments	$ (2)
Portion of other-than-temporary impairments included in other comprehensive income	0
Net other-than-temporary impairments	(2)	$ (2)
Gains (losses) on derivatives and embedded derivatives	164
Other investment gains (losses)	78
Net investment gains (losses)	$ 240	(191)
Predecessor
Revenues:
Premiums		18
Net investment income		263
Net investment gains (losses)		(191)
Insurance and investment product fees and other		48
Total revenues		138
Benefits and expenses:
Benefits and other changes in policy reserves		(39)
Acquisition and operating expenses, net of deferrals		40
Amortization of intangibles		27
Total benefits and expenses		28
Operating income		110
Interest expense		(6)
Income (loss) before income taxes		104
Income tax expense		(39)
Net income (loss)		65
Less Preferred stock dividend		$ 7
Net income per common share
Basic (in USD per share)		$ 0.27
Diluted (in USD per share)		$ 0.27
Weighted average common shares used in computing net income per common share:
Basic (in shares)		214,370,000
Diluted (in shares)		214,370,000
Total other-than-temporary impairments		$ (2)
Portion of other-than-temporary impairments included in other comprehensive income		0
Net other-than-temporary impairments		(2)
Gains (losses) on derivatives and embedded derivatives		(145)
Other investment gains (losses)		(44)
Net investment gains (losses)		$ (191)

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Net income (loss)	$ 171	$ 65
Unrealized investment gains/losses:
Net change in unrealized gains/losses on investments	724	(359)
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	(3)	2
Net changes to derive comprehensive income (loss) for the period	721	(357)
Comprehensive income (loss), net of tax	$ 892	(292)
Predecessor
Net income (loss)		$ 65

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock [Member]	Common Stock	Common Stock Additional Paid-in Capital	Common Stock Retained Earnings (Accumulated Deficit)	Preferred Stock	Preferred Stock Additional Paid-in Capital	Preferred Stock Retained Earnings (Accumulated Deficit)
Beginning Balance at Dec. 31, 2017	$ 1,963	$ 0	$ 0	$ 2,037	$ (149)	$ 75	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends	(5)			2	(7)
Net income (loss) | Predecessor	65
Net income (loss)	65				65
Unrealized investment losses, net	(359)					(359)
Ending Balance at Mar. 31, 2018	1,666	0	0	2,039	(95)	(278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	2
Cumulative Effect of New Accounting Principle in Period of Adoption					(4)	4
Stock Repurchased During Period, Value	(30)						(30)
Beginning Balance at Dec. 31, 2018	890	0	0	1,998	(167)	(937)	(4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends								$ (2)	$ 0	$ (2)	$ 0	$ 8	$ (8)
Net income (loss)	171				171
Unrealized investment losses, net	724					724
Ending Balance at Mar. 31, 2019	1,751	$ 0	$ 0	2,007	$ (6)	(216)	$ (34)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	(3)					$ (3)
Stock Issued During Period, Value, Stock Dividend	$ 1			$ 1

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income (loss)	$ 171	$ 65
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock based compensation	1	0
Amortization	4	15
Increase (Decrease) in Deferred Income Taxes	5	12
Interest credited/index credits to contractholder account balances	308	(30)
Net recognized losses (gains) on investments and derivatives	(240)	191
Charges assessed to contractholders for mortality and administration	(32)	(38)
Intangibles, net	(90)	(55)
Changes in operating assets and liabilities:
Reinsurance recoverable	(16)	(8)
Future policy benefits	36	(40)
Funds withheld for reinsurers	(129)	(12)
Collateral (returned) posted	141	(145)
Other assets and other liabilities	(63)	10
Net cash provided by (used in) operating activities	96	(35)
Cash flows from investing activities:
Proceeds from mortgage loans	4	20
Costs of mortgage loans	12	0
Capital expenditures	(1)	(3)
Contingent purchase price payment	0	(30)
Net cash provided by (used in) investing activities	404	(377)
Cash flows from financing activities:
Treasury stock	30	0
Draw on revolving credit facility	0	30
Dividends paid	(2)	0
Contractholder account deposits	1,225	959
Contractholder account withdrawals	(907)	(635)
Net cash provided by (used in) financing activities	286	354
Change in cash & cash equivalents	786	(58)
Cash & cash equivalents, beginning of period	571
Cash & cash equivalents, end of period	1,357	1,157
Supplemental disclosures of cash flow information:
Interest paid	0	2
Income taxes (refunded) paid	(1)	(30)
Deferred sales inducements	35	26
Available-for-sale Securities
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	962	3,286
Cost of available-for-sale investments:	(421)	(3,699)
Derivative and other
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	44	143
Cost of available-for-sale investments:	$ (172)	(94)
Predecessor
Cash flows from operating activities:
Net income (loss)		$ 65

XML

Basis of Presentation and Nature of Business

3 Months Ended

Mar. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Nature of Business

Basis of Presentation

FGL Holdings (the “Company”), a Cayman Islands exempted company, markets products through its wholly-owned insurance subsidiaries, Fidelity & Guaranty Life Insurance Company (“FGL Insurance”) and Fidelity & Guaranty Life Insurance Company of New York (“FGL NY Insurance”), which together are licensed in all fifty states and the District of Columbia.

F&G Reinsurance Ltd (“F&G Re”), an exempted company incorporated in Bermuda with limited liability, provides a platform for non-affiliated international business. Front Street Re Cayman Ltd (“FSRC”), an exempted company incorporated in the Cayman Islands with limited liability, has a license to carry on business as an Unrestricted Class “B” Insurer that permits FSRC to conduct offshore direct and reinsurance business. F&G Re and FSRC (together herein referred to as the “F&G Reinsurance Companies”), are indirect wholly owned subsidiaries of FGL Holdings and parties to reinsurance transactions.

The accompanying unaudited condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and with the instructions for the Securities and Exchange Commission (“SEC”) Quarterly Report on Form 10-Q, including Article 10 of Regulation S-X, for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. Therefore, the information contained in the Notes to Consolidated Financial Statements included in the Company's 2018 Form 10-K, should be read in connection with the reading of these interim unaudited condensed consolidated financial statements.

In the opinion of management, these statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results.  Operating results for the threemonths endedMarch 31, 2019, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2019.  Amounts reclassified out of other comprehensive income are reflected in net investment gains in the unaudited Condensed Consolidated Statements of Operations.

Dollar amounts in the accompanying sections are presented in millions, unless otherwise noted.

XML

Significant Accounting Policies and Practices

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Significant Accounting Policies and Practices

Adoption of New Accounting Pronouncements

Premium Amortization on Purchased Callable Debt Securities

In March 2017, the FASB issued new guidance on the amortization of callable securities (ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The ASU requires premiums paid on purchased debt securities with an explicit call option to be amortized to the earliest call date, as opposed to the maturity date (as under current GAAP). The updated guidance is applicable to instruments that are callable based on explicit, non-contingent call features that are callable at fixed prices on preset dates. The amendments in this update should be applied using the modified retrospective method through a cumulative effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted this new accounting guidance effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements.

Amendments to Lease Accounting

In February 2016, the FASB issued amended guidance (ASU 2016-02, Leases (Topic 842)), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Notable amendments in this update will:

• require entities to recognize the rights and obligations resulting from all leases or lease components of contracts, including operating leases, as lease assets and lease liabilities, with an exception allowed for leases with a term of 12 months or less

• create a distinction between finance leases and operating leases, with classification criteria substantially similar to that for distinguishing between capital leases and operating leases under previous guidance

• not retain the accounting model for leveraged leases under previous guidance for leases that commence after the effective date of ASU 2016-02

• provide additional guidance on separating the lease components from the nonlease components of a contract

• require qualitative disclosures along with specific quantitative disclosures to provide information regarding the amount, timing, and uncertainty of cash flows arising from leases

• include modifications to align lessor accounting with the changes to lessee accounting, as well as changes to the requirements of recognizing a transaction as a sale and leaseback transaction, however, these changes will have no impact on the Company's current lease arrangements

The amendments are required to be applied at the beginning of the earliest period presented using a modified retrospective approach (including several optional practical expedients related to leases commenced before the effective date). The Company has adopted this standard effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements.

Future Accounting Pronouncements

Accounting pronouncements that will impact the Company in future periods have been disclosed in the Company’s 2018 Form 10-K. There have not been any additional accounting pronouncements issued during the quarter ended March 31, 2019 that are expected to impact the Company. The following two pronouncements were discussed in our 2018 Form 10-K but have been included below so as to provide an update on the Company’s status of adoption.

New Credit Loss Standard

In June 2016, the FASB issued new guidance (ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments), effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Notable amendments in this update will change the accounting for impairment of most financial assets and certain other instruments in the following ways:

• financial assets (or a group of financial assets) measured at amortized cost will be required to be presented at the net amount expected to be collected, with an allowance for credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset at purchase

• credit losses relating to AFS fixed maturity securities will be recorded through an allowance for credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for credit losses will be limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value

• the income statement will reflect the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount

• disclosures will be required to include information around how the credit loss allowance was developed, further details on information currently disclosed about credit quality of financing receivables and net investments in leases, and a rollforward of the allowance for credit losses for AFS fixed maturity securities as well as an aging analysis for securities that are past due

The amendments in this ASU may be early adopted during any interim or annual period beginning after December 15, 2018, however the Company has elected not to. The Company has identified the material asset classes impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply with the new guidance. The Company has developed a project plan to complete our adoption of this new standard, and is evaluating the impact of the new guidance on its consolidated financial statements.

Long-Duration Contracts

In August 2018, the FASB issued new guidance (ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts), effective for fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. Under this update:

• assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations

• the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income

• market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income

• deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts

• deferred acquisition costs must be written off for unexpected contract terminations

• disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed

The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not currently expect to early adopt this standard. The Company has identified specific areas that will be impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply as well as the impact of the new guidance on its consolidated financial statements.

XML

Significant Risks and Uncertainties

3 Months Ended

Mar. 31, 2019

Risks and Uncertainties [Abstract]

Significant Risks and Uncertainties

Significant Risks and Uncertainties

Federal Regulation

In April 2016, the Department of Labor (“DOL”) issued the “fiduciary” rule which could have had a material impact on the Company, its products, distribution, and business model. The rule provided that persons who render investment advice for a fee or other compensation with respect to an employer plan or individual retirement account ("IRA") are fiduciaries of that plan or IRA and would have expanded the definition of fiduciary under ERISA to apply to commissioned insurance agents who sell the Company’s IRA products. On June 21, 2018, the United States Court of Appeals for the Fifth Circuit formally vacated the DOL fiduciary rule in total when it issued its mandate following the court’s decision on March 15, 2018, in U.S. Chamber of Commerce v. U.S. Department of Labor, 885 F.3d 360 (5th Cir. 2018). Management will continue to monitor for potential action by state officials or the SEC to implement rules similar to the vacated DOL rule.

Use of Estimates and Assumptions

The preparation of the Company's unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used.

Concentrations of Financial Instruments

As of March 31, 2019 and December 31, 2018, the Company’s most significant investment in one industry, excluding United States ("U.S.") Government securities, was its investment securities in the Bankingindustry with a fair value of $2,348 or 10% and $2,491 or 10%, respectively, of the invested assets portfolio and an amortized cost of $2,416 and $2,691, respectively. As of March 31, 2019, the Company’s holdings in this industry include investments in 107 different issuers with the top ten investments accounting for 35% of the total holdings in this industry. As of March 31, 2019 the Company had no investments in issuers that exceeded 10% of shareholders' equity. As of December 31, 2018, the Company had 16 investments in issuers that exceeded 10% of shareholders' equity, with a total fair value of $1,634 or 7% of the invested assets portfolio: JP Morgan Chase & Co, Metropolitan Transportation Authority (NY), AT&T Inc, HSBC Holdings, Wells Fargo & Company, General Motors Co, Nationwide Mutual Insurance Company, Goldman Sachs Group Inc, United Mexican States, Energy Transfer Partners, Prudential Financial Inc, Citigroup Inc, HP Enterprise Co, Viacom Inc, Kinder Morgan Energy Partners, and Fuel Trust. The Company's largest concentration in any single issuer as of March 31, 2019 and December 31, 2018 was AT&T and JP Morgan Chase & Co, respectively, with a total fair value of $124 or 1% and $115 or 1% of the invested assets portfolio, respectively.

Concentrations of Financial and Capital Markets Risk

The Company is exposed to financial and capital markets risk, including changes in interest rates and credit spreads which can have an adverse effect on the Company’s results of operations, financial condition and liquidity. The Company expects to continue to face challenges and uncertainties that could adversely affect its results of operations and financial condition. The Company attempts to mitigate the risk, including changes in interest rates by investing in less rate-sensitive investments, including senior tranches of collateralized loan obligations, non-agency residential mortgage-backed securities, and various types of asset backed securities.

The Company’s exposure to such financial and capital markets risk relates primarily to the market price and cash flow variability associated with changes in interest rates. A rise in interest rates, in the absence of other countervailing changes, will increase the net unrealized loss position of the Company’s investment portfolio and, if long-term interest rates rise dramatically within a six to twelve month time period, certain of the Company’s products may be exposed to disintermediation risk. Disintermediation risk refers to the risk that policyholders surrender their contracts in a rising interest rate environment, requiring the Company to liquidate assets in an unrealized loss position. Management believes this risk is mitigated to some extent by surrender charge protection provided by the Company’s products.

Concentration of Reinsurance Risk

The Company has a significant concentration of reinsurance risk with third party reinsurers, Wilton Reassurance Company (“Wilton Re”) and Kubera Insurance (SAC) Ltd. acting in respect of Annuity Reinsurance Cell A1 ("Kubera") that could have a material impact on the Company’s financial position in the event that Wilton Re or Kubera fail to perform their obligations under the various reinsurance treaties. Wilton Re is a wholly-owned subsidiary of Canada Pension Plan Investment Board ("CPPIB"). CPPIB has an AAA issuer credit rating from Standard & Poor's Ratings Services ("S&P") as of March 31, 2019. Kubera is not rated, however, management has attempted to mitigate the risk of non-performance through the funds withheld arrangement. As of March 31, 2019, the net amount recoverable from Wilton Re was $1,541 and the net amount recoverable from Kubera was $681. The Company monitors both the financial condition of individual reinsurers and risk concentration arising from similar activities and economic characteristics of reinsurers to attempt to reduce the risk of default by such reinsurers. Wilton Re and Kubera are current on all amounts due as of March 31, 2019.

On March 6, 2019, Scottish Re (U.S.), Inc. (“SRUS”), a Delaware domestic life and health reinsurer of FGL Insurance, was ordered into receivership for purposes rehabilitation. As of March 31, 2019, the net amount recoverable from SRUS was $47. The financial exposure related to these ceded reserves are substantially mitigated via a reinsurance agreement whereby Wilton Re assumes treaty non-performance including credit risk for this business.

XML

Investments

3 Months Ended

Mar. 31, 2019

Investments, Debt and Equity Securities [Abstract]

Investments

Investments

The Company’s fixed maturity securities investments have been designated as available-for-sale and are carried at fair value with unrealized gains and losses included in AOCI, net of associated adjustments for deferred acquisition costs ("DAC"), value of business acquired ("VOBA"), deferred sales inducements ("DSI"), unearned revenue ("UREV"), and deferred income taxes. The Company's equity securities investments are carried at fair value with unrealized gains and losses included in net income. The Company’s consolidated investments at March 31, 2019 and December 31, 2018 are summarized as follows:

	March 31, 2019
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	5,033	$	23	$	(82	)	$	4,974	$	4,974
Commercial mortgage-backed securities	2,596		60		(9		)	2,647		2,647
Corporates	10,886		60		(356		)	10,590		10,590
Hybrids	988		6		(33		)	961		961
Municipals	1,211		16		(10		)	1,217		1,217
Residential mortgage-backed securities	1,000		27		(5		)	1,022		1,022
U.S. Government	56		—		—			56		56
Foreign Governments	138		2		(2		)	138		138
Total available-for-sale securities	21,908		194		(497		)	21,605		21,605
Equity securities	1,226		3		(58		)	1,171		1,171
Derivative investments	318		74		(87		)	305		305
Commercial mortgage loans	479		—		—			485		479
Residential mortgage loans	195		—		—			199		195
Other invested assets	759		—		(4		)	744		755
Total investments	$	24,885	$	271	$	(646	)	$	24,509	$	24,510

	December 31, 2018
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	4,954	$	15	$	(137	)	$	4,832	$	4,832
Commercial mortgage-backed securities	2,568		9		(40		)	2,537		2,537
Corporates	11,213		16		(848		)	10,381		10,381
Hybrids	992		—		(91		)	901		901
Municipals	1,216		3		(32		)	1,187		1,187
Residential mortgage-backed securities	1,027		12		(8		)	1,031		1,031
U.S. Government	120		—		(1		)	119		119
Foreign Governments	129		—		(8		)	121		121
Total available-for-sale securities	22,219		55		(1,165		)	21,109		21,109
Equity securities	1,526		1		(145		)	1,382		1,382
Derivative investments	330		2		(235		)	97		97
Commercial mortgage loans	482		—		—			483		482
Residential mortgage loans	185		—		—			187		185
Other invested assets	662		—		—			651		662
Total investments	$	25,404	$	58	$	(1,545	)	$	23,909	$	23,917

Included in AOCI were cumulative gross unrealized gains of $0 and gross unrealized losses of $0 related to the non-credit portion of other-than-temporary-impairments ("OTTI") on non-agency residential mortgage backed securities ("RMBS") for both March 31, 2019 and December 31, 2018.

Securities held on deposit with various state regulatory authorities had a fair value of $16,135 and $19,930 at March 31, 2019 and December 31, 2018, respectively. Under Iowa regulations, insurance companies are required to hold securities on deposit in an amount no less than the legal reserve.

At March 31, 2019 and December 31, 2018, the Company held no material investments that were non-income producing for a period greater than twelve months.

In accordance with the Company's FHLB agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to the Company for general purposes. The collateral investments had a fair value of $1,186 and $1,401 at March 31, 2019 and December 31, 2018, respectively.

The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations.

	March 31, 2019
	Amortized Cost		Fair Value
Corporates, Non-structured Hybrids, Municipal and Government securities:
Due in one year or less	$	160	$	160
Due after one year through five years	758		749
Due after five years through ten years	2,080		2,059
Due after ten years	10,281		9,994
Subtotal	13,279		12,962
Other securities which provide for periodic payments:
Asset-backed securities	5,033		4,974
Commercial mortgage-backed securities	2,596		2,647
Residential mortgage-backed securities	1,000		1,022
Subtotal	8,629		8,643
Total fixed maturity available-for-sale securities	$	21,908	$	21,605

The Company's available-for-sale securities with unrealized losses are reviewed for potential OTTI. For factors considered in evaluating whether a decline in value is other-than-temporary, please refer to “Note 2. Significant Accounting Policies and Practices" to the Company’s 2018 Form 10-K.

The Company analyzes its ability to recover the amortized cost by comparing the net present value of cash flows expected to be collected with the amortized cost of the security. Additionally, the Company considers other factors, including, but not limited to: whether the issuer is currently meeting its financial obligations and its ability to continue to meet these obligations, its existing cash available, and its access to additional available capital. For mortgage-backed and asset-backed securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions, based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. For structured securities, the payment priority within the tranche structure is also considered. For all other fixed maturity securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. If the net present value is less than the amortized cost of the investment, an OTTI is recognized.

Based on the results of our process for evaluating available-for-sale securities in unrealized loss positions for OTTI, as discussed above, the Company determined the unrealized losses as of March 31, 2019 decreased due to lower interest rates during the first quarter in conjunction with tighter credit spreads over Treasuries.

The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows:

	March 31, 2019
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	2,696	$	(63	)	$	886	$	(19	)	$	3,582	$	(82	)
Commercial mortgage-backed securities	243		(4		)	250		(5		)	493		(9		)
Corporates	684		(15		)	7,227		(341		)	7,911		(356		)
Hybrids	333		(14		)	343		(19		)	676		(33		)
Municipals	45		—			482		(10		)	527		(10		)
Residential mortgage-backed securities	41		(1		)	238		(4		)	279		(5		)
U.S. Government	—		—			50		—			50		—
Foreign Government	—		—			81		(2		)	81		(2		)
Total available-for-sale securities	$	4,042	$	(97	)	$	9,557	$	(400	)	$	13,599	$	(497	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													468
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													1164
Total number of available-for-sale securities in an unrealized loss position													1,632

	December 31, 2018
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	2,924	$	(116	)	$	643	$	(21	)	$	3,567	$	(137	)
Commercial mortgage-backed securities	1,466		(34		)	262		(6		)	1,728		(40		)
Corporates	8,016		(772		)	1,465		(76		)	9,481		(848		)
Hybrids	858		(90		)	7		(1		)	865		(91		)
Municipals	850		(27		)	172		(5		)	1,022		(32		)
Residential mortgage-backed securities	139		(3		)	190		(5		)	329		(8		)
U.S. Government	69		—			50		(1		)	119		(1		)
Foreign Government	47		(3		)	68		(5		)	115		(8		)
Total available-for-sale securities	$	14,369	$	(1,045	)	$	2,857	$	(120	)	$	17,226	$	(1,165	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													556
Total number of available-for-sale securities in an unrealized loss position													2,107

At March 31, 2019 and December 31, 2018, securities in an unrealized loss position were primarily concentrated in corporate debt.

At March 31, 2019 and December 31, 2018, securities with a fair value of $40 and $132, respectively, had an unrealized loss greater than 20% of amortized cost (excluding U.S. Government and U.S. Government sponsored agency securities), which were insignificant to the carrying value of all investments, respectively.

The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the threemonths endedMarch 31, 2019 and 2018, for which a portion of the OTTI was recognized in AOCI:

	Three months ended
	March 31, 2019		March 31, 2018
Beginning balance	$	—	$	—
Increases attributable to credit losses on securities:
OTTI was previously recognized	—		—
OTTI was not previously recognized	—		—
Ending balance	$	—	$	—

The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the threemonths endedMarch 31, 2019 and 2018:

	Three months ended
	March 31, 2019			March 31, 2018
Credit impairment losses in operations	$	(2	)	$	(2	)
Change-of-intent losses in operations	—			—
Amortized cost	1			—
Fair value	1			—
Non-credit losses in other comprehensive income for investments which experienced OTTI	—			—

Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Corporates	(2		)	(2		)
Total	$	(2	)	$	(2	)

Mortgage Loans

The Company's mortgage loans are collateralized by commercial and residential properties.

Commercial Mortgage Loans

Commercial mortgage loans ("CMLs") represented approximately 2% of the Company’s total investments as of March 31, 2019 and December 31, 2018. The Company primarily invests in mortgage loans on income producing properties including hotels, industrial properties, retail buildings, multifamily properties and office buildings. The Company diversifies its CML portfolio by geographic region and property type to attempt to reduce concentration risk. The Company continuously evaluates CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables:

	March 31, 2019				December 31, 2018
	Gross Carrying Value		% of Total		Gross Carrying Value		% of Total
Property Type:
Hotel	21		4	%	21		4	%
Industrial - General	37		8	%	37		8	%
Industrial - Warehouse	20		4	%	20		4	%
Multifamily	55		11	%	56		12	%
Office	146		31	%	147		30	%
Retail	200		42	%	201		42	%
Total commercial mortgage loans, gross of valuation allowance	$	479	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	479			$	482
U.S. Region:
East North Central	$	97	20	%	$	98	20	%
East South Central	19		4	%	19		4	%
Middle Atlantic	78		16	%	79		17	%
Mountain	65		14	%	65		13	%
New England	10		2	%	10		2	%
Pacific	115		24	%	116		24	%
South Atlantic	57		12	%	57		12	%
West North Central	13		3	%	13		3	%
West South Central	25		5	%	25		5	%
Total commercial mortgage loans, gross of valuation allowance	$	479	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	479			$	482

All of the Company's investments in CMLs had a loan-to-value ("LTV") ratio of less than 75% at March 31, 2019 and December 31, 2018, as measured at inception of the loans unless otherwise updated. As of March 31, 2019, all CMLs are current and have not experienced credit or other events which would require the recording of an impairment loss.

LTV and DSC ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. We normalize our DSC ratios to a 25-year amortization period for purposes of our general loan allowance evaluation.

The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at March 31, 2019 and December 31, 2018:

	Debt-Service Coverage Ratios				Total Amount		% of Total		Estimated Fair Value		% of Total
	>1.25		1.00 - 1.25
March 31, 2019
LTV Ratios:
Less than 50%	$	299	$	6	$	305	64	%	$	309	64	%
50% to 60%	163		—		163		34	%	165		34	%
60% to 75%	11		—		11		2	%	11		2	%
Commercial mortgage loans	$	473	$	6	$	479	100	%	$	485	100	%
December 31, 2018
LTV Ratios:
Less than 50%	$	296	$	6	$	302	63	%	$	302	63	%
50% to 60%	169		—		169		35	%	170		35	%
60% to 75%	11		—		11		2	%	11		2	%
Commercial mortgage loans	$	476	$	6	$	482	100	%	$	483	100	%

(a) N/A - Current DSC ratio not available.

The Company establishes a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using DSC ratio and LTV ratio. The Company believes that the LTV ratio is an indicator of the principal recovery risk for loans that default. A higher LTV ratio will result in a higher allowance. The Company believes that the DSC ratio is an indicator of default risk on loans. A higher DSC ratio will result in a lower allowance.

The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At March 31, 2019 and December 31, 2018, the Company had no CMLs that were delinquent in principal or interest payments.

Mortgage loan workouts, refinances or restructures that are classified as troubled debt restructurings ("TDRs") are individually evaluated and measured for impairment. As of March 31, 2019 and December 31, 2018, our CML portfolio had no impairments, modifications or TDRs.

Residential Mortgage Loans

Residential mortgage loans ("RMLs") represented approximately 1% of the Company’s total investments as of March 31, 2019 and December 31, 2018. The Company's residential mortgage loans are closed end, amortizing loans. 100% of the properties are located in the United States. The Company diversifies its RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables:

	March 31, 2019
US State:	Unpaid Principal Balance		% of Total
Illinois	$	29	15	%
Florida	25		13	%
South Carolina	24		13	%
All Other States (a)	112		59	%
Total mortgage loans	$	190	100	%

(a) The individual concentration of each state is less than 9% as of March 31, 2019.

	December 31, 2018
US State:	Unpaid Principal Balance		% of Total
Florida	$	25	14	%
Illinois	24		13	%
New Jersey	17		9	%
All Other States (a)	114		64	%
Total mortgage loans	$	180	100	%

(a) The individual concentration of each state is less than 9% as of December 31, 2018.

Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines non-performing residential mortgage loans as those that are 90 or more days past due and/or in nonaccrual status which is assessed monthly. The credit quality of RMLs as at March 31, 2019 and December 31, 2018, respectively, was as follows:

	March 31, 2019				December 31, 2018
Performance indicators:	Carrying Value		% of Total		Carrying Value		% of Total
Performing	$	195	100	%	$	185	100	%
Non-performing	—		—	%	—		—	%
Total residential mortgage loans, gross of valuation allowance	$	195	100	%	$	185	100	%
Allowance for loan loss	—		—	%	—		—	%
Total residential mortgage loans	$	195	100	%	$	185	100	%

Net Investment Income

The major sources of “Net investment income” on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Fixed maturity securities, available-for-sale	$	265		$	242
Equity securities	21			10
Mortgage loans	7			7
Invested cash and short-term investments	3			3
Funds withheld	8			7
Limited partnerships	8			3
Other investments	5			1
Gross investment income	317			273
Investment expense	(28		)	(10		)
Net investment income	$	289		$	263

Net Investment Gains (Losses)

Details underlying “Net investment gains (losses)” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Net realized gains (losses) on fixed maturity available-for-sale securities	$	(3	)	$	(37	)
Net realized/unrealized gains (losses) on equity securities	78			(6		)
Realized gains (losses) on other invested assets	1			(3		)
Derivatives and embedded derivatives:
Realized gains (losses) on certain derivative instruments	(26		)	11
Unrealized gains (losses) on certain derivative instruments	190			(135		)
Change in fair value of reinsurance related embedded derivatives (a)	(3		)	(21		)
Change in fair value of other derivatives and embedded derivatives	3			—
Realized gains (losses) on derivatives and embedded derivatives	164			(145		)
Net investment gains (losses)	$	240		$	(191	)

(a) Change in fair value of reinsurance related embedded derivatives is due to F&G Re and FSRC unaffiliated third party business.

The proceeds from the sale of fixed-maturity available for-sale-securities and the gross gains and losses associated with those transactions were as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Proceeds	$	474		$	2,778
Gross gains	5			8
Gross losses	(10		)	(43		)

Unconsolidated Variable Interest Entities

FGL Insurance owns investments in VIEs that are not consolidated within the Company’s financial statements.  VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest.  These VIEs are not consolidated in the Company’s financial statements for the following reasons: 1)  FGL Insurance either does not control or does not have any voting rights or notice rights; 2)  the Company does not have any substantive rights to remove the investment manager; and 3)  the Company was not involved in the design of the investment.  These characteristics indicate that FGL Insurance lacks the ability to direct the activities, or otherwise exert control, of the VIEs and is not considered the primary beneficiary of them. 

The Company previously executed a commitment of $75 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, the Company does not have voting power.  The initial capital call occurred June 30, 2015, with the remaining commitment expected to fund June 2019. The Company has funded $54 as of March 31, 2019.

The Company invests in various limited partnerships as a passive investor. These investments are in corporate credit and real estate debt strategies that have a current income bias. Limited partnership interests are accounted for under the equity method and are included in “Other invested assets” on the Company’s consolidated balance sheet. The Company's maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in the Company's consolidated balance sheet in addition to any required unfunded commitments. As of March 31, 2019, the Company's maximum exposure to loss was $595 in recorded carrying value and $1,093 in unfunded commitments.

XML

Derivative Financial Instruments

3 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments

The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows:

	March 31, 2019		December 31, 2018
Assets:
Derivative investments:
Call options	$	304	$	97
Futures contracts	1		—
Other invested assets:
Other derivatives and embedded derivatives	17		14
	$	322	$	111

Liabilities:
Contractholder funds:
FIA embedded derivative	$	2,720	$	2,476
Other liabilities:
Preferred shares reimbursement feature embedded derivative	27		29
	$	2,747	$	2,505

The change in fair value of derivative instruments included in the accompanying unaudited Condensed Consolidated Statements of Operations is as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Revenues:
Net investment gains (losses):
Call options	$	154		$	(122	)
Futures contracts	8			(2		)
Foreign currency forward	2			—
Other derivatives and embedded derivatives	3			—
Reinsurance related embedded derivatives	(3		)	(21		)
Total net investment gains (losses)	$	164		$	(145	)
Benefits and other changes in policy reserves:
FIA embedded derivatives	$	244		$	(98	)
Acquisition and operating expenses, net of deferrals:
Preferred shares reimbursement feature embedded derivative	$	2		$	(1	)

Additional Disclosures

Other Derivatives and Embedded Derivatives

The Company holds a $35 fund-linked note issued by Nomura International Funding Pte. Ltd. The note provides for an additional payment at maturity based on the value of an embedded derivative in AnchorPath Dedicated Return Fund (the "AnchorPath Fund") of $11 which was based on the actual return of the fund. At March 31, 2019, the fair value of the fund-linked note and embedded derivative were $27 and $17, respectively. At December 31, 2018, the fair value of the fund-linked note and embedded derivative were $26 and $14, respectively. At maturity of the fund-linked note, FGL Insurance will receive the $35 face value of the note plus the value of the embedded derivative in the AnchorPath Fund. The additional payment at maturity is an embedded derivative reported in "Other invested assets", while the host is an available-for-sale security reported in "Fixed maturities, available-for-sale".

Fixed Index Annuity ("FIA") Embedded Derivative and Call Options and Futures

The Company has FIA Contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, primarily the S&P 500 Index. This feature represents an embedded derivative under GAAP. The FIA embedded derivative is valued at fair value and included in the liability for contractholder funds in the accompanying Condensed Consolidated Balance Sheets with changes in fair value included as a component of “Benefits and other changes in policy reserves” in the unaudited Condensed Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments".

The Company purchases derivatives consisting of a combination of call options and futures contracts on the applicable market indices to fund the index credits due to FIA contractholders. The call options are one, two, three, and five year options purchased to match the funding requirements of the underlying policies. On the respective anniversary dates of the index policies, the index used to compute the interest credit is reset and the Company purchases new one, two, three, or five year call options to fund the next index credit. The Company manages the cost of these purchases through the terms of its FIA contracts, which permit the Company to change caps, spreads or participation rates, subject to guaranteed minimums, on each contract’s anniversary date. The change in the fair value of the call options and futures contracts is generally designed to offset the portion of the change in the fair value of the FIA embedded derivative related to index performance. The call options and futures contracts are marked to fair value with the change in fair value included as a component of “Net investment gains (losses).” The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instrument term or upon early termination and the changes in fair value of open positions.

Other market exposures are hedged periodically depending on market conditions and the Company’s risk tolerance. The Company’s FIA hedging strategy economically hedges the equity returns and exposes the Company to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. The Company uses a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. The Company intends to continue to adjust the hedging strategy as market conditions and the Company’s risk tolerance change.

Preferred Equity Remarketing Reimbursement Embedded Derivative Liability

On November 30, 2017 the Company issued 275,000 Series A cumulative preferred shares and 100,000 Series B cumulative preferred shares (together the “Preferred Shares”). The Preferred Shares do not have a maturity date and are non-callable for the first five years.From and after November 30, 2022, the original holders of the Preferred Shares may request and thus require, the Company (subject to customary blackout provisions) to remarket the Preferred Shares on their existing terms. If the remarketing is successful and the original holders elect to sell their preferred shares at the remarketed price and proceeds from such sale are less than the outstanding balance of the applicable shares (including dividends paid in kind and accumulated but unpaid dividends), the Company will be required to reimburse the sellers, up to a maximum of 10% of the par value of the originally issued preferred shares (including dividends paid in kind and accumulated but unpaid dividends) with such amount payable either in cash, ordinary shares, or any combination thereof, at the Company's option (the “Reimbursement Feature”). The Reimbursement Feature represents an embedded derivative that is not clearly and closely related to the preferred stock host and must be bifurcated. The Reimbursement Feature liability is held at fair value within “Other liabilities” in the accompanying Condensed Consolidated Balance Sheets using a Black Derman Toy model incorporating among other things the paid in kind dividend coupon rate and the Company’s call option. Changes in fair value of this derivative are recognized within “Acquisition and operating expenses, net of deferrals” in the accompanying unaudited Condensed Consolidated Statements of Operations.

Credit Risk

The Company is exposed to credit loss in the event of non-performance by its counterparties on the call options and reflects assumptions regarding this non-performance risk in the fair value of the call options. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. The Company maintains a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement.

Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table:

		March 31, 2019
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	3,496	$	70	$	25	$	45
Deutsche Bank	A-/A3/BBB+	1,151		14		14		—
Morgan Stanley	*/A1/A+	1,657		25		24		1
Barclay's Bank	A+/A2/A	2,752		79		61		18
Canadian Imperial Bank of Commerce	*/Aa2/A+	1,430		41		29		12
Wells Fargo	A+/A2/A-	2,034		58		56		2
Goldman Sachs	A/A3/BBB+	1,030		17		16		1
Total		$	13,550	$	304	$	225	$	79

		December 31, 2018
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	3,952	$	25	$	—	$	25
Deutsche Bank	A-/A3/BBB+	1,327		5		6		(1		)
Morgan Stanley	*/A1/A+	1,648		9		6		3
Barclay's Bank	A+/A2/A	2,205		27		20		7
Canadian Imperial Bank of Commerce	*/Aa2/A+	1,716		11		8		3
Wells Fargo	A+/A2/A-	1,635		17		16		1
Goldman Sachs	A/A3/BBB+	647		3		3		—
Total		$	13,130	$	97	$	59	$	38

(a) An * represents credit ratings that were not available.

Collateral Agreements

The Company is required to maintain minimum ratings as a matter of routine practice as part of its over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, the Company has agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open option contracts between the parties, at which time any amounts payable by the Company or the counterparty would be dependent on the market value of the underlying option contracts. The Company's current rating doesn't allow any counterparty the right to terminate ISDA agreements. In certain transactions, the Company and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. For all counterparties, except one, this threshold is set to zero. As of March 31, 2019 and December 31, 2018, counterparties posted $225 and $59 of collateral, respectively, of which $200 and $59 is included in "Cash and cash equivalents" with an associated payable for this collateral included in "Other liabilities" on the Condensed Consolidated Balance Sheets. The remaining $25 and $0 of non-cash collateral was held by a third-party custodian and may not be sold or re-pledged, except in the event of default, and, therefore, is not included in the Company's Condensed Consolidated Balance Sheets at March 31, 2019 and December 31, 2018, respectively. This collateral generally consists of U.S. treasury bonds and mortgage-backed securities. Accordingly, the maximum amount of loss due to credit risk that the Company would incur if parties to the call options failed completely to perform according to the terms of the contracts was $79 and $38 at March 31, 2019 and December 31, 2018, respectively.

The Company is required to pay counterparties the effective federal funds rate each day for cash collateral posted to FGL for daily mark to market margin changes.  The Company reinvests derivative cash collateral to reduce the interest cost. Cash collateral is invested in short term Treasury securities and A1/P1 commercial paper which are included in "Cash and cash equivalents" in the accompanying Condensed Consolidated Balance Sheets.

The Company held 774 and 664 futures contracts at March 31, 2019 and December 31, 2018, respectively. The fair value of the futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements). The Company provides cash collateral to the counterparties for the initial and variation margin on the futures contracts which is included in "Cash and cash equivalents" in the accompanying Condensed Consolidated Balance Sheets. The amount of cash collateral held by the counterparties for such contracts was $4 and $3 at March 31, 2019 and December 31, 2018, respectively.

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The Company’s measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or non-performance risk, which may include the Company’s own credit risk. The Company’s estimate of an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market for that asset or liability in the absence of a principal market as opposed to the price that would be paid to acquire the asset or assume a liability (“entry price”). The Company categorizes financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is defined as follows:

Level 1 - Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date.

Level 2 - Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads, and yield curves.

Level 3 - Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.

When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. In addition to the unobservable inputs, Level 3 fair value investments may include observable components, which are components that are actively quoted or can be validated to market-based sources.

The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows:

	March 31, 2019
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	1,357	$	—	$	—	$	1,357	$	1,357
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,466		508		4,974		4,974
Commercial mortgage-backed securities	—		2,579		68		2,647		2,647
Corporates	—		9,381		1,209		10,590		10,590
Hybrids	277		674		10		961		961
Municipals	—		1,179		38		1,217		1,217
Residential mortgage-backed securities	—		403		619		1,022		1,022
U.S. Government	51		5		—		56		56
Foreign Governments	—		122		16		138		138
Equity securities	441		657		20		1,118		1,118
Derivative investments	1		304		—		305		305
Other invested assets	—		—		41		41		41
Funds withheld for reinsurance receivables, at fair value	161		664		7		832		832
Total financial assets at fair value	$	2,288	$	20,434	$	2,536	$	25,258	$	25,258
Liabilities
Derivatives:
FIA embedded derivatives, included in contractholder funds	—		—		2,720		2,720		2,720
Preferred shares reimbursement feature embedded derivative	—		—		27		27		27
Fair value of future policy benefits	—		—		797		797		797
Total financial liabilities at fair value	$	—	$	—	$	3,544	$	3,544	$	3,544

	December 31, 2018
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	571	$	—	$	—	$	571	$	571
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,388		444		4,832		4,832
Commercial mortgage-backed securities	—		2,470		67		2,537		2,537
Corporates	—		9,150		1,231		10,381		10,381
Hybrids	265		626		10		901		901
Municipals	—		1,150		37		1,187		1,187
Residential mortgage-backed securities	—		417		614		1,031		1,031
U.S. Government	114		5		—		119		119
Foreign Governments	—		105		16		121		121
Equity securities	454		874		4		1,332		1,332
Derivative investments	—		97		—		97		97
Other invested assets	—		—		39		39		39
Funds withheld for reinsurance receivables, at fair value	169		576		4		749		749
Total financial assets at fair value	$	1,573	$	19,858	$	2,466	$	23,897	$	23,897
Liabilities
Derivatives:
FIA embedded derivatives, included in contractholder funds	$	—	$	—	$	2,476	$	2,476	$	2,476
Preferred shares reimbursement feature embedded derivative	—		—		29		29		29
Fair value of future policy benefits	—		—		725		725		725
Total financial liabilities at fair value	$	—	$	—	$	3,230	$	3,230	$	3,230

Valuation Methodologies

Fixed Maturity Securities & Equity Securities

The Company measures the fair value of its securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity or equity security, and the Company will then consistently apply the valuation methodology to measure the security’s fair value. The Company's fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services, independent broker quotations, or pricing matrices. The Company uses observable and unobservable inputs in its valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met.

For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant unobservable input used in the fair value measurement of equity securities for which the market approach valuation technique is employed is yield for comparable securities. Increases or decreases in the yields would result in lower or higher, respectively, fair value measurements. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. Management believes the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices. The Company has an equity investment in a private business development company which is not traded on an exchange or valued by other sources such as analytics or brokers. The Company based the fair value of this investment on an estimated net asset value provided by the investee. Management did not make any adjustments to this valuation.

The fair value of the Company's investment in mutual funds is based on the net asset value published by the respective mutual fund and represents the value the Company would have received if it withdrew its investment on the balance sheet date.

The Company did not adjust prices received from third parties as of March 31, 2019 or December 31, 2018. However, the Company does analyze the third-party valuation methodologies and related inputs to perform assessments to determine the appropriate level within the fair value hierarchy.

Derivative Financial Instruments

The fair value of call option assets is based upon valuation pricing models, which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the options, entered into offsetting positions, or exercised the options. Fair values for these instruments are determined internally, based on valuation pricing models which use market-observable inputs, including interest rates, yield curve volatilities, and other factors.

The fair value of futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements) which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the futures contract or entered into offsetting positions. These contracts are classified as Level 1.

The fair value measurement of the FIA embedded derivatives included in contractholder funds is determined through a combination of market observable information and significant unobservable inputs. The market observable inputs are the market value of option and interest swap rates. The significant unobservable inputs are the mortality multiplier, surrender rates, non-performance spread and option costs. The mortality multiplier at March 31, 2019 and December 31, 2018 was applied to the Annuity 2000 mortality tables. Significant increases or decreases in the market value of an option in isolation would result in a higher or lower, respectively, fair value measurement. Significant increases or decreases in interest swap rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher fair value measurement, respectively. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input.

The fair value of the Reimbursement Feature is determined using a Black Derman Toy model, incorporating the paid in kind dividend coupon, the Company's redemption option and the preferred shareholder's remarketing feature. The remarketing feature allows the shareholder to put the preferred shares to the Company for a value of par after five years and, if after a successful remarketing event the amount is less than 90% par, up to a maximum of 10% of liquidation price defined. Fair value of this derivative decreased $2 during the threemonths endedMarch 31, 2019, due to changes in the credit spread.

Other Invested Assets

Fair value of the AnchorPath embedded derivative is based on an unobservable input, the net asset value of the AnchorPath fund at the balance sheet date.  The embedded derivative is similar to a call option on the net asset value of the AnchorPath fund with a strike price of zero since FGL Insurance will not be required to make any additional payments at maturity of the fund-linked note in order to receive the net asset value of the AnchorPath fund on the maturity date.  A Black-Scholes model determines the net asset value of the AnchorPath fund as the fair value of the call option regardless of the values used for the other inputs to the option pricing model.  The net asset value of the AnchorPath fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black-Scholes model is the value of the AnchorPath fund. As the value of the AnchorPath fund increases or decreases, the fair value of the embedded derivative will increase or decrease.

FSRC and F&G Re Funds Withheld for Reinsurance Receivables and Future Policy Benefits

FSRC and F&G Re elected to apply the Fair Value Option to account for its funds withheld receivables and future policy benefits liability related to its assumed reinsurance. FSRC and F&G Re measures the fair value of the Funds Withheld for Reinsurance Receivables based on the fair values of the securities in the underlying funds withheld portfolio held by the cedant. FSRC and F&G Re use a discounted cash flows approach to measure the fair value of the Future Policy Benefits Reserve. The cash flows associated with future policy premiums and benefits are generated using best estimate assumptions (plus a risk margin, where applicable) and are consistent with market prices, where available. Risk margins are typically applied to non-observable, non-hedgeable market inputs such as long term volatility, mortality, morbidity, lapse, etc.

The significant unobservable inputs used in the fair value measurement of the FSRC and F&G Re future policy benefit liability are undiscounted cash flows, non-performance risk spread and risk margin to reflect uncertainty.  Undiscounted cash flows used in our March 31, 2019 discounted cash flow model equaled $1,152.  Increases or decreases in non-performance risk spread and risk margin to reflect uncertainty would result in a lower or higher fair value measurement, respectively. 

Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of March 31, 2019 and December 31, 2018, are as follows:

	Fair Value at		Valuation Technique	Unobservable Input(s)	Range (Weighted average)
	March 31, 2019				March 31, 2019
Assets
Asset-backed securities	$	489	Broker-quoted	Offered quotes	97.50% - 105.17% (100.84%)
Asset-backed securities	19		Third-Party Valuation	Offered quotes	0.00% - 98.30% (28.44%)
Commercial mortgage-backed securities	43		Broker-quoted	Offered quotes	81.01% - 100.14% (87.90%)
Commercial mortgage-backed securities	25		Matrix Pricing	Quoted prices	121.01% - 121.01% (121.01%)
Corporates	731		Broker-quoted	Offered quotes	54.00% - 107.83% (99.49%)
Corporates	478		Matrix Pricing	Quoted prices	95.94% - 117.55% (101.67%)
Hybrids	10		Matrix Pricing	Quoted prices	98.84% - 98.84% (98.84%)
Municipals	38		Broker-quoted	Offered quotes	114.61% - 114.61% (114.61%)
Residential mortgage-backed securities	619		Broker-quoted	Offered quotes	92.52% - 103.81% (103.34%)
Foreign governments	16		Broker-quoted	Offered quotes	101.38% - 103.55% (102.06%)
Equity securities	16		Broker-quoted	Offered quotes	100.00%
Equity securities (Salus preferred equity)	4		Income-Approach	Yield	7.18%
Other Invested Assets:
Available-for-sale embedded derivative (AnchorPath)	16		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit Linked Note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables at fair value	6		Matrix pricing	Quoted prices	100.00%
Funds withheld for reinsurance receivables at fair value	1		Loan recovery value	Recovery rate	14.00%
Total	$	2,536
Liabilities
Future policy benefits	$	797	Discounted cash flow	Market value of option	0.88% - 6.95% (1.90%)
				Mortality multiplier	90.00% - 100.00% (100.00%)
				Surrender rates	0.65% - 40.00% (4.63%)
				Partial withdrawals	0.00% - 2.50% (0.93%)
				Non-performance spread	0.00% - 0.10% (0.03%)
				Option cost	1.14% - 4.58% (1.72%)
				Risk margin to reflect uncertainty	0.35% - 0.62% (0.44%)
				Morbidity risk margin	0.00% - 2.00% (0.17%)
Derivatives:
FIA embedded derivatives included in contractholder funds	2,720		Discounted cash flow	Market value of option	0.00% - 32.37% (2.23%)
				SWAP rates	2.29% - 2.41% (2.34%)

				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.86%)
				Partial withdrawals	1.00% - 2.50% (2.00%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.18% - 16.61% (2.16%)
Preferred shares reimbursement feature embedded derivative	27		Black Derman Toy model	Credit Spread	4.50%
				Yield Volatility	20.00%
Total liabilities at fair value	$	3,544

	Fair Value at		Valuation Technique	Unobservable Input(s)	Range (Weighted average)
	December 31, 2018				December 31, 2018
Assets
Asset-backed securities	$	405	Broker-quoted	Offered quotes	97.00% - 102.00% (99.77%)
Asset-backed securities	24		Matrix Pricing	Quoted prices	96.07% - 96.07% (96.07%)
Asset-backed securities	15		Third-Party Valuation	Offered quotes	0.00% - 99.29% (23.05%)
Commercial mortgage-backed securities	43		Broker-quoted	Offered quotes	77.12% - 100.08% (85.46%)
Commercial mortgage-backed securities	24		Matrix Pricing	Quoted prices	117.72% - 117.72% (117.72%)
Corporates	577		Broker-quoted	Offered quotes	74.63% - 104.62% (97.80%)
Corporates	654		Matrix Pricing	Quoted prices	91.74% - 113.25% (98.86%)
Hybrids	10		Matrix Pricing	Quoted prices	96.60% - 96.60% (96.60%)
Municipals	37		Broker-quoted	Offered quotes	111.23% - 111.23% (111.23%)
Residential mortgage-backed securities	614		Broker-quoted	Offered quotes	89.80% - 100.99% (100.73%)
Foreign governments	16		Broker-quoted	Offered quotes	98.38% - 99.01% (98.58%)
Equity securities (Salus preferred equity)	4		Income-Approach	Yield	7.15%
Other Invested Assets:
Available-for-sale embedded derivative (AnchorPath)	14		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit Linked Note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables, at fair value	4		Matrix pricing	Calculated prices	100.00%
Total	$	2,466
Liabilities
Future policy benefits	$	725	Discounted cash flow	Non-Performance risk spread	0.00% - 0.22% (0.18%)
				Risk margin to reflect uncertainty	0.35% - 0.71% (0.68%)
Derivatives:
FIA embedded derivatives included in contractholder funds	2,476		Discounted cash flow	Market value of option	0.00% - 31.06% (0.94%)
				SWAP rates	2.57% - 2.71% (2.63%)
				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.90%)
				Partial withdrawals	1.00% - 2.50% (2.00%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.11% - 16.61% (2.18%)
Preferred shares reimbursement feature embedded derivative	29		Black Derman Toy model	Credit Spread	5.14%
				Yield Volatility	20.00%
Total liabilities at fair value	$	3,230

Changes in unrealized losses (gains), net in the Company’s FIA embedded derivatives are included in "Benefits and other changes in policy reserves" in the unaudited Condensed Consolidated Statements of Operations.

The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the threemonths endedMarch 31, 2019 and 2018, respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.

	Three months ended March 31, 2019
	Balance at Beginning of Period		Total Gains (Losses)					Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	444	$	—		$	5	$	114	$	—		$	(31	)	$	(24	)	$	508
Commercial mortgage-backed securities	67		—			2		—		—			(1		)	—			68
Corporates	1,231		(1		)	24		—		(21		)	(35		)	11			1,209
Hybrids	10		—			—		—		—			—			—			10
Municipals	37		—			1		—		—			—			—			38
Residential mortgage-backed securities	614		—			16		7		—			(18		)	—			619
Foreign Governments	16		—			—		—		—			—			—			16
Equity securities	4		—			1		—		—			—			15			20
Other invested assets:
Available-for-sale embedded derivative	14		2			—		—		—			—			—			16
Credit linked note	25		—			—		—		—			—			—			25
Funds withheld for reinsurance receivables at fair value	4		—			—		5		—			—			(2		)	7
Total assets at Level 3 fair value	$	2,466	$	1		$	49	$	126	$	(21	)	$	(85	)	$	—		$	2,536
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,476	$	244		$	—	$	—	$	—		$	—		$	—		$	2,720
Future policy benefits	725		29			—		—		—			43			—			797
Preferred shares reimbursement feature embedded derivative	29		(2		)	—		—		—			—			—			27
Total liabilities at Level 3 fair value	$	3,230	$	271		$	—	$	—	$	—		$	43		$	—		$	3,544

(a) The net transfers out of Level 3 during the three months ended March 31, 2019 were exclusively to Level 2.

	Three months ended March 31, 2018
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales		Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	412	$	—		$	(2	)	$	28	$	—	$	(6	)	$	(131	)	$	301
Commercial mortgage-backed securities	49		—			(1		)	—		—		(6		)	—			42
Corporates	1,169		—			(20		)	100		—		(34		)	—			1,215
Hybrids	10		—			—			—		—		—			—			10
Municipals	38		—			(1		)	—		—		—			—			37
Residential mortgage-backed securities	66		—			—			—		—		(1		)	—			65
Foreign Governments	17		—			—			—		—		—			—			17
Equity securities	3		1			—			—		—		—			—			4
Other invested assets:
Available-for-sale embedded derivative	17		—			—			—		—		—			—			17
Funds withheld for reinsurance receivables, at fair value	4		—			—			2		—		—			—			6
Total assets at Level 3 fair value	$	1,785	$	1		$	(24	)	$	130	$	—	$	(47	)	$	(131	)	$	1,714
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,277	$	(98	)	$	—		$	—	$	—	$	—		$	—		$	2,179
Future policy benefits	728		(20		)	—			—		—		4			—			712
Preferred shares reimbursements feature embedded derivative	23		1			—			—		—		—			—			24
Total liabilities at Level 3 fair value	$	3,028	$	(117	)	$	—		$	—	$	—	$	4		$	—		$	2,915

(a) The net transfers out of Level 3 during the three months ended March 31, 2018 were exclusively to Level 2.

Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value

The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments.

Mortgage Loans

The fair value of mortgage loans is established using a discounted cash flow method based on credit rating, maturity and future income. This yield-based approach is sourced from our third-party vendor. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt service coverage, loan-to-value, quality of tenancy, borrower, and payment record. In the event of an impairment, the carrying value is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price, or the fair value of the collateral if the loan is collateral-dependent. The inputs used to measure the fair value of our mortgage loans are classified as Level 3 within the fair value hierarchy.

Policy Loans (included within Other Invested Assets)

Fair values for policy loans are estimated from a discounted cash flow analysis, using interest rates currently being offered for loans with similar credit risk.  Loans with similar characteristics are aggregated for purposes of the calculations.

Investment Contracts

Investment contracts include deferred annuities, FIAs, indexed universal life policies ("IULs") and immediate annuities. The fair value of deferred annuity, FIA, and IUL contracts is based on their cash surrender value (i.e. the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of immediate annuities contracts is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. At March 31, 2019 and December 31, 2018, this resulted in lower fair value reserves relative to the carrying value. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value.

Debt

The fair value of debt is based on quoted market prices. The inputs used to measure the fair value of our outstanding debt are classified as Level 2 within the fair value hierarchy. Our revolving credit facility debt is classified as Level 3 within the fair value hierarchy, and the estimated fair value reflects the carrying value as the revolver has no maturity date.

The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Condensed Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described.

	March 31, 2019
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	56	$	—	$	56	$	56
Commercial mortgage loans	—		—		485		485		479
Residential mortgage loans	—		—		199		199		195
Policy loans, included in other invested assets	—		—		12		12		23
Affiliated other invested assets	—		—		40		40		40
Funds withheld for reinsurance receivables, at fair value	—		—		5		5		5
Total	$	—	$	56	$	741	$	797	$	798
Liabilities
Investment contracts, included in contractholder funds	—		—		18,355		18,355		21,161
Debt	—		543		—		543		541
Total	$	—	$	543	$	18,355	$	18,898	$	21,702

	December 31, 2018
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	52	$	—	$	52	$	52
Commercial mortgage loans	—		—		483		483		482
Residential mortgage loans	—		—		187		187		185
Policy loans, included in other invested assets	—		—		11		11		22
Affiliated other invested assets	—		—		39		39		39
Funds withheld for reinsurance receivables, at fair value	—		—		8		8		8
Total	$	—	$	52	$	728	$	780	$	788
Liabilities
Investment contracts, included in contractholder funds	$	—	$	—	$	18,358	$	18,358	$	20,911
Debt	—		520		—		520		541
Total	$	—	$	520	$	18,358	$	18,878	$	21,452

The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments are measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices” to the Company's 2018 Form 10-K.

	Carrying Value After Measurement
	March 31, 2019		December 31, 2018
Equity securities	$	53	$	50
Limited partnership investment, included in other invested assets	595		510

For investments for which NAV is used as a practical expedient for fair value, the Company does not have any significant restrictions in their ability to liquidate their positions in these investments, other than obtaining general partner approval, nor does the Company believe it is probable a price less than NAV would be received in the event of a liquidation.

The Company reviews the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3, or between other levels, at the beginning fair value for the reporting period in which the changes occur. The transfers into and out of Level 3 were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value.

The Company’s assessment resulted in gross transfers into and gross transfers out of certain fair value levels by asset class for the threemonths endedMarch 31, 2019 and 2018, are as follows:

	Transfers Between Fair Value Levels
	Level 1				Level 2				Level 3
	In		Out		In		Out		In		Out
Three months ended March 31, 2019
Asset-backed securities	$	—	$	—	$	24	$	—	$	—	$	24
Corporates	—		—		—		11		11		—
Equity securities	5		17		2		5		15		—
Funds withheld for reinsurance receivables	—		—		2		—		—		2
Total transfers	$	5	$	17	$	28	$	16	$	26	$	26
Three months ended March 31, 2018
Asset-backed securities	$	—	$	—	$	131	$	—	$	—	$	131
Hybrids	15		—		—		15		—		—
Total transfers	$	15	$	—	$	131	$	15	$	—	$	131

XML

Intangible Assets

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Intangibles

A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows:

	VOBA			DAC			DSI			Total
Balance at December 31, 2018	$	866		$	344		$	149		$	1,359
Deferrals	—			91			35			126
Amortization	(31		)	(3		)	(2		)	(36		)
Interest	4			2			1			7
Unlocking	—			—			—			—
Adjustment for net unrealized investment (gains) losses	(35		)	—			—			(35		)
Balance at March 31, 2019	$	804		$	434		$	183		$	1,421

	VOBA			DAC			DSI			Total
Balance at December 31, 2017	$	821		$	22		$	10		$	853
Deferrals	—			59			26			85
Amortization	(30		)	(1		)	(1		)	(32		)
Interest	5			—			—			5
Unlocking	—			—			—			—
Adjustment for net unrealized investment (gains) losses	38			4			1			43
Balance at March 31, 2018	$	834		$	84		$	36		$	954

Amortization of VOBA, DAC, and DSI is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 0.05% to 4.01%. The adjustment for unrealized net investment losses (gains) represents the amount of VOBA, DAC, and DSI that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the unaudited Condensed Consolidated Statements of Operations. As of March 31, 2019 and 2018, the VOBA balances included cumulative adjustments for net unrealized investment (gains) losses of $40 and $22, respectively, the DAC balances included cumulative adjustments for net unrealized investment (gains) losses of $5 and $0, respectively, and the DSI balance included net unrealized investment (gains) losses of $2 and $2, respectively.

Estimated amortization expense for VOBA in future fiscal periods is as follows:

	Estimated Amortization Expense
Fiscal Year
2019	48
2020	83
2021	89
2022	84
2023	75
Thereafter	385

The Company had an unearned revenue liability balance of $(39) as of March 31, 2019, including deferrals of $(9), amortization of $2, unlocking of $0, and adjustment for net unrealized investment gains (losses) of $9.

Definite and Indefinite Lived Intangible Assets

Amortizable intangible assets as of March 31, 2019 consist of the following:

	Cost		Accumulated amortization		Net carrying amount		Weighted average useful life (years)
Trade marks / trade names	$	16	$	2	$	14	10
State insurance licenses	6		N/A		6		Indefinite
Total					$	20

XML

Debt

3 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

Debt

Debt

The carrying amount of the Company's outstanding debt as of March 31, 2019 and December 31, 2018 is as follows:

	March 31, 2019		December 31, 2018
Debt	$	541	$	541

As of March 31, 2019 and December 31, 2018, the company had not drawn on the revolver, which would have carried interest rates equal to 5.25% and 5.27%, respectively, had we drawn on the revolver. As of March 31, 2019 and December 31, 2018, the amount available to be drawn on the revolver was $250.

The interest expense and amortization of debt issuance costs for the threemonths endedMarch 31, 2019 and 2018, respectively, were as follows:

	Three months ended
	March 31, 2019		March 31, 2018
	Interest Expense	Amortization	Interest Expense	Amortization
Debt	8	—	5	—
Revolving credit facility	—	—	1	—

XML

Equity

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Equity

Equity

Share Repurchases

On December 19, 2018, the Company's Board of Directors authorized a share repurchase program of up to $150 of the Company's outstanding common stock. This program will expire on December 15, 2020, and may be modified at any time. Under the share repurchase program, the Company may repurchase shares from time to time in open market transactions or through privately negotiated transactions in accordance with applicable federal securities laws. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934. The extent to which the Company repurchases its shares, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other considerations, as determined by the Company.

During the three months ended March 31, 2019, the Company repurchased 3,728 thousand shares for a total cost of $30. As of March 31, 2019, the Company had repurchased a total of 4,328 thousand shares for a total cost of $34.

Dividends

The Company declared the following cash dividend to its common shareholders during the threemonths endedMarch 31, 2019.

Date Declared	Date Paid	Date Shareholders of record	Shareholders of record (in thousands)	Cash Dividend declared (per share)	Total cash paid
February 27, 2019	April 1, 2019	March 18, 2019	221,661	$0.01	$2

On May 7, 2019, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend will be paid on June 10, 2019 to shareholders of record as of the close of business on May 28, 2019.

The Company did not declare a cash dividend to its common shareholders during the threemonths endedMarch 31, 2018.

The Company declared the following dividends to its preferred shareholders during the threemonths endedMarch 31, 2019:

Type of Preferred Share	Date Declared	Date Paid	Date Shareholders of record	Shares outstanding at date of record (in thousands)	Method of Payment	Total cash paid	Total shares paid in kind (in thousands)
Series A Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	298	Paid in kind	$—	6
Series B Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	108	Paid in kind	$—	2

The Company declared the following dividends to its preferred shareholders during the threemonths endedMarch 31, 2018:

Type of Preferred Share	Date Declared	Date Paid	Date Shareholders of record	Shares outstanding at date of record (in thousands)	Method of Payment	Total cash paid	Total shares paid in kind (in thousands)
Series A Preferred Shares	March 29, 2018	April 1, 2018	March 15, 2018	277	Paid in kind	$—	5
Series B Preferred Shares	March 29, 2018	April 1, 2018	March 15, 2018	101	Paid in kind	$—	1

XML

Stock Compensation

3 Months Ended

Mar. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Compensation

Stock Compensation

On August 8, 2017, the Company adopted a stock-based incentive plan (the “FGL Incentive Plan”) that permits the granting of awards in the form of qualified stock options, non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, unrestricted stock, performance-based awards, dividend equivalents, cash awards and any combination of the foregoing. The Company’s Compensation Committee is authorized to grant up to 15,006 thousand equity awards under the Incentive Plan. At March 31, 2019, 5,588 thousand equity awards are available for future issuance.

FGL Incentive Plan

On February 26, 2019 FGL granted 1,699 thousand stock options to a certain officer of the Company. The following table summarizes the vesting conditions for these options:

Vesting mechanism	Vest Dates	Number of options subject to these vesting conditions
Service	Each March 15 from 2020 through 2023; subject to continued service	485
Service and return on equity performance	March 15 2020, 2021 and 2022 subject to continued service and targeted return on equity	607
Service and stock price performance	Each March 15 from 2019 through 2023; subject to continued service and target stock price goals being achieved	607

The total fair value of the options granted on February 26, 2019 was $3. The fair value of the awards is expensed over the service period, which generally corresponds to the vesting period.

At March 31, 2019, the intrinsic value of stock options outstanding or expected to vest was $76. At March 31, 2019, the weighted average remaining contractual term of stock options outstanding, exercisable and vested or expected to vest was 7 years, 6 years and 7 years, respectively. At March 31, 2019 there were 485 options that were exercisable.

A summary of the Company’s outstanding stock options as of March 31, 2019, and related activity during the threemonths endedMarch 31, 2019, is as follows (share amount in thousands):

Stock Option Awards	Options		Weighted Average Exercise Price
Stock options outstanding at December 31, 2018	13,007		$	9.68
Granted	1,699		10.00
Exercised	—		—
Forfeited or expired	(1,869	)	(10.00		)
Stock options outstanding at March 31, 2019	12,837		9.67
Exercisable at March 31, 2019	485		10.00
Vested or projected to vest at March 31, 2019	12,837		9.67

To value the options granted with service and return on equity performance vesting conditions, we used a Black Scholes valuation model. To value the options granted with stock price market performance vesting conditions, we used a Monte Carlo simulation. The following inputs and assumptions were used in the determination of the grant date fair values of the February 26, 2019 grants for each.

	Black-Scholes Model		Monte Carlo Model
	Serviced based	ROE Performance based	Stock Price Performance based	Source of input/ assumption
Weighted average fair value per options granted	$1.68	$1.74	$1.26	N/A
Risk-free interest rate	2.48%	2.50%	2.54%	US Treasury Curve
Assumed dividend yield	0.49%	0.49%	0.49%	Internal projection
Expected option term	5.75 years	6.0 years	N/A	Internal model
Contractual term	N/A	N/A	7.0 years	N/A
Volatility	26.00%	26.00%	26.00%	Predecessor and peer group experience
Early exercise multiple	N/A	N/A	2.8	Hull White model
Cost of equity	N/A	N/A	10.50%	Capital asset pricing model - 20 year risk free rate

The Company granted 147 thousand restricted shares to directors in the threemonths endedMarch 31, 2019. These shares will vest on December 31, 2019. The total fair value of the restricted shares granted in the threemonths endedMarch 31, 2019 was $1.

A summary of the Company’s nonvested restricted shares outstanding as of March 31, 2019, and related activity during the threemonths ended, is as follows (share amount in thousands):

Restricted Stock Awards	Shares	Weighted Average Grant Date Fair Value
Restricted shares outstanding at December 31, 2018	—	$	—
Granted	147	6.82
Vested	—	—
Forfeited or expired	—	—
Vested or expected to vest at March 31, 2019	147	6.82

Management Incentive Plan

In the threemonths endedMarch 31, 2019, the Company granted 424 thousand phantom units to members of management under a management incentive plan (the "Management Incentive Plan"). The total fair value of the restricted shares granted in the threemonths endedMarch 31, 2019 was $4.

One half of the phantom units vest in three equal installments on each March 15^th from 2020 to 2022, subject to awardees continued service with the Company. The other half will begin vesting on March 15, 2021 and cliff vest on March 15, 2022 based on continued service and attainment of a performance metric: adjusted operating income return on equity.

At March 31, 2019, the liability for phantom units of $1 was based on the number of units granted, the elapsed portion of the service period and the fair value of the Company’s common stock on that date which was $7.87.

A summary of the Management Incentive Plan nonvested phantom units outstanding as of March 31, 2019, and related activity during the threemonths ended, is as follows (share amount in thousands):

Phantom units	Shares		Weighted Average Grant Date Fair Value
Phantom units outstanding at December 31, 2018	356		$	8.95
Granted	424		8.64
Vested	(59	)	10.00
Forfeited or expired	(10	)	8.96
Phantom units outstanding at March 31, 2019	711		9.19

The Company recognized total stock compensation expense related to the FGL Incentive Plan and Management Incentive Plan is as follows:

	Three months ended
	March 31, 2019
FGL Incentive Plan
Stock options	$	1
Restricted shares	—
	1
Management Incentive Plan
Phantom units	—
	—
Total stock compensation expense	1
Related tax benefit	—
Net stock compensation expense	$	1

The stock compensation expense is included in "Acquisition and operating expenses, net of deferrals" in the unaudited Condensed Consolidated Statements of Operations.

Total compensation expense related to the FGL Incentive Plan and Management Incentive Plan not yet recognized as of March 31, 2019 and the weighted-average period over which this expense will be recognized are as follows:

	Unrecognized Compensation Expense		Weighted Average Recognition Period in Years
FGL Incentive Plan
Stock options	$	18	3
Restricted shares	1		1
	19
Management Incentive Plan
Phantom units	3		3
	3
Total unrecognized stock compensation expense	$	22	3

XML

Income Taxes

3 Months Ended

Mar. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The Company is a Cayman-domiciled corporation that has operations in Bermuda and the U.S. Neither the Cayman Islands nor Bermuda impose a corporate income tax. The Company’s U.S. non-life subsidiaries file a consolidated non-life U.S. Federal income tax return. The Company’s US life insurance subsidiaries file a separate life consolidated U.S. Federal income tax return. The life insurance companies will be eligible to join in a consolidated filing with the U.S. non-life companies in 2022.

The provision for income taxes represents federal income taxes. The effective tax rate for the threemonths endedMarch 31, 2019 was 5%. The effective tax rate for the threemonths endedMarch 31, 2018 was 38%. The effective tax rate on pre-tax income for the current threemonths endedMarch 31, 2019 differs from the U.S Federal statutory rate for 2019 of 21% primarily due to two factors. First, in 2018, a partial valuation allowance was established against the US Life companies' unrealized loss deferred tax assets because there were not sufficient sources of income to recover those assets. During the first quarter of 2019, the unrealized loss position recovered enough that the valuation allowance was no longer needed and it was released. Secondly, the Company had substantial income in jurisdictions that do not impose an income tax. The effective tax rate on pre-tax income for the threemonths endedMarch 31, 2018 differed from the U.S. Federal statutory rate for 2018 of 21% primarily due to the impact of an intended tax election. During the first quarter of 2018, there was uncertainty surrounding the impact of the Base-Erosion and Anti-Abuse Tax ("BEAT") that was enacted as part of the Tax Cut and Jobs Act and how it would impact the reinsurance agreement between F&G Life Re and FGL Insurance. As a result of the uncertainty, F&G Life Re intended to make an election under IRC Code Section 953(d) for the 2018 tax year to be treated as if it were a US taxpayer for the year.  As such, an opening balance sheet deferred tax liability was set up resulting in a discrete expense being recorded in the first quarter of 2018 that increased the first quarter effective rate. Based on clarifying guidance, the Company ultimately decided not to make that election in the fourth quarter of 2018.

As of March 31, 2019, the Company had a partial valuation allowance of $33 against its gross deferred tax assets of $316. The valuation allowance is an offset to the non-life companies deferred tax assets and FSRC deferred tax assets. The non-life insurance company subsidiaries have a history of losses and insufficient sources of future income that would allow for recognition of any of their deferred tax assets. FSRC is in a cumulative loss position and does not have a sufficient track record of earnings to recognize any portion of its deferred tax assets

The valuation allowance is reviewed quarterly and will be maintained until there is sufficient positive evidence to support a release. At each reporting date, management considers new evidence, both positive and negative, that could impact the future realization of deferred tax assets. Management will consider a release of the valuation allowance once there is sufficient positive evidence that it is more likely than not that the deferred tax assets will be realized. Any release of the valuation allowance will be recorded as a tax benefit increasing net income or other comprehensive income.

All other deferred tax assets are more likely than not to be realized based on expectations as to our future taxable income and considering all other available evidence, both positive and negative.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Commitments

The Company has unfunded investment commitments as of March 31, 2019 based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. A summary of unfunded commitments by invested asset class are included below:

	March 31, 2019
Asset Type
Other invested assets	$	1,093
Equity securities	21
Fixed maturity securities, available-for-sale	39
Other assets	5
Total	$	1,158

As of March 31, 2019, the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information.

Lease Commitments

The Company leases office space under non-cancelable operating leases that expire in May 2021. Rent expense and minimum rental commitments under non-cancelable leases are immaterial.

Contingencies

Regulatory and Litigation Matters

The Company is involved in various pending or threatened legal proceedings, including purported class actions, arising in the ordinary course of business. In some instances, these proceedings include claims for unspecified or substantial punitive damages and similar types of relief in addition to amounts for alleged contractual liability or requests for equitable relief. In the opinion of the Company's management and in light of existing insurance and other potential indemnification, reinsurance and established accruals, such litigation is not expected to have a material adverse effect on the Company's financial position, although it is possible that the results of operations and cash flows could be materially affected by an unfavorable outcome in any one period.

The Company is assessed amounts by state guaranty funds to cover losses to policyholders of insolvent or rehabilitated insurance companies. Those mandatory assessments may be partially recovered through a reduction in future premium taxes in certain states. At March 31, 2019, the Company has accrued $2 for guaranty fund assessments that is expected to be offset by estimated future premium tax deductions of $2.

The Company has received inquiries from a number of state regulatory authorities regarding our use of the U.S. Social Security Administration’s Death Master File (“Death Master File”) and compliance with state claims practices regulations and unclaimed property or escheatment laws. We have established procedures to periodically compare our in-force life insurance and annuity policies against the Death Master File or similar databases; investigate any identified potential matches to confirm the death of the insured; and determine whether benefits are due and attempt to locate the beneficiaries of any benefits due or, if no beneficiary can be located, escheat the benefit to the state as unclaimed property. We believe we have established sufficient reserves with respect to these matters; however, it is possible that third parties could dispute these amounts and additional payments or additional unreported claims or liabilities could be identified which could be significant and could have a material adverse effect on our results of operations.

On June 30, 2017, a putative class action complaint was filed against FGL Insurance, FGL, and FS Holdco II Ltd in the United States District Court for the District of Maryland, captioned Brokerage Insurance Partners v. Fidelity & Guaranty Life Insurance Company, Fidelity & Guaranty Life, FS Holdco II Ltd, and John Doe, No. 17-cv-1815. The complaint alleges that FGL Insurance breached the terms of its agency agreement with Brokerage Insurance Partners (“BIP”) and other agents by changing certain compensation terms. The complaint asserts, among other causes of action, breach of contract, defamation, tortious interference with contract, negligent misrepresentation, and violation of the Racketeer Influenced and Corrupt Organizations Act (“RICO”).  The complaint seeks to certify a class composed of all persons who entered into an agreement with FGL Insurance to sell life insurance and who sold at least one life insurance policy between January 1, 2015 and January 1, 2017.  The complaint seeks unspecified compensatory, consequential, and punitive damages in an amount not presently determinable, among other forms of relief.

On September 1, 2017, FGL Insurance filed a counterclaim against BIP and John and Jane Does 1-10, asserting, among other causes of action, breach of contract, fraud, civil conspiracy and violations of RICO. On September 22, 2017, Plaintiff filed an Amended Complaint, and on October 16, 2017, FGL Insurance filed an Amended Counterclaim against BIP, Agent Does 1-10, and Other Person Does 1-10. The parties also filed cross-Motions to Dismiss in Part.

On August 17, 2018, the Court in the BIP Litigation denied all pending Motions to Dismiss filed by all parties without prejudice, pending a decision as to whether the BIP Litigation will be consolidated into related litigation, captioned Fidelity & Guaranty Life Insurance Company v. Network Partners, et al., Case No. 17-cv-1508. On August 31, 2018, FGL Insurance filed its Answer to BIP’s Amended Complaint. Also on that date, FGL Insurance filed its Answer to Amended Complaint, Affirmative Defenses, and Counterclaim, Filed Pursuant to Fed. R. Civ. P. 12(a)(4)(A). As of March 31, 2019, BIP has not filed any paper or pleading in response to the Court’s August 17, 2018 Order or to FGL Insurance’s filing. BIP's response date has been adjourned to May 15, 2019.

As of the date of this report, the Company does not have sufficient information to determine whether it has exposure to any losses that would be either probable or reasonably estimable.

XML

Reinsurance

3 Months Ended

Mar. 31, 2019

Reinsurance Disclosures [Abstract]

Reinsurance

Reinsurance

The Company reinsures portions of its policy risks with other insurance companies. The use of indemnity reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding the Company's retention limit is reinsured. The Company primarily seeks reinsurance coverage in order to limit its exposure to mortality losses and enhance capital management. The Company follows reinsurance accounting when there is adequate risk transfer. Otherwise, the deposit method of accounting is followed. The Company also assumes policy risks from other insurance companies.

The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the threemonths endedMarch 31, 2019 and 2018 were as follows:

	Three months ended
	March 31, 2019				March 31, 2018
	Net Premiums Earned		Net Benefits Incurred		Net Premiums Earned		Net Benefits Incurred
Direct	57		372		60		41
Assumed	—		20		—		(21	)
Ceded	(41	)	(53	)	(42	)	(59	)
Net	16		339		18		(39	)

Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. The Company did not write off any significant reinsurance balances during the threemonths endedMarch 31, 2019 and 2018. The Company did not commute any ceded reinsurance treaties during the threemonths endedMarch 31, 2019 or 2018.

No policies issued by the Company have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance.

The Company has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues.

Effective January 1, 2017, FGL Insurance entered into an indemnity reinsurance agreement with Hannover Re, a third party reinsurer, to reinsure an inforce block of its FIA and fixed deferred annuity contracts with  GMWB and Guaranteed Minimum Death Benefit (“GMDB”) guarantees. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of the net retention of guarantee payments in excess of account value for GMWB and GMDB guarantees. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. Effective July 1, 2017, FGL Insurance extended this agreement to include new business issued during 2017. Effective January 1, 2018 FGL Insurance extended this agreement to include new business issued during 2018, and extended the recapture period from 8 to 12 years. Effective January 1, 2019, FGL Insurance extended this agreement to include new business issued during 2019. FGL Insurance incurred risk charge fees of $4 during the threemonths endedMarch 31, 2019, in relation to this reinsurance agreement.

Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $758 of certain MYGA and deferred annuity GAAP reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes a 40%, 45%, and 63% quota share percentage of these annuity plans for issue years 2013, 2001 through 2012, and 2000 and prior, respectively.

Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $4 billion of certain FIA statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes an 80% and 90% quota share percentage of these annuity plans for issue years 2013 through 2014, and 2007 and prior, respectively. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk.

F&G Reinsurance Companies

FSRC, an affiliate of FGL Insurance, has entered into various reinsurance agreements on a funds withheld basis, meaning that funds are withheld by the ceding company from the coinsurance premium owed to FSRC as collateral for FSRC's payment obligations. Accordingly, the collateral assets remain under the ultimate ownership of the ceding company. FSRC manages the assets supporting the reserves assumed in accordance with the internal investment policy of the ceding companies and applicable law. At March 31, 2019, FSRC had $286 of funds withheld receivables and $270 of insurance reserves related to these reinsurance treaties.

F&G Re, an affiliate of FGL Insurance, has entered into two reinsurance agreements on a funds withheld basis with unaffiliated parties. At March 31, 2019, F&G Re had $551 of funds withheld receivables and $527 of insurance reserves related to these reinsurance treaties.

See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts in "Note 2. Significant Accounting Policies and Practices" within the Company's 2018 Form 10-K.

XML

Related Party Transactions

3 Months Ended

Mar. 31, 2019

Related Party Transactions [Abstract]

Related Party Transactions

Related Party Transactions

Affiliated Investments

The Company, and certain subsidiaries of the Company, entered into investment management agreements with Blackstone ISG-I Advisors LLC ("BISGA"), a wholly-owned subsidiary of The Blackstone Group LP ("Blackstone") on December 1, 2017. Pursuant to the terms of the investment management agreements, BISGA may delegate certain of its investment management services to sub-managers and any fees or other remuneration payable to such sub-managers is payable by the Company out of the assets managed by such sub-managers. BISGA has delegated certain investment management services to its affiliates, Blackstone Real Estate Special Situations Advisors L.L.C. (“BRESSA”) and GSO Capital Advisors II LLC (“GSO Capital Advisors II”), pursuant to sub-management agreements executed between BISGA and each of BRESSA and GSO Capital Advisors. As of March 31, 2019 and December 31, 2018, the Company has a net liability of $25 and $20, respectively, for the services consumed under the investment management agreements and related sub-management agreements, partially offset by fees received and expense reimbursements from BISGA.

During the threemonths endedMarch 31, 2019, the Company received expense reimbursements from BISGA for the services consumed under these agreements. Fees received for these types of services are $2 for the threemonths endedMarch 31, 2019.

The Company holds certain fixed income security interests, limited partnerships and bank loans issued by portfolio companies that are affiliates of Blackstone Tactical Opportunities, an affiliate of Blackstone Tactical Opportunities LR Associates-B (Cayman) Ltd (the “Blackstone Fixed Income Securities”) both on a direct and indirect basis.  Indirect investments include an investment made in an affiliates’ asset backed fund while direct investments are an investment in affiliates' equity or debt securities.  As of March 31, 2019 and December 31, 2018, the Company held $1,549 and $1,461 in affiliated investments, respectively, which includes foreign exchange unrealized loss of $(4) and $(2), respectively. As of March 31, 2019 and December 31, 2018, the Company had unfunded commitments relating to affiliated investments of $971 and $990, respectively.

The Company purchased $12 and $185 of residential loans from Finance of America Holdings LLC, a Blackstone affiliate, during the three months ended March 31, 2019 and on December 17, 2018, respectively. 

On December 1, 2017, the Company executed an agreement with Blackstone Tactical Opportunities Advisors LLC ("BTO Advisors") and Fidelity National Financial, Inc. ("FNF"), to provide the Company transactional and operational services and advice through December 31, 2018. The agreement was amended on November 2, 2018 to provide services through June 30, 2019. The Company will pay fees to BTO Advisors (or its designee(s)), and to FNF in consideration for such services in cash, ordinary shares or warrants exercisable for ordinary shares of the Company. As of March 31, 2019, no such services have been provided.

The Company paid-in-kind dividends on preferred shares held by GSO Capital Partners, an indirect wholly owned subsidiary of The Blackstone Group LP, of 6 thousand shares for the threemonths endedMarch 31, 2019.

The Company had no gross realized gains or realized impairment losses on related party investments during the threemonths endedMarch 31, 2019 and 2018.

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands):

	Three months ended
	March 31, 2019		March 31, 2018
Net income (loss)	$	171	$	65
Less Preferred stock dividend	8		7
Net income (loss) available to common shares	163		58
Weighted-average common shares outstanding - basic	219,646		214,370
Dilutive effect of unvested restricted stock	36		—
Weighted-average shares outstanding - diluted	219,682		214,370
Net income (loss) per common share:
Basic	$	0.74	$	0.27
Diluted	$	0.74	$	0.27

The number of shares of common stock outstanding used in calculating the weighted average thereof reflects the actual number of FGL Holdings shares of common stock outstanding, excluding unvested restricted stock and shares held in treasury.

The calculation of diluted earnings per share for the threemonths endedMarch 31, 2019 excludes the incremental effect of 6 million weighted average common stock warrants outstanding due to their anti-dilutive effect. This calculation also excludes the potential dilutive effect of the 406 thousand preferred stock shares outstanding as of March 31, 2019 as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met. The calculation of diluted earnings per share for the threemonths endedMarch 31, 2019 excludes the incremental effect related to certain outstanding stock options due to their anti-dilutive effect. The number of weighted average equivalent shares excluded is 1,737 thousand shares for the threemonths endedMarch 31, 2019.

The calculation of diluted earnings per share for the threemonths endedMarch 31, 2018 excludes the potential dilutive effective of the 377 thousand preferred stock shares outstanding as of March 31, 2018 as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met.

XML

Insurance Subsidiary Financial Information and Regulatory Matters

3 Months Ended

Mar. 31, 2019

Insurance [Abstract]

Insurance Subsidiary Financial Information and Regulatory Matters

Insurance Subsidiary Financial Information and Regulatory Matters

The Company’s U.S. insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect DAC, DSI and VOBA, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items.

FSRC (Cayman), F&G Re (Bermuda), and F&G Life Re (Bermuda) file financial statements with their respective regulators that are based on U.S. GAAP.

FGL Insurance applies Iowa-prescribed accounting practices that permit Iowa-domiciled insurers to report equity call options used to economically hedge FIA index credits at amortized cost for statutory accounting purposes and to calculate FIA statutory reserves such that index credit returns will be included in the reserve only after crediting to the annuity contract. This resulted in a $48 decrease and $30 increase to statutory capital and surplus at March 31, 2019 and December 31, 2018, respectively.

FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset which increased Raven Re’s statutory capital and surplus by $100 and $110 at March 31, 2019 and December 31, 2018, respectively.

Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance which increased Raven Re’s statutory capital and surplus by $1 and $0 at March 31, 2019 and December 31, 2018, respectively. Without such permitted statutory accounting practices Raven Re’s statutory capital and (deficit) surplus would be $(4) and $(16) as of March 31, 2019 and December 31, 2018, respectively, and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by NAIC 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent. FGL Insurance’s statutory carrying value of Raven Re at March 31, 2019 and December 31, 2018 was $97 and $94, respectively.

As of March 31, 2019, FGL NY Insurance did not follow any prescribed or permitted statutory accounting practices that differ from the NAIC's statutory accounting practices.

The prescribed and permitted statutory accounting practices have no impact on the Company’s unaudited condensed consolidated financial statements which are prepared in accordance with GAAP.

XML

Significant Accounting Policies and Practices (Policies)

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Principles of Consolidation

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and all other entities in which the Company has a controlling financial interest and any variable interest entities ("VIEs") in which we are the primary beneficiary. All intercompany accounts and transactions have been eliminated in consolidation.

VIE

We are involved in certain entities that are considered VIEs as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support or where investors lack certain characteristics of a controlling financial interest. We assess our relationships to determine if we have the ability to direct the activities, or otherwise exert control, to evaluate if we are the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in our unaudited condensed consolidated financial statements. The Company has determined that we are not the primary beneficiary of a VIE as of March 31, 2019. See "Note 4. Investments" to the Company’s unaudited condensed consolidated financial statements for additional information on the Company’s investments in unconsolidated VIEs.

Significant Accounting Policies and Practices

Adoption of New Accounting Pronouncements

Premium Amortization on Purchased Callable Debt Securities

In March 2017, the FASB issued new guidance on the amortization of callable securities (ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The ASU requires premiums paid on purchased debt securities with an explicit call option to be amortized to the earliest call date, as opposed to the maturity date (as under current GAAP). The updated guidance is applicable to instruments that are callable based on explicit, non-contingent call features that are callable at fixed prices on preset dates. The amendments in this update should be applied using the modified retrospective method through a cumulative effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted this new accounting guidance effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements.

Amendments to Lease Accounting

In February 2016, the FASB issued amended guidance (ASU 2016-02, Leases (Topic 842)), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Notable amendments in this update will:

• require entities to recognize the rights and obligations resulting from all leases or lease components of contracts, including operating leases, as lease assets and lease liabilities, with an exception allowed for leases with a term of 12 months or less

• create a distinction between finance leases and operating leases, with classification criteria substantially similar to that for distinguishing between capital leases and operating leases under previous guidance

• not retain the accounting model for leveraged leases under previous guidance for leases that commence after the effective date of ASU 2016-02

• provide additional guidance on separating the lease components from the nonlease components of a contract

• require qualitative disclosures along with specific quantitative disclosures to provide information regarding the amount, timing, and uncertainty of cash flows arising from leases

• include modifications to align lessor accounting with the changes to lessee accounting, as well as changes to the requirements of recognizing a transaction as a sale and leaseback transaction, however, these changes will have no impact on the Company's current lease arrangements

The amendments are required to be applied at the beginning of the earliest period presented using a modified retrospective approach (including several optional practical expedients related to leases commenced before the effective date). The Company has adopted this standard effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements.

Future Accounting Pronouncements

Accounting pronouncements that will impact the Company in future periods have been disclosed in the Company’s 2018 Form 10-K. There have not been any additional accounting pronouncements issued during the quarter ended March 31, 2019 that are expected to impact the Company. The following two pronouncements were discussed in our 2018 Form 10-K but have been included below so as to provide an update on the Company’s status of adoption.

New Credit Loss Standard

In June 2016, the FASB issued new guidance (ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments), effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Notable amendments in this update will change the accounting for impairment of most financial assets and certain other instruments in the following ways:

• financial assets (or a group of financial assets) measured at amortized cost will be required to be presented at the net amount expected to be collected, with an allowance for credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset at purchase

• credit losses relating to AFS fixed maturity securities will be recorded through an allowance for credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for credit losses will be limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value

• the income statement will reflect the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount

• disclosures will be required to include information around how the credit loss allowance was developed, further details on information currently disclosed about credit quality of financing receivables and net investments in leases, and a rollforward of the allowance for credit losses for AFS fixed maturity securities as well as an aging analysis for securities that are past due

The amendments in this ASU may be early adopted during any interim or annual period beginning after December 15, 2018, however the Company has elected not to. The Company has identified the material asset classes impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply with the new guidance. The Company has developed a project plan to complete our adoption of this new standard, and is evaluating the impact of the new guidance on its consolidated financial statements.

Long-Duration Contracts

In August 2018, the FASB issued new guidance (ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts), effective for fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. Under this update:

• assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations

• the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income

• market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income

• deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts

• deferred acquisition costs must be written off for unexpected contract terminations

• disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed

The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not currently expect to early adopt this standard. The Company has identified specific areas that will be impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply as well as the impact of the new guidance on its consolidated financial statements.

XML

Investments (Tables)

3 Months Ended

Mar. 31, 2019

Investments, Debt and Equity Securities [Abstract]

Investments Classified by Contractual Maturity Date [Table Text Block]

The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations.

	March 31, 2019
	Amortized Cost		Fair Value
Corporates, Non-structured Hybrids, Municipal and Government securities:
Due in one year or less	$	160	$	160
Due after one year through five years	758		749
Due after five years through ten years	2,080		2,059
Due after ten years	10,281		9,994
Subtotal	13,279		12,962
Other securities which provide for periodic payments:
Asset-backed securities	5,033		4,974
Commercial mortgage-backed securities	2,596		2,647
Residential mortgage-backed securities	1,000		1,022
Subtotal	8,629		8,643
Total fixed maturity available-for-sale securities	$	21,908	$	21,605

Consolidated Investments

The Company's equity securities investments are carried at fair value with unrealized gains and losses included in net income. The Company’s consolidated investments at March 31, 2019 and December 31, 2018 are summarized as follows:

	March 31, 2019
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	5,033	$	23	$	(82	)	$	4,974	$	4,974
Commercial mortgage-backed securities	2,596		60		(9		)	2,647		2,647
Corporates	10,886		60		(356		)	10,590		10,590
Hybrids	988		6		(33		)	961		961
Municipals	1,211		16		(10		)	1,217		1,217
Residential mortgage-backed securities	1,000		27		(5		)	1,022		1,022
U.S. Government	56		—		—			56		56
Foreign Governments	138		2		(2		)	138		138
Total available-for-sale securities	21,908		194		(497		)	21,605		21,605
Equity securities	1,226		3		(58		)	1,171		1,171
Derivative investments	318		74		(87		)	305		305
Commercial mortgage loans	479		—		—			485		479
Residential mortgage loans	195		—		—			199		195
Other invested assets	759		—		(4		)	744		755
Total investments	$	24,885	$	271	$	(646	)	$	24,509	$	24,510

	December 31, 2018
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	4,954	$	15	$	(137	)	$	4,832	$	4,832
Commercial mortgage-backed securities	2,568		9		(40		)	2,537		2,537
Corporates	11,213		16		(848		)	10,381		10,381
Hybrids	992		—		(91		)	901		901
Municipals	1,216		3		(32		)	1,187		1,187
Residential mortgage-backed securities	1,027		12		(8		)	1,031		1,031
U.S. Government	120		—		(1		)	119		119
Foreign Governments	129		—		(8		)	121		121
Total available-for-sale securities	22,219		55		(1,165		)	21,109		21,109
Equity securities	1,526		1		(145		)	1,382		1,382
Derivative investments	330		2		(235		)	97		97
Commercial mortgage loans	482		—		—			483		482
Residential mortgage loans	185		—		—			187		185
Other invested assets	662		—		—			651		662
Total investments	$	25,404	$	58	$	(1,545	)	$	23,909	$	23,917

Fair Value and Gross Unrealized Losses of Available-for-Sale-Securities

The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows:

	March 31, 2019
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	2,696	$	(63	)	$	886	$	(19	)	$	3,582	$	(82	)
Commercial mortgage-backed securities	243		(4		)	250		(5		)	493		(9		)
Corporates	684		(15		)	7,227		(341		)	7,911		(356		)
Hybrids	333		(14		)	343		(19		)	676		(33		)
Municipals	45		—			482		(10		)	527		(10		)
Residential mortgage-backed securities	41		(1		)	238		(4		)	279		(5		)
U.S. Government	—		—			50		—			50		—
Foreign Government	—		—			81		(2		)	81		(2		)
Total available-for-sale securities	$	4,042	$	(97	)	$	9,557	$	(400	)	$	13,599	$	(497	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													468
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													1164
Total number of available-for-sale securities in an unrealized loss position													1,632

	December 31, 2018
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	2,924	$	(116	)	$	643	$	(21	)	$	3,567	$	(137	)
Commercial mortgage-backed securities	1,466		(34		)	262		(6		)	1,728		(40		)
Corporates	8,016		(772		)	1,465		(76		)	9,481		(848		)
Hybrids	858		(90		)	7		(1		)	865		(91		)
Municipals	850		(27		)	172		(5		)	1,022		(32		)
Residential mortgage-backed securities	139		(3		)	190		(5		)	329		(8		)
U.S. Government	69		—			50		(1		)	119		(1		)
Foreign Government	47		(3		)	68		(5		)	115		(8		)
Total available-for-sale securities	$	14,369	$	(1,045	)	$	2,857	$	(120	)	$	17,226	$	(1,165	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													556
Total number of available-for-sale securities in an unrealized loss position													2,107

Reconciliation of Other-than-Temporary Impairment on Fixed Maturity

Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Corporates	(2		)	(2		)
Total	$	(2	)	$	(2	)

The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the threemonths endedMarch 31, 2019 and 2018, for which a portion of the OTTI was recognized in AOCI:

	Three months ended
	March 31, 2019		March 31, 2018
Beginning balance	$	—	$	—
Increases attributable to credit losses on securities:
OTTI was previously recognized	—		—
OTTI was not previously recognized	—		—
Ending balance	$	—	$	—

The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the threemonths endedMarch 31, 2019 and 2018:

	Three months ended
	March 31, 2019			March 31, 2018
Credit impairment losses in operations	$	(2	)	$	(2	)
Change-of-intent losses in operations	—			—
Amortized cost	1			—
Fair value	1			—
Non-credit losses in other comprehensive income for investments which experienced OTTI	—			—

Schedule of Accounts, Notes, Loans and Financing Receivable

The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables:

	March 31, 2019				December 31, 2018
	Gross Carrying Value		% of Total		Gross Carrying Value		% of Total
Property Type:
Hotel	21		4	%	21		4	%
Industrial - General	37		8	%	37		8	%
Industrial - Warehouse	20		4	%	20		4	%
Multifamily	55		11	%	56		12	%
Office	146		31	%	147		30	%
Retail	200		42	%	201		42	%
Total commercial mortgage loans, gross of valuation allowance	$	479	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	479			$	482
U.S. Region:
East North Central	$	97	20	%	$	98	20	%
East South Central	19		4	%	19		4	%
Middle Atlantic	78		16	%	79		17	%
Mountain	65		14	%	65		13	%
New England	10		2	%	10		2	%
Pacific	115		24	%	116		24	%
South Atlantic	57		12	%	57		12	%
West North Central	13		3	%	13		3	%
West South Central	25		5	%	25		5	%
Total commercial mortgage loans, gross of valuation allowance	$	479	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	479			$	482

Schedule of Investment in Mortgage Loans by Loan to Value and Debt Service Coverage Ratios

The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at March 31, 2019 and December 31, 2018:

	Debt-Service Coverage Ratios				Total Amount		% of Total		Estimated Fair Value		% of Total
	>1.25		1.00 - 1.25
March 31, 2019
LTV Ratios:
Less than 50%	$	299	$	6	$	305	64	%	$	309	64	%
50% to 60%	163		—		163		34	%	165		34	%
60% to 75%	11		—		11		2	%	11		2	%
Commercial mortgage loans	$	473	$	6	$	479	100	%	$	485	100	%
December 31, 2018
LTV Ratios:
Less than 50%	$	296	$	6	$	302	63	%	$	302	63	%
50% to 60%	169		—		169		35	%	170		35	%
60% to 75%	11		—		11		2	%	11		2	%
Commercial mortgage loans	$	476	$	6	$	482	100	%	$	483	100	%

XML

Derivative Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows:

	March 31, 2019		December 31, 2018
Assets:
Derivative investments:
Call options	$	304	$	97
Futures contracts	1		—
Other invested assets:
Other derivatives and embedded derivatives	17		14
	$	322	$	111

Liabilities:
Contractholder funds:
FIA embedded derivative	$	2,720	$	2,476
Other liabilities:
Preferred shares reimbursement feature embedded derivative	27		29
	$	2,747	$	2,505

FGL's Exposure to Credit Loss on Call Options Held

Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table:

		March 31, 2019
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	3,496	$	70	$	25	$	45
Deutsche Bank	A-/A3/BBB+	1,151		14		14		—
Morgan Stanley	*/A1/A+	1,657		25		24		1
Barclay's Bank	A+/A2/A	2,752		79		61		18
Canadian Imperial Bank of Commerce	*/Aa2/A+	1,430		41		29		12
Wells Fargo	A+/A2/A-	2,034		58		56		2
Goldman Sachs	A/A3/BBB+	1,030		17		16		1
Total		$	13,550	$	304	$	225	$	79

		December 31, 2018
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	3,952	$	25	$	—	$	25
Deutsche Bank	A-/A3/BBB+	1,327		5		6		(1		)
Morgan Stanley	*/A1/A+	1,648		9		6		3
Barclay's Bank	A+/A2/A	2,205		27		20		7
Canadian Imperial Bank of Commerce	*/Aa2/A+	1,716		11		8		3
Wells Fargo	A+/A2/A-	1,635		17		16		1
Goldman Sachs	A/A3/BBB+	647		3		3		—
Total		$	13,130	$	97	$	59	$	38

(a) An * represents credit ratings that were not available.

Derivative Instruments, Gain (Loss) [Table Text Block]

The change in fair value of derivative instruments included in the accompanying unaudited Condensed Consolidated Statements of Operations is as follows:

	Three months ended
	March 31, 2019			March 31, 2018
Revenues:
Net investment gains (losses):
Call options	$	154		$	(122	)
Futures contracts	8			(2		)
Foreign currency forward	2			—
Other derivatives and embedded derivatives	3			—
Reinsurance related embedded derivatives	(3		)	(21		)
Total net investment gains (losses)	$	164		$	(145	)
Benefits and other changes in policy reserves:
FIA embedded derivatives	$	244		$	(98	)
Acquisition and operating expenses, net of deferrals:
Preferred shares reimbursement feature embedded derivative	$	2		$	(1	)

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Assets and Liabilities Carrying at Fair Value on Recurring Basis

The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows:

	March 31, 2019
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	1,357	$	—	$	—	$	1,357	$	1,357
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,466		508		4,974		4,974
Commercial mortgage-backed securities	—		2,579		68		2,647		2,647
Corporates	—		9,381		1,209		10,590		10,590
Hybrids	277		674		10		961		961
Municipals	—		1,179		38		1,217		1,217
Residential mortgage-backed securities	—		403		619		1,022		1,022
U.S. Government	51		5		—		56		56
Foreign Governments	—		122		16		138		138
Equity securities	441		657		20		1,118		1,118
Derivative investments	1		304		—		305		305
Other invested assets	—		—		41		41		41
Funds withheld for reinsurance receivables, at fair value	161		664		7		832		832
Total financial assets at fair value	$	2,288	$	20,434	$	2,536	$	25,258	$	25,258
Liabilities
Derivatives:
FIA embedded derivatives, included in contractholder funds	—		—		2,720		2,720		2,720
Preferred shares reimbursement feature embedded derivative	—		—		27		27		27
Fair value of future policy benefits	—		—		797		797		797
Total financial liabilities at fair value	$	—	$	—	$	3,544	$	3,544	$	3,544

	December 31, 2018
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	571	$	—	$	—	$	571	$	571
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,388		444		4,832		4,832
Commercial mortgage-backed securities	—		2,470		67		2,537		2,537
Corporates	—		9,150		1,231		10,381		10,381
Hybrids	265		626		10		901		901
Municipals	—		1,150		37		1,187		1,187
Residential mortgage-backed securities	—		417		614		1,031		1,031
U.S. Government	114		5		—		119		119
Foreign Governments	—		105		16		121		121
Equity securities	454		874		4		1,332		1,332
Derivative investments	—		97		—		97		97
Other invested assets	—		—		39		39		39
Funds withheld for reinsurance receivables, at fair value	169		576		4		749		749
Total financial assets at fair value	$	1,573	$	19,858	$	2,466	$	23,897	$	23,897
Liabilities
Derivatives:
FIA embedded derivatives, included in contractholder funds	$	—	$	—	$	2,476	$	2,476	$	2,476
Preferred shares reimbursement feature embedded derivative	—		—		29		29		29
Fair value of future policy benefits	—		—		725		725		725
Total financial liabilities at fair value	$	—	$	—	$	3,230	$	3,230	$	3,230

The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Condensed Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described.

	March 31, 2019
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	56	$	—	$	56	$	56
Commercial mortgage loans	—		—		485		485		479
Residential mortgage loans	—		—		199		199		195
Policy loans, included in other invested assets	—		—		12		12		23
Affiliated other invested assets	—		—		40		40		40
Funds withheld for reinsurance receivables, at fair value	—		—		5		5		5
Total	$	—	$	56	$	741	$	797	$	798
Liabilities
Investment contracts, included in contractholder funds	—		—		18,355		18,355		21,161
Debt	—		543		—		543		541
Total	$	—	$	543	$	18,355	$	18,898	$	21,702

	December 31, 2018
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	52	$	—	$	52	$	52
Commercial mortgage loans	—		—		483		483		482
Residential mortgage loans	—		—		187		187		185
Policy loans, included in other invested assets	—		—		11		11		22
Affiliated other invested assets	—		—		39		39		39
Funds withheld for reinsurance receivables, at fair value	—		—		8		8		8
Total	$	—	$	52	$	728	$	780	$	788
Liabilities
Investment contracts, included in contractholder funds	$	—	$	—	$	18,358	$	18,358	$	20,911
Debt	—		520		—		520		541
Total	$	—	$	520	$	18,358	$	18,878	$	21,452

Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis

Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of March 31, 2019 and December 31, 2018, are as follows:

	Fair Value at		Valuation Technique	Unobservable Input(s)	Range (Weighted average)
	March 31, 2019				March 31, 2019
Assets
Asset-backed securities	$	489	Broker-quoted	Offered quotes	97.50% - 105.17% (100.84%)
Asset-backed securities	19		Third-Party Valuation	Offered quotes	0.00% - 98.30% (28.44%)
Commercial mortgage-backed securities	43		Broker-quoted	Offered quotes	81.01% - 100.14% (87.90%)
Commercial mortgage-backed securities	25		Matrix Pricing	Quoted prices	121.01% - 121.01% (121.01%)
Corporates	731		Broker-quoted	Offered quotes	54.00% - 107.83% (99.49%)
Corporates	478		Matrix Pricing	Quoted prices	95.94% - 117.55% (101.67%)
Hybrids	10		Matrix Pricing	Quoted prices	98.84% - 98.84% (98.84%)
Municipals	38		Broker-quoted	Offered quotes	114.61% - 114.61% (114.61%)
Residential mortgage-backed securities	619		Broker-quoted	Offered quotes	92.52% - 103.81% (103.34%)
Foreign governments	16		Broker-quoted	Offered quotes	101.38% - 103.55% (102.06%)
Equity securities	16		Broker-quoted	Offered quotes	100.00%
Equity securities (Salus preferred equity)	4		Income-Approach	Yield	7.18%
Other Invested Assets:
Available-for-sale embedded derivative (AnchorPath)	16		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit Linked Note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables at fair value	6		Matrix pricing	Quoted prices	100.00%
Funds withheld for reinsurance receivables at fair value	1		Loan recovery value	Recovery rate	14.00%
Total	$	2,536
Liabilities
Future policy benefits	$	797	Discounted cash flow	Market value of option	0.88% - 6.95% (1.90%)
				Mortality multiplier	90.00% - 100.00% (100.00%)
				Surrender rates	0.65% - 40.00% (4.63%)
				Partial withdrawals	0.00% - 2.50% (0.93%)
				Non-performance spread	0.00% - 0.10% (0.03%)
				Option cost	1.14% - 4.58% (1.72%)
				Risk margin to reflect uncertainty	0.35% - 0.62% (0.44%)
				Morbidity risk margin	0.00% - 2.00% (0.17%)
Derivatives:
FIA embedded derivatives included in contractholder funds	2,720		Discounted cash flow	Market value of option	0.00% - 32.37% (2.23%)
				SWAP rates	2.29% - 2.41% (2.34%)

				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.86%)
				Partial withdrawals	1.00% - 2.50% (2.00%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.18% - 16.61% (2.16%)
Preferred shares reimbursement feature embedded derivative	27		Black Derman Toy model	Credit Spread	4.50%
				Yield Volatility	20.00%
Total liabilities at fair value	$	3,544

	Fair Value at		Valuation Technique	Unobservable Input(s)	Range (Weighted average)
	December 31, 2018				December 31, 2018
Assets
Asset-backed securities	$	405	Broker-quoted	Offered quotes	97.00% - 102.00% (99.77%)
Asset-backed securities	24		Matrix Pricing	Quoted prices	96.07% - 96.07% (96.07%)
Asset-backed securities	15		Third-Party Valuation	Offered quotes	0.00% - 99.29% (23.05%)
Commercial mortgage-backed securities	43		Broker-quoted	Offered quotes	77.12% - 100.08% (85.46%)
Commercial mortgage-backed securities	24		Matrix Pricing	Quoted prices	117.72% - 117.72% (117.72%)
Corporates	577		Broker-quoted	Offered quotes	74.63% - 104.62% (97.80%)
Corporates	654		Matrix Pricing	Quoted prices	91.74% - 113.25% (98.86%)
Hybrids	10		Matrix Pricing	Quoted prices	96.60% - 96.60% (96.60%)
Municipals	37		Broker-quoted	Offered quotes	111.23% - 111.23% (111.23%)
Residential mortgage-backed securities	614		Broker-quoted	Offered quotes	89.80% - 100.99% (100.73%)
Foreign governments	16		Broker-quoted	Offered quotes	98.38% - 99.01% (98.58%)
Equity securities (Salus preferred equity)	4		Income-Approach	Yield	7.15%
Other Invested Assets:
Available-for-sale embedded derivative (AnchorPath)	14		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit Linked Note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables, at fair value	4		Matrix pricing	Calculated prices	100.00%
Total	$	2,466
Liabilities
Future policy benefits	$	725	Discounted cash flow	Non-Performance risk spread	0.00% - 0.22% (0.18%)
				Risk margin to reflect uncertainty	0.35% - 0.71% (0.68%)
Derivatives:
FIA embedded derivatives included in contractholder funds	2,476		Discounted cash flow	Market value of option	0.00% - 31.06% (0.94%)
				SWAP rates	2.57% - 2.71% (2.63%)
				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.90%)
				Partial withdrawals	1.00% - 2.50% (2.00%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.11% - 16.61% (2.18%)
Preferred shares reimbursement feature embedded derivative	29		Black Derman Toy model	Credit Spread	5.14%
				Yield Volatility	20.00%
Total liabilities at fair value	$	3,230

Changes in unrealized losses (gains), net in the Company’s FIA embedded derivatives are included in "Benefits and other changes in policy reserves" in the unaudited Condensed Consolidated Statements of Operations.

Changes in Fair Value of Financial Instruments - Assets

The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the threemonths endedMarch 31, 2019 and 2018, respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.

	Three months ended March 31, 2019
	Balance at Beginning of Period		Total Gains (Losses)					Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	444	$	—		$	5	$	114	$	—		$	(31	)	$	(24	)	$	508
Commercial mortgage-backed securities	67		—			2		—		—			(1		)	—			68
Corporates	1,231		(1		)	24		—		(21		)	(35		)	11			1,209
Hybrids	10		—			—		—		—			—			—			10
Municipals	37		—			1		—		—			—			—			38
Residential mortgage-backed securities	614		—			16		7		—			(18		)	—			619
Foreign Governments	16		—			—		—		—			—			—			16
Equity securities	4		—			1		—		—			—			15			20
Other invested assets:
Available-for-sale embedded derivative	14		2			—		—		—			—			—			16
Credit linked note	25		—			—		—		—			—			—			25
Funds withheld for reinsurance receivables at fair value	4		—			—		5		—			—			(2		)	7
Total assets at Level 3 fair value	$	2,466	$	1		$	49	$	126	$	(21	)	$	(85	)	$	—		$	2,536
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,476	$	244		$	—	$	—	$	—		$	—		$	—		$	2,720
Future policy benefits	725		29			—		—		—			43			—			797
Preferred shares reimbursement feature embedded derivative	29		(2		)	—		—		—			—			—			27
Total liabilities at Level 3 fair value	$	3,230	$	271		$	—	$	—	$	—		$	43		$	—		$	3,544

(a) The net transfers out of Level 3 during the three months ended March 31, 2019 were exclusively to Level 2.

	Three months ended March 31, 2018
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales		Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	412	$	—		$	(2	)	$	28	$	—	$	(6	)	$	(131	)	$	301
Commercial mortgage-backed securities	49		—			(1		)	—		—		(6		)	—			42
Corporates	1,169		—			(20		)	100		—		(34		)	—			1,215
Hybrids	10		—			—			—		—		—			—			10
Municipals	38		—			(1		)	—		—		—			—			37
Residential mortgage-backed securities	66		—			—			—		—		(1		)	—			65
Foreign Governments	17		—			—			—		—		—			—			17
Equity securities	3		1			—			—		—		—			—			4
Other invested assets:
Available-for-sale embedded derivative	17		—			—			—		—		—			—			17
Funds withheld for reinsurance receivables, at fair value	4		—			—			2		—		—			—			6
Total assets at Level 3 fair value	$	1,785	$	1		$	(24	)	$	130	$	—	$	(47	)	$	(131	)	$	1,714
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,277	$	(98	)	$	—		$	—	$	—	$	—		$	—		$	2,179
Future policy benefits	728		(20		)	—			—		—		4			—			712
Preferred shares reimbursements feature embedded derivative	23		1			—			—		—		—			—			24
Total liabilities at Level 3 fair value	$	3,028	$	(117	)	$	—		$	—	$	—	$	4		$	—		$	2,915

(a) The net transfers out of Level 3 during the three months ended March 31, 2018 were exclusively to Level 2.

Changes in Fair Value of Financial Instruments - Liabilities

The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the threemonths endedMarch 31, 2019 and 2018, respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.

	Three months ended March 31, 2019
	Balance at Beginning of Period		Total Gains (Losses)					Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	444	$	—		$	5	$	114	$	—		$	(31	)	$	(24	)	$	508
Commercial mortgage-backed securities	67		—			2		—		—			(1		)	—			68
Corporates	1,231		(1		)	24		—		(21		)	(35		)	11			1,209
Hybrids	10		—			—		—		—			—			—			10
Municipals	37		—			1		—		—			—			—			38
Residential mortgage-backed securities	614		—			16		7		—			(18		)	—			619
Foreign Governments	16		—			—		—		—			—			—			16
Equity securities	4		—			1		—		—			—			15			20
Other invested assets:
Available-for-sale embedded derivative	14		2			—		—		—			—			—			16
Credit linked note	25		—			—		—		—			—			—			25
Funds withheld for reinsurance receivables at fair value	4		—			—		5		—			—			(2		)	7
Total assets at Level 3 fair value	$	2,466	$	1		$	49	$	126	$	(21	)	$	(85	)	$	—		$	2,536
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,476	$	244		$	—	$	—	$	—		$	—		$	—		$	2,720
Future policy benefits	725		29			—		—		—			43			—			797
Preferred shares reimbursement feature embedded derivative	29		(2		)	—		—		—			—			—			27
Total liabilities at Level 3 fair value	$	3,230	$	271		$	—	$	—	$	—		$	43		$	—		$	3,544

(a) The net transfers out of Level 3 during the three months ended March 31, 2019 were exclusively to Level 2.

	Three months ended March 31, 2018
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales		Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	412	$	—		$	(2	)	$	28	$	—	$	(6	)	$	(131	)	$	301
Commercial mortgage-backed securities	49		—			(1		)	—		—		(6		)	—			42
Corporates	1,169		—			(20		)	100		—		(34		)	—			1,215
Hybrids	10		—			—			—		—		—			—			10
Municipals	38		—			(1		)	—		—		—			—			37
Residential mortgage-backed securities	66		—			—			—		—		(1		)	—			65
Foreign Governments	17		—			—			—		—		—			—			17
Equity securities	3		1			—			—		—		—			—			4
Other invested assets:
Available-for-sale embedded derivative	17		—			—			—		—		—			—			17
Funds withheld for reinsurance receivables, at fair value	4		—			—			2		—		—			—			6
Total assets at Level 3 fair value	$	1,785	$	1		$	(24	)	$	130	$	—	$	(47	)	$	(131	)	$	1,714
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,277	$	(98	)	$	—		$	—	$	—	$	—		$	—		$	2,179
Future policy benefits	728		(20		)	—			—		—		4			—			712
Preferred shares reimbursements feature embedded derivative	23		1			—			—		—		—			—			24
Total liabilities at Level 3 fair value	$	3,028	$	(117	)	$	—		$	—	$	—	$	4		$	—		$	2,915

(a) The net transfers out of Level 3 during the three months ended March 31, 2018 were exclusively to Level 2.

Schedule of Net Asset Value

The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments are measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices” to the Company's 2018 Form 10-K.

	Carrying Value After Measurement
	March 31, 2019		December 31, 2018
Equity securities	$	53	$	50
Limited partnership investment, included in other invested assets	595		510

Gross Transfers Into and Out of Certain Fair Value Levels by Asset Class

The Company’s assessment resulted in gross transfers into and gross transfers out of certain fair value levels by asset class for the threemonths endedMarch 31, 2019 and 2018, are as follows:

	Transfers Between Fair Value Levels
	Level 1				Level 2				Level 3
	In		Out		In		Out		In		Out
Three months ended March 31, 2019
Asset-backed securities	$	—	$	—	$	24	$	—	$	—	$	24
Corporates	—		—		—		11		11		—
Equity securities	5		17		2		5		15		—
Funds withheld for reinsurance receivables	—		—		2		—		—		2
Total transfers	$	5	$	17	$	28	$	16	$	26	$	26
Three months ended March 31, 2018
Asset-backed securities	$	—	$	—	$	131	$	—	$	—	$	131
Hybrids	15		—		—		15		—		—
Total transfers	$	15	$	—	$	131	$	15	$	—	$	131

XML

Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Information Regarding Intangible Assets, VOBA and DAC

A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows:

	VOBA			DAC			DSI			Total
Balance at December 31, 2018	$	866		$	344		$	149		$	1,359
Deferrals	—			91			35			126
Amortization	(31		)	(3		)	(2		)	(36		)
Interest	4			2			1			7
Unlocking	—			—			—			—
Adjustment for net unrealized investment (gains) losses	(35		)	—			—			(35		)
Balance at March 31, 2019	$	804		$	434		$	183		$	1,421

	VOBA			DAC			DSI			Total
Balance at December 31, 2017	$	821		$	22		$	10		$	853
Deferrals	—			59			26			85
Amortization	(30		)	(1		)	(1		)	(32		)
Interest	5			—			—			5
Unlocking	—			—			—			—
Adjustment for net unrealized investment (gains) losses	38			4			1			43
Balance at March 31, 2018	$	834		$	84		$	36		$	954

Amortization of VOBA, DAC, and DSI is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 0.05% to 4.01%. The adjustment for unrealized net investment losses (gains) represents the amount of VOBA, DAC, and DSI that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the unaudited Condensed Consolidated Statements of Operations. As of March 31, 2019 and 2018, the VOBA balances included cumulative adjustments for net unrealized investment (gains) losses of $40 and $22, respectively, the DAC balances included cumulative adjustments for net unrealized investment (gains) losses of $5 and $0, respectively, and the DSI balance included net unrealized investment (gains) losses of $2 and $2, respectively.

Estimated Amortization Expense for VOBA in Future Fiscal Periods

Estimated amortization expense for VOBA in future fiscal periods is as follows:

	Estimated Amortization Expense
Fiscal Year
2019	48
2020	83
2021	89
2022	84
2023	75
Thereafter	385

XML

Debt (Tables)

3 Months Ended

Mar. 31, 2019

Debt Disclosure [Abstract]

Schedule of Debt

The interest expense and amortization of debt issuance costs for the threemonths endedMarch 31, 2019 and 2018, respectively, were as follows:

	Three months ended
	March 31, 2019		March 31, 2018
	Interest Expense	Amortization	Interest Expense	Amortization
Debt	8	—	5	—
Revolving credit facility	—	—	1	—

XML

Equity (Tables)

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Dividends Declared

The Company declared the following cash dividend to its common shareholders during the threemonths endedMarch 31, 2019.

Date Declared	Date Paid	Date Shareholders of record	Shareholders of record (in thousands)	Cash Dividend declared (per share)	Total cash paid
February 27, 2019	April 1, 2019	March 18, 2019	221,661	$0.01	$2

On May 7, 2019, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend will be paid on June 10, 2019 to shareholders of record as of the close of business on May 28, 2019.

The Company did not declare a cash dividend to its common shareholders during the threemonths endedMarch 31, 2018.

The Company declared the following dividends to its preferred shareholders during the threemonths endedMarch 31, 2019:

Type of Preferred Share	Date Declared	Date Paid	Date Shareholders of record	Shares outstanding at date of record (in thousands)	Method of Payment	Total cash paid	Total shares paid in kind (in thousands)
Series A Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	298	Paid in kind	$—	6
Series B Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	108	Paid in kind	$—	2

XML

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Summary of Unfunded Commitments

summary of unfunded commitments by invested asset class are included below:

	March 31, 2019
Asset Type
Other invested assets	$	1,093
Equity securities	21
Fixed maturity securities, available-for-sale	39
Other assets	5
Total	$	1,158

As of March 31, 2019, the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information.

XML

Reinsurance (Tables)

3 Months Ended

Mar. 31, 2019

Reinsurance Disclosures [Abstract]

Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes

The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the threemonths endedMarch 31, 2019 and 2018 were as follows:

	Three months ended
	March 31, 2019				March 31, 2018
	Net Premiums Earned		Net Benefits Incurred		Net Premiums Earned		Net Benefits Incurred
Direct	57		372		60		41
Assumed	—		20		—		(21	)
Ceded	(41	)	(53	)	(42	)	(59	)
Net	16		339		18		(39	)

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Summary of Basic and Diluted EPS

The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands):

	Three months ended
	March 31, 2019		March 31, 2018
Net income (loss)	$	171	$	65
Less Preferred stock dividend	8		7
Net income (loss) available to common shares	163		58
Weighted-average common shares outstanding - basic	219,646		214,370
Dilutive effect of unvested restricted stock	36		—
Weighted-average shares outstanding - diluted	219,682		214,370
Net income (loss) per common share:
Basic	$	0.74	$	0.27
Diluted	$	0.74	$	0.27

XML

Basis of Presentation and Nature of Business - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Goodwill	$ 467	$ 467

XML

Significant Accounting Policies and Practices (Details)	3 Months Ended
	Mar. 31, 2018
Benefits and Other Changes in Policy Reserves [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Immaterial Error Correction	21
Amortization of Intangible Assets [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Immaterial Error Correction	4
income tax expense [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Immaterial Error Correction	4

XML

Significant Risks and Uncertainties - Narrative (Details) $ in Millions	Mar. 31, 2019 USD ($) issuer	Dec. 31, 2018 USD ($) issuer
Concentration Risk [Line Items]
Exposure of FGL's invested assets	10.00%	7.00%
Fair Value In Investments		$ 1,634
Number of issuers in investment | issuer	0	16
Wilton Reassurance Company
Concentration Risk [Line Items]
Net amount recoverable	$ 1,541
Kubera Reassurance Company [Member]
Concentration Risk [Line Items]
Net amount recoverable	$ 681
Scottish Re [Member]
Concentration Risk [Line Items]
Ceded Credit Risk, Disclosure	47
All Financial Instruments
Concentration Risk [Line Items]
FGL's investment securities in the banking industry	$ 2,348	$ 2,491
Exposure of FGL's invested assets	10.00%	10.00%
Single Issuer
Concentration Risk [Line Items]
FGL's investment securities in the banking industry	$ 124	$ 115
Exposure of FGL's invested assets	1.00%	1.00%
Banking Industry | All Financial Instruments
Concentration Risk [Line Items]
Investment securities held by subsidiaries subject to specialized industry accounting principles, amortized cost	$ 2,416	$ 2,691
Top Ten Holdings [Member]
Concentration Risk [Line Items]
Exposure of FGL's invested assets	35.00%
Number of issuers in investment | issuer	107
Minimum
Concentration Risk [Line Items]
Exposure of FGL's invested assets		10.00%

XML

Investments - Credit Impairment Loss Type (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Schedule of Investments [Line Items]
Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Including Credit Impairments	$ (2)	$ (2)
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Change in Status	0	0
Amortized cost	21,908		$ 22,219
Available-for-sale Securities	21,605		$ 21,109
Other than temporary impairment, non-credit losses recognized in OCI	0	0
Asset Backed Securities and Corporate Securities [Member]
Schedule of Investments [Line Items]
Amortized cost	1	0
Available-for-sale Securities	$ 1	$ 0

XML

Investments - Available-for-Sale Securities Table (Details) $ in Millions	Mar. 31, 2019 USD ($) Security	Dec. 31, 2018 USD ($) Security
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	$ 21,908	$ 22,219
Available-for sale securities
Gross Unrealized Gains	194	55
Gross Unrealized Losses	(497)	(1,165)
Fair Value	21,605	21,109
Carrying Value	21,605	21,109
Equity Securities, Amortized Cost Basis	1,226	1,526
Investments, Cost or Amortized Cost	24,885	25,404
Investments, Accumulated Gross Unrealized Gain, before Tax	271	58
Investments, Accumulated Gross Unrealized Loss, before Tax	646	1,545
Investments, Fair Value Disclosure	24,509	23,909
Equity Securities, Accumulated Gross Unrealized Gain, before Tax	3	1
Equity Securities, Accumulated Gross Unrealized Loss, before tax	(58)	(145)
Equity Securities, Fair Value	1,171	1,382
Equity Securities, Carrying Value	1,171	1,382
Derivative investments
Amortized Cost	318	330
Gross Unrealized Gains	74	2
Gross Unrealized Losses	(87)	(235)
Fair Value	305	97
Carrying Value	305	97
Commercial mortgage loans
Loans and Leases Receivable, Net Amount	674	667
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	9,557	2,857
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(400)	(120)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	13,599	17,226
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	$ (497)	$ (1,165)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | Security	468	1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | Security	1,164	556
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | Security	1,632	2,107
Investments	$ 24,510	$ 23,917
Asset-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	5,033	4,954
Available-for sale securities
Gross Unrealized Gains	23	15
Gross Unrealized Losses	(82)	(137)
Fair Value	4,974	4,832
Carrying Value	4,974	4,832
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	886	643
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(19)	(21)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	3,582	3,567
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(82)	(137)
Commercial mortgage-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	2,596	2,568
Available-for sale securities
Gross Unrealized Gains	60	9
Gross Unrealized Losses	(9)	(40)
Fair Value	2,647	2,537
Carrying Value	2,647	2,537
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	250	262
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(5)	(6)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	493	1,728
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(9)	(40)
Corporates
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	10,886	11,213
Available-for sale securities
Gross Unrealized Gains	60	16
Gross Unrealized Losses	(356)	(848)
Fair Value	10,590	10,381
Carrying Value	10,590	10,381
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	7,227	1,465
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(341)	(76)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	7,911	9,481
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(356)	(848)
Hybrids
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	988	992
Available-for sale securities
Gross Unrealized Gains	6	0
Gross Unrealized Losses	(33)	(91)
Fair Value	961	901
Carrying Value	961	901
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	343	7
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(19)	(1)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	676	865
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(33)	(91)
Municipals
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	1,211	1,216
Available-for sale securities
Gross Unrealized Gains	16	3
Gross Unrealized Losses	(10)	(32)
Fair Value	1,217	1,187
Carrying Value	1,217	1,187
Residential mortgage-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	1,000	1,027
Available-for sale securities
Gross Unrealized Gains	27	12
Gross Unrealized Losses	(5)	(8)
Fair Value	1,022	1,031
Carrying Value	1,022	1,031
U.S. Government
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	56	120
Available-for sale securities
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	(1)
Fair Value	56	119
Carrying Value	56	119
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	50	50
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	0	(1)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	50	119
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	0	(1)
Foreign Government Debt Securities [Member]
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	138	129
Available-for sale securities
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax	2	0
Gross Unrealized Losses	(2)	(8)
Fair Value	138	121
Carrying Value	138	121
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	81
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(2)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	81
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(2)
Other invested assets
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	759	662
Available-for sale securities
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(4)	0
Fair Value	744	651
Carrying Value	755	662
Municipals
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	482	172
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(10)	(5)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	527	1,022
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(10)	(32)
Residential mortgage-backed securities
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	238	190
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(4)	(5)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	279	329
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(5)	(8)
Commercial Portfolio Segment [Member]
Commercial mortgage loans
Investment, Commercial Mortgage Loans, Amortized Cost	479	482
Investments, Commercial Mortgage Loans, Accumulated Gross Unrealized Gain before Tax	0	0
Investments, Commercial Mortgage Loans, Accumulated Gross Unrealized Loss before Tax	0	0
Investments, Commercial Mortgage Loans, Fair Value Disclosure	485	483
Loans and Leases Receivable, Net Amount	479	482
Residential Portfolio Segment [Member]
Commercial mortgage loans
Loans and Leases Receivable, Net Amount	195	185
Investment, Residential Mortgage Loans, Amortized Cost	195	185
Investments, Residential Mortgage Loans, Accumulated Gross Unrealized Gain before Tax	0	0
Investments, Residential Mortgage Loans, Fair Value Disclosure	$ 199	187
Predecessor | Foreign Government Debt Securities [Member]
Total investments
Available-for-sale securities, Fair Value, 12 months or longer		68
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss		(5)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value		115
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss		$ (8)

XML

Investments - Amortized Cost and Fair Value of Fixed Maturity Available-for-Sale Securities (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Schedule of Available-for-sale Securities [Line Items]
Equity Securities, Amortized Cost Basis	$ 1,226	$ 1,526
Due in one year or less, Amortized Cost	160
Due after one year through five years, Amortized Cost	758
Due after five years through ten years, Amortized Cost	2,080
Due after ten years, Amortized Cost	10,281
Subtotal, Amortized Cost	13,279
Other securities which provide for periodic payments, Amortized Cost	8,629
Total fixed maturity available-for-sale securities, Amortized Cost	21,908	$ 22,219
Due in one year or less, Fair Value	160
Due after one year through five years, Fair Value	749
Due after five years through ten years, Fair Value	2,059
Due after ten years, Fair Value	9,994
Subtotal, Fair Value	12,962
Other securities which provide for periodic payments, Fair Value	8,643
Total fixed maturity available-for-sale securities, Fair Value	21,605
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Other securities which provide for periodic payments, Amortized Cost	5,033
Other securities which provide for periodic payments, Fair Value	4,974
Commercial mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Other securities which provide for periodic payments, Amortized Cost	2,596
Other securities which provide for periodic payments, Fair Value	2,647
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Other securities which provide for periodic payments, Amortized Cost	1,000
Other securities which provide for periodic payments, Fair Value	$ 1,022

XML

Investments - Fair Value and Gross Unrealized Losses of Available-for-Sale Securities (Details)	Mar. 31, 2019 USD ($) Security	Dec. 31, 2018 USD ($) Security
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	$ 4,042,000,000	$ 14,369,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(97,000,000)	(1,045,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	9,557,000,000	2,857,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(400,000,000)	(120,000,000)
Available-for-sale securities, Fair Value, Total	13,599,000,000	17,226,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	$ (497,000,000)	$ (1,165,000,000)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | Security	468	1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | Security	1,164	556
Total number of available-for-sale securities in an unrealized loss position | Security	1,632	2,107
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Unrealized Losses Related To Non Credit Portion Of Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income		$ 0
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	$ 2,696,000,000	2,924,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(63,000,000)	(116,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	886,000,000	643,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(19,000,000)	(21,000,000)
Available-for-sale securities, Fair Value, Total	3,582,000,000	3,567,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(82,000,000)	(137,000,000)
Commercial mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	243,000,000	1,466,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(4,000,000)	(34,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	250,000,000	262,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(5,000,000)	(6,000,000)
Available-for-sale securities, Fair Value, Total	493,000,000	1,728,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(9,000,000)	(40,000,000)
Corporates
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	684,000,000	8,016,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(15,000,000)	(772,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	7,227,000,000	1,465,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(341,000,000)	(76,000,000)
Available-for-sale securities, Fair Value, Total	7,911,000,000	9,481,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(356,000,000)	(848,000,000)
Hybrids
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	333,000,000	858,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(14,000,000)	(90,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	343,000,000	7,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(19,000,000)	(1,000,000)
Available-for-sale securities, Fair Value, Total	676,000,000	865,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(33,000,000)	(91,000,000)
Municipals
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	45,000,000	850,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	0	(27,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	482,000,000	172,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(10,000,000)	(5,000,000)
Available-for-sale securities, Fair Value, Total	527,000,000	1,022,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(10,000,000)	(32,000,000)
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	41,000,000	139,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(1,000,000)	(3,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	238,000,000	190,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(4,000,000)	(5,000,000)
Available-for-sale securities, Fair Value, Total	279,000,000	329,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(5,000,000)	(8,000,000)
U.S. Government
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months		69,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		0
Available-for-sale securities, Fair Value, 12 months or longer	50,000,000	50,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	0	(1,000,000)
Available-for-sale securities, Fair Value, Total	50,000,000	119,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	0	(1,000,000)
Foreign Government Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, 12 months or longer	81,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(2,000,000)
Available-for-sale securities, Fair Value, Total	81,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	$ (2,000,000)
Predecessor | Foreign Government Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months		47,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		(3,000,000)
Available-for-sale securities, Fair Value, 12 months or longer		68,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer		(5,000,000)
Available-for-sale securities, Fair Value, Total		115,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total		$ (8,000,000)

XML

Investments - Reconciliation of Other than Temporary Impairment on Fixed Maturity (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]
Balance at the beginning of the period	$ 0	$ 0
Increases attributable to credit losses on securities:
OTTI was previously recognized	0	0
OTTI was not previously recognized	0	0
Balance at the end of the period	$ 0	$ 0

XML

Investments - Other-than-Temporary Impairments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule of Investments [Line Items]
Document Period End Date	Mar. 31, 2019
Total other-than-temporary impairments	$ (2)	$ (2)
Corporates
Schedule of Investments [Line Items]
Total other-than-temporary impairments	$ (2)	(2)
Predecessor
Schedule of Investments [Line Items]
Total other-than-temporary impairments		$ (2)

XML

Investments - Schedule of Commercial Mortgage Loan Investment (Details) $ in Millions			3 Months Ended
	Mar. 31, 2019 USD ($) loan	Dec. 31, 2018 USD ($) loan	Mar. 31, 2019 USD ($)
Schedule of Investments [Line Items]
Document Period End Date			Mar. 31, 2019
Impaired loans, number | loan	0	0
Commercial mortgage loans	$ 479	$ 482	$ 479
Commercial mortgage loans, % of total	100.00%	100.00%	100.00%
Loans and Leases Receivable, Net Amount	$ 674	$ 667	$ 674
Hotel
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 21	$ 21	$ 21
Commercial mortgage loans, % of total	4.00%	4.00%	4.00%
Industrial - General
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 37	$ 37	$ 37
Commercial mortgage loans, % of total	8.00%	8.00%	8.00%
Industrial - Warehouse
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 20	$ 20	$ 20
Commercial mortgage loans, % of total	4.00%	4.00%	4.00%
Multifamily
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 55	$ 56	$ 55
Commercial mortgage loans, % of total	11.00%	12.00%	11.00%
Office
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 146	$ 147	$ 146
Commercial mortgage loans, % of total	31.00%	30.00%	31.00%
Retail
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 200	$ 201	$ 200
Commercial mortgage loans, % of total	42.00%	42.00%	42.00%
LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 305	$ 302	$ 305
Commercial mortgage loans, % of total	64.00%	63.00%	64.00%
LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 163	$ 169	$ 163
Commercial mortgage loans, % of total	34.00%	35.00%	34.00%
LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 11	$ 11	$ 11
Commercial mortgage loans, % of total	2.00%	2.00%	2.00%
East North Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 97	$ 98	$ 97
Commercial mortgage loans, % of total	20.00%	20.00%	20.00%
East South Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 19	$ 19	$ 19
Commercial mortgage loans, % of total	4.00%	4.00%	4.00%
Middle Atlantic
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 78	$ 79	$ 78
Commercial mortgage loans, % of total	16.00%	17.00%	16.00%
Mountain
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 65	$ 65	$ 65
Commercial mortgage loans, % of total	14.00%	13.00%	14.00%
New England
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 10	$ 10	$ 10
Commercial mortgage loans, % of total	2.00%	2.00%	2.00%
Pacific
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 115	$ 116	$ 115
Commercial mortgage loans, % of total	24.00%	24.00%	24.00%
South Atlantic
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 57	$ 57	$ 57
Commercial mortgage loans, % of total	12.00%	12.00%	12.00%
West North Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 13	$ 13	$ 13
Commercial mortgage loans, % of total	3.00%	3.00%	3.00%
West South Central
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 25	$ 25	$ 25
Commercial mortgage loans, % of total	5.00%	5.00%	5.00%
Greater than 1.25
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 473	$ 476	$ 473
Greater than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	299	296	299
Greater than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	163	169	163
Greater than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	11	11	11
Greater than 1.00 but less than 1.25
Schedule of Investments [Line Items]
Commercial mortgage loans	6	6	6
Greater than 1.00 but less than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	6	6	6
Greater than 1.00 but less than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	0	0	0
Greater than 1.00 but less than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	0	0	0
Fair Value
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 485	$ 483	$ 485
Commercial mortgage loans, % of total	100.00%	100.00%	100.00%
Fair Value | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 309	$ 302	$ 309
Commercial mortgage loans, % of total	64.00%	63.00%	64.00%
Fair Value | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 165	$ 170	$ 165
Commercial mortgage loans, % of total	34.00%	35.00%	34.00%
Fair Value | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 11	$ 11	$ 11
Commercial mortgage loans, % of total	2.00%	2.00%	2.00%
Commercial Portfolio Segment [Member]
Schedule of Investments [Line Items]
Commercial mortgage loans	$ 479	$ 482	$ 479
Commercial mortgage loans, % of total	100.00%	100.00%	100.00%
Allowance for loan loss	$ 0	$ 0	$ 0
Loans and Leases Receivable, Net Amount	$ 479	$ 482	$ 479

XML

Investments - Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule of Investments [Line Items]
Document Period End Date	Mar. 31, 2019
Gross investment income	$ 317
Investment expense	(28)
Net investment income	289
Fixed maturity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income	265
Equity securities
Schedule of Investments [Line Items]
Gross investment income	21
Commercial mortgage loans
Schedule of Investments [Line Items]
Gross investment income	7
Invested cash and short-term investments
Schedule of Investments [Line Items]
Gross investment income	3
Other investments
Schedule of Investments [Line Items]
Gross investment income	5
Funds Withheld [Member]
Schedule of Investments [Line Items]
Gross investment income	8	$ 7
Limited Partnership [Member]
Schedule of Investments [Line Items]
Gross investment income	$ 8	3
Predecessor
Schedule of Investments [Line Items]
Gross investment income		273
Investment expense		(10)
Net investment income		263
Predecessor | Fixed maturity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income		242
Predecessor | Equity securities
Schedule of Investments [Line Items]
Gross investment income		10
Predecessor | Commercial mortgage loans
Schedule of Investments [Line Items]
Gross investment income		7
Predecessor | Invested cash and short-term investments
Schedule of Investments [Line Items]
Gross investment income		3
Predecessor | Other investments
Schedule of Investments [Line Items]
Gross investment income		$ 1

XML

Investments - Net Investment Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Gain (Loss) on Investments [Line Items]
Document Period End Date	Mar. 31, 2019
Net realized losses on fixed maturity available-for-sale securities	$ (3)	$ (37)
Realized gains on equity securities	78	(6)
Change in fair value of other derivatives and embedded derivatives	3	0
Realized losses on other invested assets	1	(3)
Realized gains (losses) on certain derivative instruments	(26)	11
Unrealized gains (losses) on certain derivative instruments	190	(135)
Derivative, Gain (Loss) on Derivative, Net	(3)	(21)
Change In Fair Value Derivatives, Including Other Derivatives	164	(145)
Realized gains (losses) on hedging derivatives and reinsurance-related embedded derivatives	164	(145)
Net investment gains (losses)	$ 240	(191)
Predecessor
Gain (Loss) on Investments [Line Items]
Net investment gains (losses)		$ (191)

XML

Investments - Narrative (Details)			3 Months Ended
	Mar. 31, 2019 USD ($) loan	Dec. 31, 2018 USD ($) loan	Mar. 31, 2019 USD ($)	Mar. 31, 2018 USD ($)	Jun. 30, 2015 USD ($)
Schedule of Available-for-sale Securities [Line Items]
Non-income producing investment fair value	$ 0	$ 0	$ 0
FHLB collateral pledged	1,186,000,000	1,401,000,000	1,186,000,000
Available for sale depressed securities fair value disclosure	40,000,000	132,000,000	$ 40,000,000
Percentage of available for sale depressed securities above amortized cost			20.00%
Other than temporary impairment credit losses recognized in earnings, including credit impairments			$ 2,000,000	$ 2,000,000
Other than temporary impairment credit losses recognized in earnings, reductions, change in status			0	0
Amortized cost	21,908,000,000	22,219,000,000	21,908,000,000
Fair Value	$ 21,605,000,000	$ 21,109,000,000	21,605,000,000
Other than temporary impairment, non-credit losses recognized in OCI			0	0
Realized gains (losses) on other invested assets			1,000,000	(3,000,000)
Impaired loans, number | loan	0	0
Unrealized Gain (Loss) on Investments			724,000,000	(359,000,000)
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Unrealized Gain Related To Non Credit Portion Of Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income	$ 0	$ 0	0
Unrealized losses related to non-credit portion of OTTI included in AOCI		0
Asset Backed Securities and Corporate Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	1,000,000		1,000,000	0
Fair Value	1,000,000		1,000,000	0
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	1,000,000,000	1,027,000,000	1,000,000,000
Fair Value	1,022,000,000	1,031,000,000	1,022,000,000
Available-for-sale Securities
Schedule of Available-for-sale Securities [Line Items]
Assets held by insurance regulators	$ 16,135,000,000	$ 19,930,000,000	16,135,000,000
Proceeds from available-for-sale investments, sold, matured or repaid:			$ 962,000,000	3,286,000,000
Commercial mortgage loans
Schedule of Available-for-sale Securities [Line Items]
Investments, costs or amortized, percentage of total investments	2.00%		2.00%
Loan to value, threshold	75.00%	75.00%	75.00%
Total fixed maturities | Available-for-sale Securities
Schedule of Available-for-sale Securities [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:			$ 474,000,000
Gain on sale of investments			5,000,000
Loss on sale of investments			(10,000,000)
Predecessor | Total fixed maturities | Available-for-sale Securities
Schedule of Available-for-sale Securities [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:				2,778,000,000
Gain on sale of investments				8,000,000
Loss on sale of investments				$ (43,000,000)
Commitment to Invest
Schedule of Available-for-sale Securities [Line Items]
Unfunded investment commitment	$ 1,158,000,000		1,158,000,000
Crescent Capital BDC Inc. | Commitment to Invest
Schedule of Available-for-sale Securities [Line Items]
Unfunded investment commitment					$ 75,000,000
Other Investments	54,000,000		54,000,000
Golub Capital Partners 10, L.P. [Member] | Commitment to Invest
Schedule of Available-for-sale Securities [Line Items]
Unfunded investment commitment	595,000,000		595,000,000
Other Investments	$ 1,093,000,000		$ 1,093,000,000

XML

Investments Impact of Adoption of New Accounting Pronouncement (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net investment gains (losses)	$ 240	$ (191)
Gain (Loss) on Sale of Equity Investments	78	(6)
Unrealized Gain (Loss) on Investments	$ 724	$ (359)

XML

Investments Schedule of Residential Mortgage Loan Investment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Document Period End Date	Mar. 31, 2019
Commercial mortgage loans	$ 479,000,000	$ 482,000,000
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Residential Mortgage [Member]
Investments, costs or amortized, percentage of total investments	1.00%
FLORIDA
Commercial mortgage loans	$ 29,000,000	$ 25,000,000
Residential Mortgage Receivable, Percentage of Total	15.00%	14.00%
ILLINOIS
Commercial mortgage loans	$ 25,000,000	$ 24,000,000
Residential Mortgage Receivable, Percentage of Total	13.00%	13.00%
NEW JERSEY
Commercial mortgage loans	$ 24,000,000	$ 17,000,000
Residential Mortgage Receivable, Percentage of Total	13.00%
All Other States [Member]
Commercial mortgage loans	$ 112,000,000	$ 114,000,000
Residential Mortgage Receivable, Percentage of Total	59.00%	64.00%
Residential Portfolio Segment [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 195,000,000	$ 185,000,000
Commercial mortgage loans	$ 190,000,000	$ 180,000,000
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Loans and Leases Receivable, Allowance	$ 0	$ 0.00
Performing [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 195,000,000	$ 185,000,000
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Non-performing [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 0	$ 0
Residential Mortgage Receivable, Percentage of Total	0.00%	0.00%
Maximum | All Other States [Member]
Residential Mortgage Receivable, Percentage of Total	9.00%	9.00%

XML

Derivative Financial Instruments - Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Total asset derivatives	$ 322	$ 111
Total liability derivatives	2,747	2,505
Call options | Derivative Instruments
Derivative [Line Items]
Total asset derivatives	304	97
Futures contracts | Derivative Instruments
Derivative [Line Items]
Total asset derivatives	1	0
Other derivatives and embedded derivatives | Other invested assets
Derivative [Line Items]
Total asset derivatives	17	14
FIA embedded derivative | Contractholder funds
Derivative [Line Items]
Total liability derivatives	2,720	2,476
Preferred shares reimbursement feature embedded derivative | Other Liabilities [Member]
Derivative [Line Items]
Total liability derivatives	$ 27	$ 29

XML

Derivative Financial Instruments - Schedule of Change in Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	$ (3)	$ (21)
Change In Fair Value Of Derivatives	164	(145)
Call options | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	154	(122)
Futures contracts | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	8	(2)
Foreign Exchange Forward [Member] | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	2	0
Other derivatives and embedded derivatives | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	3	0
Reinsurance related embedded derivative | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	(3)	(21)
Preferred shares reimbursement feature embedded derivative | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	2	(1)
FIA embedded derivative
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	$ 244	$ (98)

XML

Derivative Financial Instruments - FGL's Exposure to Credit Loss on Call Options Held (Detail) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Derivatives, Fair Value [Line Items]
Fair Value	$ 322	$ 111
Merrill Lynch
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/*/A+
Deutsche Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A-/A3/BBB+
Notional Amount	$ 1,151	1,327
Fair Value	14	5
Collateral	14	6
Net Credit Risk	$ 0	(1)
Morgan Stanley
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	*/A1/A+
Notional Amount	$ 1,657	1,648
Fair Value	25	9
Collateral	24	6
Net Credit Risk	$ 1	3
Barclay's Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/A2/A
Notional Amount	$ 2,752	2,205
Fair Value	79	27
Collateral	61	20
Net Credit Risk	$ 18	7
Canadian Imperial Bank of Commerce [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	*/Aa2/A+
Notional Amount	$ 1,430	1,716
Fair Value	41	11
Collateral	29	8
Net Credit Risk	$ 12	3
Wells Fargo [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/A2/A-
Notional Amount	$ 2,034	1,635
Fair Value	58	17
Collateral	56	16
Net Credit Risk	$ 2	1
GOLDMAN SACH MTF [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A/A3/BBB+
Notional Amount	$ 1,030	647
Fair Value	17	3
Collateral	16	3
Net Credit Risk	1	0
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivatives, Fair Value [Line Items]
Notional Amount	13,550	13,130
Fair Value	304	97
Collateral	225	59
Net Credit Risk	79	38
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options | Merrill Lynch
Derivatives, Fair Value [Line Items]
Notional Amount	3,496	3,952
Fair Value	70	25
Collateral	25	0
Net Credit Risk	$ 45	$ 25

XML

Derivative Financial Instruments - Narrative (Details) $ in Millions		3 Months Ended
	Nov. 30, 2017 shares	Mar. 31, 2019 USD ($) contract	Mar. 31, 2018 USD ($)	Dec. 31, 2018 USD ($) contract	Dec. 31, 2017 USD ($)	Jun. 16, 2014 USD ($)
Derivative [Line Items]
Fair Value		$ 322		$ 111
Fair value of assets		2,536		$ 2,466
Derivative, Gain (Loss) on Derivative, Net		$ (3)	$ (21)
Other derivatives and embedded derivatives
Derivative [Line Items]
Term of contract, term one		1 year
Term of contract, term two		2 years
Term of contract, term three		3 years
Term of contract, term four		5 years
Futures contracts
Derivative [Line Items]
Number of instruments held | contract		774,000,000		664,000,000
Collateral held		$ 4		$ 3
Other invested assets | Other derivatives and embedded derivatives
Derivative [Line Items]
Fair Value		17		14
Derivative investments | Call options
Derivative [Line Items]
Fair Value		304		97
Derivative investments | Futures contracts
Derivative [Line Items]
Fair Value		1		0
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Fair Value		304		97
Derivative notional amount		13,550		13,130
Collateral posted		225		59
Maximum amount of loss due to credit risk		79		38
Cash and Cash Equivalents | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Collateral posted		200		59
Other Investments Asset | Other invested assets
Derivative [Line Items]
Fixed maturities securities, available-for-sale, at fair value		27		26		$ 35
Other Investments Asset | Other invested assets | Other derivatives and embedded derivatives
Derivative [Line Items]
Derivative notional amount						$ 11
Merrill Lynch [Member] | Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Fair Value		70		25
Derivative notional amount		3,496		3,952
Collateral posted		25		0
Maximum amount of loss due to credit risk		45		$ 25
Predecessor
Derivative [Line Items]
Fair value of assets			1,714		$ 1,785
Preferred Stock
Derivative [Line Items]
Preferred Stock, Call Features, Minimum Term	5 years
Preferred stock dividend rate	10.00%
Series A Cumulative Preferred Stock [Member] | Preferred Stock
Derivative [Line Items]
Stock Issued During Period, Shares, New Issues | shares	275,000
Series B Cumulative Preferred Stock [Member] | Preferred Stock
Derivative [Line Items]
Stock Issued During Period, Shares, New Issues | shares	100,000
Net investment (losses) gains | Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		2	0
Net investment (losses) gains | Other derivatives and embedded derivatives
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		3	0
Net investment (losses) gains | Call options
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		154	(122)
Net investment (losses) gains | Futures contracts
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		$ 8	$ (2)

XML

Fair Value of Financial Instruments - Assets and Liabilities Carrying at Fair Value Measured on a Recurring Basis (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	$ 271
Available-for-sale Securities	21,605			$ 21,109
Derivative investments	305			97
Total financial assets at fair value	2,536			2,466
Funds withheld for reinsurance receivables, at fair value	837			757
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	1
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FHLB Common Stock, Fair Value	0			0
Cash and cash equivalents	1,357
Equity securities	441
Derivative investments	1
Total financial assets at fair value	2,288
FHLB common stock	0			0
Commercial mortgage loans	0			0
Investments, Affiliated Bank Loan, Fair Value Disclosure	0			0
Funds withheld for reinsurance receivables, at fair value	0			0
Total assets carried on balance sheet at amounts other than fair value	0			0
Liabilities Related to Investment Contracts, Fair Value Disclosure	0			0
Total liabilities carried on balance sheet at amounts other than fair value	0			0
Debt Instrument, Fair Value Disclosure	0			0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FHLB Common Stock, Fair Value	56			52
Cash and cash equivalents	0
Equity securities	657
Derivative investments	304
Total financial assets at fair value	20,434
FHLB common stock	0			0
Commercial mortgage loans	0			0
Investments, Affiliated Bank Loan, Fair Value Disclosure	0			0
Funds withheld for reinsurance receivables, at fair value	0			0
Total assets carried on balance sheet at amounts other than fair value	56			52
Liabilities Related to Investment Contracts, Fair Value Disclosure	0			0
Total liabilities carried on balance sheet at amounts other than fair value	543			520
Debt Instrument, Fair Value Disclosure	543			520
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FHLB Common Stock, Fair Value	0			0
Cash and cash equivalents	0
Equity securities	20
Derivative investments	0
Total financial assets at fair value	2,536
FHLB common stock	485			483
Commercial mortgage loans	12			187
Investments, Affiliated Bank Loan, Fair Value Disclosure	40			39
Funds withheld for reinsurance receivables, at fair value	5			8
Total assets carried on balance sheet at amounts other than fair value	741			728
Liabilities Related to Investment Contracts, Fair Value Disclosure	18,355			18,358
Total liabilities carried on balance sheet at amounts other than fair value	18,355			18,358
Debt Instrument, Fair Value Disclosure	0			0
Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FHLB Common Stock, Fair Value	56			52
Cash and cash equivalents	1,357
Equity securities	1,118
Derivative investments	305
Total financial assets at fair value	25,258
FHLB common stock	485			483
Commercial mortgage loans	12			187
Investments, Affiliated Bank Loan, Fair Value Disclosure	40			39
Funds withheld for reinsurance receivables, at fair value	5			8
Total assets carried on balance sheet at amounts other than fair value	797			780
Liabilities Related to Investment Contracts, Fair Value Disclosure	18,355			18,358
Total liabilities carried on balance sheet at amounts other than fair value	18,898			18,878
Debt Instrument, Fair Value Disclosure	543			520
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
FHLB Common Stock, Fair Value	56			52
Cash and cash equivalents	1,357
Equity securities	1,118
Derivative investments	305
Total financial assets at fair value	25,258
FHLB common stock	479			482
Commercial mortgage loans	23			185
Investments, Affiliated Bank Loan, Fair Value Disclosure	40			39
Funds withheld for reinsurance receivables, at fair value	5			8
Total assets carried on balance sheet at amounts other than fair value	798			788
Liabilities Related to Investment Contracts, Fair Value Disclosure	21,161			20,911
Total liabilities carried on balance sheet at amounts other than fair value	21,702			21,452
Debt Instrument, Fair Value Disclosure	541			541
Fixed indexed annuities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Fixed indexed annuities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Fixed indexed annuities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,544
Fixed indexed annuities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,544
Fixed indexed annuities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,544
Future Contracts [Member] | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Future Contracts [Member] | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Future Contracts [Member] | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,720
Future Contracts [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,720
Future Contracts [Member] | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,720
Future Policy Benefits [Member] | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Future Policy Benefits [Member] | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Future Policy Benefits [Member] | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	797
Future Policy Benefits [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	797
Future Policy Benefits [Member] | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	797
Preferred shares reimbursement feature embedded derivative | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Preferred shares reimbursement feature embedded derivative | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Preferred shares reimbursement feature embedded derivative | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	27
Preferred shares reimbursement feature embedded derivative | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	(2)	$ 1
Available-for-sale Securities	27	24		29	$ 23
Preferred shares reimbursement feature embedded derivative | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	27
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,974			4,832
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Asset-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Asset-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,466
Asset-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	508
Asset-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,974
Asset-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,974
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,647			2,537
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Commercial mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Commercial mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,579
Commercial mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	68
Commercial mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,647
Commercial mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,647
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,590			10,381
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	(1)
Corporates | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Corporates | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	9,381
Corporates | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,209
Corporates | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,590
Corporates | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,590
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	961			901
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Hybrids | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	277
Hybrids | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	674
Hybrids | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10
Hybrids | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	961
Hybrids | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	961
Municipals
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Municipals | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Municipals | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,179
Municipals | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	38
Municipals | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,217
Municipals | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,217
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,022			1,031
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Residential mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Residential mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	403
Residential mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	619
Residential mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,022
Residential mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,022
U.S. Government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	56			119
U.S. Government | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	51
U.S. Government | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	5
U.S. Government | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
U.S. Government | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	56
U.S. Government | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	56
Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	138			121
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0
Foreign Government Debt Securities [Member] | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Foreign Government Debt Securities [Member] | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	122
Foreign Government Debt Securities [Member] | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	16
Foreign Government Debt Securities [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	138
Foreign Government Debt Securities [Member] | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	138
Other invested assets | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Other invested assets | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Other invested assets | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	41
Other invested assets | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	41
Other invested assets | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	41
Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings	0	0
Reinsurance Receivables, Funds Withheld [Member] | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	161			169
Reinsurance Receivables, Funds Withheld [Member] | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	664			576
Reinsurance Receivables, Funds Withheld [Member] | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	7			4
Reinsurance Receivables, Funds Withheld [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	832			749
Reinsurance Receivables, Funds Withheld [Member] | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 832			749
Predecessor
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings		(117)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		1
Predecessor | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents				571
Equity securities				454
Derivative investments				0
Other invested assets				0
Total financial assets at fair value				1,573
Commercial mortgage loans				0
Financial Liabilities Fair Value Disclosure				0
Predecessor | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents				0
Equity securities				874
Derivative investments				97
Other invested assets				0
Total financial assets at fair value				19,858
Commercial mortgage loans				0
Financial Liabilities Fair Value Disclosure				0
Predecessor | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents				0
Equity securities				4
Derivative investments				0
Other invested assets				39
Total financial assets at fair value				2,466
Commercial mortgage loans				11
Financial Liabilities Fair Value Disclosure				3,230
Predecessor | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents				571
Equity securities				1,332
Derivative investments				97
Other invested assets				39
Total financial assets at fair value				23,897
Commercial mortgage loans				11
Financial Liabilities Fair Value Disclosure				3,230
Predecessor | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents				571
Equity securities				1,332
Derivative investments				97
Other invested assets				39
Total financial assets at fair value				23,897
Commercial mortgage loans				22
Financial Liabilities Fair Value Disclosure				3,230
Predecessor | Fixed indexed annuities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability				0
Predecessor | Fixed indexed annuities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability				0
Predecessor | Fixed indexed annuities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability				2,476
Predecessor | Fixed indexed annuities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability				2,476
Predecessor | Fixed indexed annuities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability				2,476
Predecessor | Call options | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Call options | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Call options | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				725
Predecessor | Call options | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				725
Predecessor | Call options | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				725
Predecessor | Preferred shares reimbursement feature embedded derivative | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Preferred shares reimbursement feature embedded derivative | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Preferred shares reimbursement feature embedded derivative | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				29
Predecessor | Preferred shares reimbursement feature embedded derivative | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				29
Predecessor | Preferred shares reimbursement feature embedded derivative | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				29
Predecessor | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		0
Predecessor | Asset-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Asset-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				4,388
Predecessor | Asset-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				444
Predecessor | Asset-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				4,832
Predecessor | Asset-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				4,832
Predecessor | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		0
Predecessor | Commercial mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Commercial mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				2,470
Predecessor | Commercial mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				67
Predecessor | Commercial mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				2,537
Predecessor | Commercial mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				2,537
Predecessor | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		0
Predecessor | Corporates | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Corporates | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				9,150
Predecessor | Corporates | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,231
Predecessor | Corporates | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				10,381
Predecessor | Corporates | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				10,381
Predecessor | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		0
Predecessor | Hybrids | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				265
Predecessor | Hybrids | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				626
Predecessor | Hybrids | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				10
Predecessor | Hybrids | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				901
Predecessor | Hybrids | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				901
Predecessor | Municipals
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		0
Predecessor | Municipals | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Municipals | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,150
Predecessor | Municipals | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				37
Predecessor | Municipals | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,187
Predecessor | Municipals | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,187
Predecessor | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings		$ 0
Predecessor | Residential mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Residential mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				417
Predecessor | Residential mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				614
Predecessor | Residential mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,031
Predecessor | Residential mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				1,031
Predecessor | U.S. Government | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				114
Predecessor | U.S. Government | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				5
Predecessor | U.S. Government | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | U.S. Government | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				119
Predecessor | U.S. Government | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				119
Predecessor | Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings			$ 0
Predecessor | Foreign Government Debt Securities [Member] | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				0
Predecessor | Foreign Government Debt Securities [Member] | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				105
Predecessor | Foreign Government Debt Securities [Member] | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				16
Predecessor | Foreign Government Debt Securities [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				121
Predecessor | Foreign Government Debt Securities [Member] | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities				$ 121

XML

Fair Value of Financial Instruments - Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 2,536,000,000	$ 2,466,000,000
Future Policy Benefit		725,000,000
Liabilities, fair value	3,544,000,000	$ 3,230,000,000
Risk Margin To Reflect Uncertainty		0.00%
Credit Spread	$ 0.0450	$ 0.0514
Yield Volatility	0.00%	0.00%
Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 489,000,000	$ 405,000,000
Market Approach | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	43,000,000	43,000,000
Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	731,000,000	577,000,000
Market Approach | Municipals
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	38,000,000	37,000,000
Market Approach | Foreign Government Debt Securities [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 16,000,000	16,000,000
Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Loan Recovery Value		$ 25,000,000
Fair value inputs, quoted prices	100.00%	100.00%
Fair Value Input Recovery Rate		7.15%
Market Approach | Residential mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 619,000,000
Residential Mortage Backed securities		$ 614,000,000
Market Approach | Credit Linked Note [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	25,000,000
Third Parties [Member] | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	19,000,000	15,000,000
Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value		654,000,000
Income Approach Valuation Technique | Hybrids
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value		$ 10,000,000
Income Approach Valuation Technique | Equity securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 16,000,000
Fair Value Input Recovery Rate	100.00%
Income Approach Valuation Technique | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	100.00%	100.00%
Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.03%	0.18%
Black Scholes Model [Member] | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 16,000,000
Matrix Pricing Valuation [Member] | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value		$ 24,000,000
Matrix Pricing Valuation [Member] | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	25,000,000	$ 24,000,000
Matrix Pricing Valuation [Member] | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	478,000,000
Matrix Pricing Valuation [Member] | Hybrids
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 10,000,000
Matrix Pricing Valuation [Member] | Funds withheld for reinsurance liabilities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	100.00%	100.00%
Loan Recovery Valuation [Member] | Funds withheld for reinsurance liabilities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	14.00%
Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Liabilities, fair value	$ 2,720,000,000	$ 2,476,000,000
Preferred shares reimbursement feature embedded derivative | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Liabilities, fair value	$ 27,000,000	$ 29,000,000
Minimum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk Margin To Reflect Uncertainty		0.00%
Minimum | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	97.50%	97.00%
Minimum | Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	54.00%	74.63%
Minimum | Market Approach | Hybrids
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	98.84%	96.60%
Minimum | Market Approach | Municipals
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	114.61%	111.23%
Minimum | Market Approach | Foreign Government Debt Securities [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	101.38%	98.38%
Minimum | Market Approach | Residential mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	92.52%	89.80%
Minimum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Minimum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	121.01%	117.72%
Minimum | Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	95.94%	91.74%
Minimum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.00%	0.00%
Minimum | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	0.00%	0.00%
Minimum | Future Policy Benefits, Mortality Multiplier [Member] | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	90.00%
Minimum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	0.00%	0.00%
Fair value inputs, swap rates	2.29%	2.57%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	0.50%	0.05%
Fair value inputs, non performance spread	0.25%	0.03%
Minimum | Fixed indexed annuities | Partial Withdrawls [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, surrender rates	1.00%	1.00%
Minimum | Fixed indexed annuities | Option Cost [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, non performance spread	0.18%	0.01%
Maximum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk Margin To Reflect Uncertainty		0.00%
Maximum | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	105.17%	102.00%
Maximum | Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	107.83%	104.62%
Maximum | Market Approach | Hybrids
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	98.84%	96.60%
Maximum | Market Approach | Municipals
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	114.61%	111.23%
Maximum | Market Approach | Foreign Government Debt Securities [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.55%	99.01%
Maximum | Market Approach | Residential mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.81%	100.99%
Maximum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Maximum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	121.01%	117.72%
Maximum | Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	117.55%	113.25%
Maximum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.10%	0.22%
Maximum | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	98.30%	99.29%
Maximum | Future Policy Benefits, Mortality Multiplier [Member] | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	100.00%
Maximum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	32.37%	31.06%
Fair value inputs, swap rates	2.41%	2.71%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	75.00%	75.00%
Fair value inputs, non performance spread	0.25%	0.03%
Maximum | Fixed indexed annuities | Partial Withdrawls [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, surrender rates	2.50%	2.50%
Maximum | Fixed indexed annuities | Option Cost [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, non performance spread	16.61%	16.61%
Weighted Average | Market Approach | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	100.84%	99.77%
Weighted Average | Market Approach | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	99.49%	97.80%
Weighted Average | Market Approach | Hybrids
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	98.84%	96.60%
Weighted Average | Market Approach | Municipals
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	114.61%	111.23%
Weighted Average | Market Approach | Foreign Government Debt Securities [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	102.06%	98.58%
Weighted Average | Market Approach | Residential mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.34%	100.73%
Weighted Average | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Weighted Average | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	121.01%	117.72%
Weighted Average | Income Approach Valuation Technique | Corporates
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	101.67%	98.86%
Weighted Average | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	28.44%	23.05%
Weighted Average | Third Party Valuation Technique [Member] | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, quoted prices	87.90%	85.46%
Weighted Average | Future Policy Benefits, Mortality Multiplier [Member] | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	100.00%
Weighted Average | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, market value of option	2.23%	94.00%
Fair value inputs, swap rates	2.34%	2.63%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	2.86%	5.90%
Fair value inputs, non performance spread	0.25%	0.03%
Weighted Average | Fixed indexed annuities | Partial Withdrawls [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, surrender rates	2.00%	2.00%
Weighted Average | Fixed indexed annuities | Option Cost [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs, non performance spread	2.16%	2.18%
Insurance Subsidiary | Market Approach | Equity securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value		$ 4,000,000
Insurance Subsidiary | Income Approach Valuation Technique | Equity securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value	$ 4,000,000
Fair Value Input Recovery Rate	7.18%
Insurance Subsidiary | Income Approach Valuation Technique | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Assets, fair value		$ 14,000,000
Insurance Subsidiary | Minimum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value Inputs, Other Loan Recoveries	81.01%	77.12%
Insurance Subsidiary | Maximum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value Inputs, Other Loan Recoveries	100.14%	100.08%
Loan Participation - JSN Jewelry, Inc. [Member] | Market Approach | Other invested assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Reinsurance Receivables, Funds Withheld		$ 4,000,000

XML

Fair Value of Financial Instruments - Changes to Fair Value of Financial Instruments Level 3 (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	$ 21,605			$ 21,109
Assets, Fair Value Disclosure	2,536			2,466
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	2,466
Assets, Total Gains (Losses) Included in Earnings	1
Assets, Total Gains (Losses) Included in AOCI	49
Assets, Purchases	126
Assets, Sales	21
Assets, Settlements	85
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	2,536
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	3,230
Liabilities, Total Gains (Losses) Included in Earnings	271
Liabilities, Total Gains (Losses) Included in AOCI	0
Liabilities, Purchases	0
Liabilities, Sales	0
Liabilities, Settlements	43
Liabilities, Net transfer In (Out) of Level 3	0
Balance at End of Period	3,544
Liabilities, fair value	3,544			3,230
FIA embedded derivatives, included in contractholder funds
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	2,476
Liabilities, Total Gains (Losses) Included in Earnings	244
Liabilities, Total Gains (Losses) Included in AOCI	0
Liabilities, Purchases	0
Liabilities, Sales	0
Liabilities, Settlements	0
Liabilities, Net transfer In (Out) of Level 3	0
Balance at End of Period	2,720
Future Policy Benefits [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	725	$ 728
Liabilities, Total Gains (Losses) Included in Earnings	29	(20)
Liabilities, Total Gains (Losses) Included in AOCI	0	0
Liabilities, Purchases	0	0
Liabilities, Sales	0	0
Liabilities, Settlements	43	4
Liabilities, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	797	712
Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	4,974			4,832
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	444
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	5
Assets, Purchases	114
Assets, Sales	0
Assets, Settlements	(31)
Assets, Net transfer In (Out) of Level 3	(24)
Balance at End of Period	508
Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	2,647			2,537
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	67
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	2
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	1
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	68
Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	10,590			10,381
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	1,231
Assets, Total Gains (Losses) Included in Earnings	(1)
Assets, Total Gains (Losses) Included in AOCI	24
Assets, Purchases	0
Assets, Sales	(21)
Assets, Settlements	(35)
Assets, Net transfer In (Out) of Level 3	11
Balance at End of Period	1,209
Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	961			901
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	10
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	10
Foreign Government Debt Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	138			121
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	16
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	16
Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	37
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	1
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	38
Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	4
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	1
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	15
Balance at End of Period	20
Available-for-sale embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	14
Assets, Total Gains (Losses) Included in Earnings	2
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	16
Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	1,022			1,031
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	614
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	16
Assets, Purchases	7
Assets, Sales	0
Assets, Settlements	18
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	619
Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	4	4
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	5	2
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	(2)	0
Balance at End of Period	7	6
Market Approach | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	489			405
Market Approach | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	43			43
Market Approach | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	731			577
Market Approach | Foreign Government Debt Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	16			16
Market Approach | Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	38			37
Market Approach | Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	619
Third Parties [Member] | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	19			15
Matrix Pricing Valuation [Member] | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				24
Matrix Pricing Valuation [Member] | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	25			24
Matrix Pricing Valuation [Member] | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	478
Matrix Pricing Valuation [Member] | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	10
Matrix Pricing Valuation [Member] | Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	6
Loan Recovery Valuation [Member] | Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	1
Income Approach Valuation Technique | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				654
Income Approach Valuation Technique | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				10
Income Approach Valuation Technique | Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	16
Black Scholes Model [Member] | Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	16
Affiliated Entity | HGI Energy Note [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	25
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	25
Affiliated Entity | Market Approach | Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				4
Affiliated Entity | Income Approach Valuation Technique | Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	4
Affiliated Entity | Income Approach Valuation Technique | Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				14
Fixed indexed annuities | Income Approach Valuation Technique
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, fair value	2,720			2,476
Preferred shares reimbursement feature embedded derivative | Income Approach Valuation Technique
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, fair value	27			29
Fair Value
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	25,258
Fair Value | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	4,974
Fair Value | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	2,647
Fair Value | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	10,590
Fair Value | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	961
Fair Value | Foreign Government Debt Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	138
Fair Value | Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	1,217
Fair Value | Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	41
Fair Value | Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	1,022
Fair Value | Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	832			749
Fair Value | Fixed indexed annuities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	3,544
Fair Value | Preferred shares reimbursement feature embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities	27	24		29	$ 23
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, Total Gains (Losses) Included in Earnings	(2)	1
Liabilities, Total Gains (Losses) Included in AOCI	0	0
Liabilities, Purchases	0	0
Liabilities, Sales	0	0
Liabilities, Settlements	0	0
Liabilities, Net transfer In (Out) of Level 3	0	0
Predecessor
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		1,785
Assets, Total Gains (Losses) Included in Earnings		1
Assets, Total Gains (Losses) Included in AOCI		(24)
Assets, Purchases		130
Assets, Sales		0
Assets, Settlements		(47)
Assets, Net transfer In (Out) of Level 3		(131)
Balance at End of Period		1,714
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		3,028
Liabilities, Total Gains (Losses) Included in Earnings		(117)
Liabilities, Total Gains (Losses) Included in AOCI		0
Liabilities, Purchases		0
Liabilities, Sales		0
Liabilities, Settlements		4
Liabilities, Net transfer In (Out) of Level 3		0
Balance at End of Period		2,915
Predecessor | FIA embedded derivatives, included in contractholder funds
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		2,277
Liabilities, Total Gains (Losses) Included in Earnings		(98)
Liabilities, Total Gains (Losses) Included in AOCI		0
Liabilities, Purchases		0
Liabilities, Sales		0
Liabilities, Settlements		0
Liabilities, Net transfer In (Out) of Level 3		0
Balance at End of Period		2,179
Predecessor | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		412
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		(2)
Assets, Purchases		28
Assets, Sales		0
Assets, Settlements		(6)
Assets, Net transfer In (Out) of Level 3		(131)
Balance at End of Period		301
Predecessor | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		49
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		(1)
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		(6)
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		42
Predecessor | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		1,169
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		(20)
Assets, Purchases		100
Assets, Sales		0
Assets, Settlements		(34)
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		1,215
Predecessor | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		10
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		10
Predecessor | Foreign Government Debt Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period			$ 17
Assets, Total Gains (Losses) Included in Earnings			0
Assets, Total Gains (Losses) Included in AOCI			0
Assets, Purchases			0
Assets, Sales			0
Assets, Settlements			0
Assets, Net transfer In (Out) of Level 3			0
Balance at End of Period			$ 17
Predecessor | Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		38
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		(1)
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		37
Predecessor | Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		3
Assets, Total Gains (Losses) Included in Earnings		1
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		4
Predecessor | Available-for-sale embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		17
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		17
Predecessor | Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		66
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		1
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		$ 65
Predecessor | Fair Value
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				23,897
Predecessor | Fair Value | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				4,832
Predecessor | Fair Value | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				2,537
Predecessor | Fair Value | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				10,381
Predecessor | Fair Value | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				901
Predecessor | Fair Value | Foreign Government Debt Securities [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				121
Predecessor | Fair Value | Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				1,187
Predecessor | Fair Value | Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				1,031
Predecessor | Fair Value | Preferred shares reimbursement feature embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Available-for-sale Securities				$ 29
FSRC [Member] | Income Approach Valuation Technique | Future Policy Benefits [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, fair value	$ 797

XML

Fair Value of Financial Instruments - NAV (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Private Equity Funds [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying value after measurement	$ 595	$ 510
Equity securities
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying value after measurement	53	$ 50
Level 1
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	0
Level 2
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	0
Level 3
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	199
Fair Value
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	199
Carrying Value
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	$ 195

XML

Fair Value of Financial Instruments - Narrative (Detail)		3 Months Ended	12 Months Ended
	Nov. 30, 2017	Mar. 31, 2019 USD ($) $ / Contract	Dec. 31, 2018 USD ($)	Jun. 30, 2018 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings		$ 271,000,000
Assets, net transfer in (out) of Level 3		0
Risk Margin To Reflect Uncertainty			0.00%
Credit Spread		$ 0.0450	$ 0.0514
Yield Volatility		0.00%	0.00%
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		$ (24,000,000)
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		11,000,000
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0
States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0
Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0
Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		$ 15,000,000
Market Approach | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		100.00%	100.00%
Fair Value Input Recovery Rate			7.15%
Income Approach Valuation Technique | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, strike price | $ / Contract		0
Fair value inputs, black scholes model		100.00%	100.00%
Income Approach Valuation Technique | Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Input Recovery Rate		100.00%
Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model		0.03%	0.18%
Matrix Pricing Valuation [Member] | Funds withheld for reinsurance liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model		100.00%	100.00%
Loan Recovery Valuation [Member] | Funds withheld for reinsurance liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model		14.00%
Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred Stock, Call Features, Minimum Term	5 years
Preferred Stock, Dividend Rate, Percentage, Less Than Par	90.00%
Available-for-sale Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held by insurance regulators		$ 16,135,000,000	$ 19,930,000,000
FSRC and F&G Re [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Undiscounted Cash flows used in fair value measurement				$ 1,152,000,000
Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk Margin To Reflect Uncertainty			0.00%
Maximum | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		105.17%	102.00%
Maximum | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		107.83%	104.62%
Maximum | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		98.84%	96.60%
Maximum | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		114.61%	111.23%
Maximum | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		103.81%	100.99%
Maximum | Market Approach | Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		103.55%	99.01%
Maximum | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			96.07%
Maximum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		121.01%	117.72%
Maximum | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		117.55%	113.25%
Maximum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model		0.10%	0.22%
Maximum | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		98.30%	99.29%
Weighted Average | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		100.84%	99.77%
Weighted Average | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		99.49%	97.80%
Weighted Average | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		98.84%	96.60%
Weighted Average | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		114.61%	111.23%
Weighted Average | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		103.34%	100.73%
Weighted Average | Market Approach | Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		102.06%	98.58%
Weighted Average | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			96.07%
Weighted Average | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		121.01%	117.72%
Weighted Average | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		101.67%	98.86%
Weighted Average | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		28.44%	23.05%
Weighted Average | Third Party Valuation Technique [Member] | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		87.90%	85.46%
Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk Margin To Reflect Uncertainty			0.00%
Minimum | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		97.50%	97.00%
Minimum | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		54.00%	74.63%
Minimum | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		98.84%	96.60%
Minimum | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		114.61%	111.23%
Minimum | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		92.52%	89.80%
Minimum | Market Approach | Foreign Government Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		101.38%	98.38%
Minimum | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices			96.07%
Minimum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		121.01%	117.72%
Minimum | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		95.94%	91.74%
Minimum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model		0.00%	0.00%
Minimum | Third Party Valuation Technique [Member] | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices		0.00%	0.00%
Affiliated Entity | Income Approach Valuation Technique | Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Input Recovery Rate		7.18%
Affiliated Entity | Maximum | Market Approach | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Inputs, Other Loan Recoveries		100.14%	100.08%
Affiliated Entity | Minimum | Market Approach | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Inputs, Other Loan Recoveries		81.01%	77.12%
Future Policy Benefits, Market Value of Option [Member] | Maximum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		6.95%
Future Policy Benefits, Market Value of Option [Member] | Weighted Average | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		1.90%
Future Policy Benefits, Market Value of Option [Member] | Minimum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		0.88%
Future Policy Benefits [Member] | Maximum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption		0.02
Fair value inputs, swap rates		40.00%
Fair value inputs, mortality multiplier		2.50%
Fair value inputs, non performance spread		4.58%
Risk Margin To Reflect Uncertainty		0.62%
Future Policy Benefits [Member] | Weighted Average | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption		0.0017
Fair value inputs, swap rates		4.63%
Fair value inputs, mortality multiplier		0.93%
Fair value inputs, non performance spread		1.72%
Risk Margin To Reflect Uncertainty		0.44%
Future Policy Benefits [Member] | Minimum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption		0
Fair value inputs, swap rates		0.65%
Fair value inputs, mortality multiplier		0.00%
Fair value inputs, non performance spread		1.14%
Risk Margin To Reflect Uncertainty		0.35%
Fixed indexed annuities | Maximum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		32.37%	31.06%
Fair value inputs, swap rates		2.41%	2.71%
Fair value inputs, mortality multiplier		80.00%	80.00%
Fair value inputs, surrender rates		75.00%	75.00%
Fair value inputs, non performance spread		0.25%	0.03%
Fixed indexed annuities | Maximum | Partial Withdrawls [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates		2.50%	2.50%
Fixed indexed annuities | Maximum | Option Cost [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread		16.61%	16.61%
Fixed indexed annuities | Weighted Average | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		2.23%	94.00%
Fair value inputs, swap rates		2.34%	2.63%
Fair value inputs, mortality multiplier		80.00%	80.00%
Fair value inputs, surrender rates		2.86%	5.90%
Fair value inputs, non performance spread		0.25%	0.03%
Fixed indexed annuities | Weighted Average | Partial Withdrawls [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates		2.00%	2.00%
Fixed indexed annuities | Weighted Average | Option Cost [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread		2.16%	2.18%
Fixed indexed annuities | Minimum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option		0.00%	0.00%
Fair value inputs, swap rates		2.29%	2.57%
Fair value inputs, mortality multiplier		80.00%	80.00%
Fair value inputs, surrender rates		0.50%	0.05%
Fair value inputs, non performance spread		0.25%	0.03%
Fixed indexed annuities | Minimum | Partial Withdrawls [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates		1.00%	1.00%
Fixed indexed annuities | Minimum | Option Cost [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread		0.18%	0.01%

XML

Fair Value of Financial Instruments - Gross Transfers Into and Out of Certain Fair Value Levels by Asset Class (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	$ 17	$ 0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	28	131
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	16	15
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	26	0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	26	131
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	5	15
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	24
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	0
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	24
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	0
Asset-backed securities | Predecessor
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount		0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount		131
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount		0
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount		0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount		131
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount		0
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	0
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	11
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	11
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	0
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	0
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount		0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount		0
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount		15
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount		0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount		0
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount		$ 15
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	17
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	2
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	5
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	15
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	0
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	5
Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	2
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	0
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	2
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	$ 0

XML

Intangible Assets - Schedule of Acquired Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Acquired Finite-Lived Intangible Assets [Line Items]
Carrying amount	$ 1,421	$ 1,359
FGL [Member] | Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net	$ 14
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
FGL [Member] | Licensing Agreements [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Carrying amount	$ 6

XML

Intangible Assets - Summary of Changes in Carrying Amounts of Intangible Assets Including DAC, VOBA , and DSI (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018	Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]
Deferred Sales Inducement Cost, Net	$ 183	$ 36	$ 149	$ 10
VOBA
VOBA at beginning of period	866	821
Deferrals	0	0
Amortization	(31)	(30)
Interest	4	5
Unlocking	0	0
Adjustment for net unrealized investment (gains) losses	(35)	38
VOBA at end of period	804	834
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	0	1
Deferred Sales Inducement Cost, Unlocking Adjustment	0	0
Deferred Sales Inducement Cost, Amortization Expense, Accrued Interest	1	0
Deferred Sales Inducement Cost, Amortization Expense	(2)	(1)
Deferred Sales Inducement Cost, Addition	35	26
DAC
DAC at beginning of period	434	84	344	22
Deferrals	91	59
Amortization	(3)	(1)
Interest	2	0
Unlocking	0	0
Adjustment for net unrealized investment (gains) losses	0	4
DAC at end of period	434	84	344	22
Total
Total VOBA and DAC at beginning of period	1,421	954	$ 1,359	$ 853
Deferrals	126	85
Amortization	(36)	(32)
Unlocking	0	0
Adjustment for net unrealized investment (gains) losses	(35)	43
Interest	$ 7	$ 5

XML

Intangible Assets - Definite Lived Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Intangibles, net	$ 1,421	$ 1,359
FGL [Member] | Trademarks and Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	16
Finite-Lived Intangible Assets, Accumulated Amortization	2
Finite-Lived Intangible Assets, Net	$ 14
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
FGL [Member] | Licensing Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net	$ 6
Licensing Agreements [Member] | FGL [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, net	$ 6

XML

Intangible Assets - Narrative (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Unearned Revenue, Net	$ (39)
Unearned Revenue, Unlocking Adjustment	0
Goodwill	467		$ 467
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	0	$ 1
Unearned Revenue, Additions	(9)
Unearned Revenue, Amortization Expense	2
Unearned Revenue, Unrealized Gain (Loss) on Investment	$ 9
Minimum
Finite-Lived Intangible Assets [Line Items]
Value of Business Acquired, Assumption, Interest Rate to Calculate Accretion on Intangible Asset	0.05%
Maximum
Finite-Lived Intangible Assets [Line Items]
Value of Business Acquired, Assumption, Interest Rate to Calculate Accretion on Intangible Asset	4.01%
Voba [Member]
Finite-Lived Intangible Assets [Line Items]
Cumulative Adjustments For Net Unrealized Investment Gains	$ (40)		(22)
Dac [Member]
Finite-Lived Intangible Assets [Line Items]
Cumulative Adjustments For Net Unrealized Investment Gains	(5)		$ 0
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	$ 2	$ 2

XML

Intangible Assets - Estimated Amortization Expense for VOBA in Future Fiscal Periods (Detail)	Mar. 31, 2019 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2019	$ 48,000,000
2020	83,000,000
2021	89,000,000
2022	84,000,000
2023	75,000,000
Thereafter	$ 385,000,000

XML

Debt - Narrative (Detail) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 541
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility	$ 0	$ 0
Interest rate if revolver drawn	5.00%
Remaining borrowing capacity	$ 250
Predecessor
Debt Instrument [Line Items]
Long-term Debt		$ 541

XML

Debt - Schedule of Debt (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 541
Interest expense excluding amortization	8
Amortization of debt issuance costs	0
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility	0		$ 0
Interest expense excluding amortization	0
Amortization of debt issuance costs	$ 0
Predecessor
Debt Instrument [Line Items]
Long-term Debt			$ 541
Interest expense excluding amortization		$ 5
Amortization of debt issuance costs		0
Predecessor | Revolving Credit Facility
Debt Instrument [Line Items]
Interest expense excluding amortization		1
Amortization of debt issuance costs		$ 0

XML

Equity - Schedule of Dividends (Details) - USD ($) $ / shares in Units, $ in Millions	Dec. 14, 2015	Nov. 12, 2015	Mar. 31, 2019	Dec. 31, 2018	Nov. 30, 2015
Accelerated Share Repurchases [Line Items]
Common stock, shares outstanding (in shares)			211,660,974	211,660,974	221,661,000
Cash dividend per common share (in dollars per share)		$ 0.01
Total cash paid	$ 2

XML

Equity - Schedule of Dividends Declared (Details) $ / shares in Units, shares in Thousands, shareholder in Thousands, $ in Thousands	Dec. 15, 2020	May 07, 2019 $ / shares	Apr. 01, 2019 USD ($) shares	Mar. 15, 2019 shares	Apr. 01, 2018 USD ($) shares	Mar. 15, 2018 shareholder	Nov. 12, 2015 $ / shares	Mar. 31, 2019 USD ($)
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount								$ 150,000
Cash dividend per common share (in dollars per share) | $ / shares							$ 0.01
Preferred Stock | Series A Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Number of Shareholders				298		277
Preferred Stock | Series B Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Number of Shareholders				108		101
Subsequent Event [Member]
Class of Stock [Line Items]
Cash dividend per common share (in dollars per share) | $ / shares		$ 0.01
Stock Repurchase Program Expiration Date	Dec. 15, 2020
Subsequent Event [Member] | Preferred Stock | Series A Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Total cash paid			$ 0		$ 0
Total shares paid in kind (in thousands) | shares			6		5
Subsequent Event [Member] | Preferred Stock | Series B Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Total cash paid			$ 0		$ 0
Total shares paid in kind (in thousands) | shares			2		1

XML

Stock Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended
	Mar. 31, 2019	May 15, 2018	Mar. 31, 2019	Dec. 31, 2018	Aug. 08, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	5,588,000		5,588,000
2017 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)					15,006,000
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			1,699,000
Vested and exercisable at end of period (in shares)	485,000
Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date			$ 3
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 76		$ 76
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	7 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	6 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	7 years
Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 6.82		$ 6.82	$ 0.00
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date			$ 1
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			147,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 6.82
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period			0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value			$ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period			0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value			$ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	147,000		147,000	0
Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 9.19		$ 9.19	$ 8.95
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date			$ 4
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			424,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 8.64
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period			(59,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value			$ 10.00
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period			(10,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value			$ 8.96
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	711,000		711,000	356,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities	$ 0		$ 0
Officer [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		1,699,000
Director [Member] | Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			147,000
Management [Member] | Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			424,000
FGL Holdings [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Price	$ 7.87		$ 7.87
Service Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		485,000
Service and Return on Equity Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		607,000
Service and Stock Price Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		607,000

XML

Stock Compensation - Schedule of Stock Based Compensation Costs (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Related tax benefit	$ 0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	1
Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	1
Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	0
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	1
FGL Incentive Plan [Member] | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	1
FGL Incentive Plan [Member] | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	$ 0

XML

Stock Compensation - Summary of Unrecognized Stock Compensation Expense (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 22
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	3 years
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 19
FGL Incentive Plan [Member] | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 18
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	3 years
FGL Incentive Plan [Member] | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 1
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year
Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 3
Management Incentive Plan [Member] | Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 3
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	3 years

XML

Stock Compensation - Summary of Stock Options Outstanding and Related Activity (Details) - $ / shares shares in Thousands				3 Months Ended
	Mar. 31, 2019	Feb. 26, 2019	May 15, 2018	Mar. 31, 2019	Dec. 31, 2018
FGL Incentive Plan [Member]
Options (in shares):
Stock options outstanding at beginning of period (in shares)				13,007
Granted (in shares)				1,699
Exercised (in shares)				0
Forfeited or expired (in shares)				(1,869)
Stock options outstanding at end (in shares)	12,837			12,837
Vested and exercisable at end of period (in shares)	485
Vested or projected to vest (in shares)	12,837			12,837
Weighted Average Exercise Price (in dollars per share):
Stock options outstanding at beginning of period (USD per share)				$ 9.68
Granted (USD per share)				10.00
Exercised (USD per share)				0.00
Forfeited or expired (USD per share)				(10.00)
Stock options outstanding at end of period (USD per share)	$ 9.67			9.67
Vested and exercisable at end of period (USD per share)	10.00
Vested and projected to vest (in dollars per share)	$ 9.67			$ 9.67
Equity Option [Member] | Officer [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)			1,699
Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	147			147	0
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 6.82			$ 6.82	$ 0.00
Granted (in shares)				147
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value				$ 6.82
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value				$ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period				0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value				$ 0.00
Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	711			711	356
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 9.19			$ 9.19	$ 8.95
Granted (in shares)				424
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value				$ 8.64
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				(59)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value				$ 10.00
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period				(10)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value				$ 8.96
Service Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)			485
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 1.68
Service and Return on Equity Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)			607
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		1.74
Service and Stock Price Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)			607
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 1.26

XML

Stock Compensation - Assumptions Used in Determination of Grant Date Fair Values Using Black-Scholes Option Pricing Model (Details) - Equity Option [Member] - FGL Incentive Plan [Member]	Feb. 26, 2019 $ / shares
Service Vesting Mechanism [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 1.68
Risk-free interest rate	2.48%
Assumed dividend yield	0.00%
Expected option term	5 years 9 months
Volatility	26.00%
Service and Return on Equity Performance Vesting Mechanism [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 1.74
Risk-free interest rate	2.50%
Assumed dividend yield	0.00%
Expected option term	6 years
Volatility	26.00%
Service and Stock Price Performance Vesting Mechanism [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 1.26
Risk-free interest rate	2.54%
Assumed dividend yield	0.00%
share-based compensation arrangement by share-based payment award, fair value assumptions, contractual term	7 years
Volatility	26.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Early Exercise Multiple	2.8
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Cost of Equity	10.50%

XML

Stock Compensation - Summary of Restricted Stock and Restricted Stock Units Outstanding and Related Activity (Details) - FGL Incentive Plan [Member] - Restricted shares shares in Thousands	3 Months Ended
	Mar. 31, 2019 $ / shares shares
Shares:
Restricted shares outstanding at beginning of period (in shares) | shares	0
Granted (in shares) | shares	147
Vested (in shares) | shares	0
Restricted shares outstanding at end of period (in shares) | shares	147
Weighted Average Grant Date Fair Value (in dollars per share):
Average grant date fair value outstanding at beginning of period (USD per share) | $ / shares	$ 0.00
Average grant date fair value, Granted (USD per share) | $ / shares	6.82
Average grant date fair value, Exercised (USD per share) | $ / shares	$ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares	0
Average grant date fair value, Forfeited or Expired (USD per share) | $ / shares	$ 0.00
Average grant date fair value outstanding at end of period (USD per share) | $ / shares	$ 6.82

XML

Income Taxes - Narrative (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Tax Credit Carryforward [Line Items]
Effective tax rate	5.00%	38.00%
Valuation allowance	$ 33,000,000
Deferred Tax Assets, Gross	$ 316,000,000

XML

Commitments and Contingencies - Schedule of Investment Commitments (Details) - Commitment to Invest $ in Millions	Mar. 31, 2019 USD ($)
Other Commitments [Line Items]
Unfunded investment commitment	$ 1,158
Other invested assets
Other Commitments [Line Items]
Unfunded investment commitment	1,093
Equity securities
Other Commitments [Line Items]
Unfunded investment commitment	21
Fixed maturity securities, available-for-sale
Other Commitments [Line Items]
Unfunded investment commitment	39
Other assets
Other Commitments [Line Items]
Unfunded investment commitment	$ 5

XML

Commitments and Contingencies - Narrative (Details)	Mar. 31, 2019 USD ($)
Loss Contingencies [Line Items]
Accrued amount of guaranty fund assessments	$ 2
Estimated future premium tax deductions	$ 2

XML

Reinsurance - Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Benefits and Other Changes in Insurance Policy Reserves:
Net	$ 339
Traditional life insurance premiums
Premiums and other considerations:
Direct	57
Assumed	0
Ceded	(41)
Net	16
Benefits and Other Changes in Insurance Policy Reserves:
Direct	372
Assumed	20
Ceded	(53)
Net	$ 339
Predecessor
Benefits and Other Changes in Insurance Policy Reserves:
Net		$ (39)
Predecessor | Traditional life insurance premiums
Premiums and other considerations:
Direct		60
Assumed		0
Ceded		(42)
Net		18
Benefits and Other Changes in Insurance Policy Reserves:
Direct		41
Assumed		(21)
Ceded		(59)
Net		$ (39)

XML

Reinsurance - Narrative (Details)		3 Months Ended
	Dec. 28, 2018 USD ($)	Mar. 31, 2019 USD ($)	Sep. 30, 2018 USD ($)	Mar. 31, 2018 USD ($)	Sep. 30, 2017 USD ($)	Dec. 31, 2018 USD ($)
Ceded Credit Risk [Line Items]
Reinsurance, Loss on Uncollectible Accounts in Period, Amount		$ 0	$ 0	$ 0	$ 0
Reinsurance Risk Charge Fee		0
Number of policies reinsured by foreign company not engaged in insurance				0
Funds withheld for reinsurance receivables, at fair value		837,000,000				$ 757,000,000
Funds Held under Reinsurance Agreements, Liability		653,000,000				$ 722,000,000
Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Ceded		0	$ 0	$ 0	$ 0
Reinsurance Retention Policy, Amount Retained	$ 758.00
Fixed indexed annuities
Ceded Credit Risk [Line Items]
Reinsurance Retention Policy, Amount Retained	$ 4,000,000,000.00
FSRC [Member]
Ceded Credit Risk [Line Items]
Funds withheld for reinsurance receivables, at fair value		286,000,000
Funds Held under Reinsurance Agreements, Liability		270,000,000
F&G Re [Member]
Ceded Credit Risk [Line Items]
Funds withheld for reinsurance receivables, at fair value		551,000,000
Funds Held under Reinsurance Agreements, Liability		$ 527,000,000
2013 [Member] | Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Reinsured risk	40.00%
2001 Through 2012 [Member] | Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Reinsured risk	45.00%
2000 And Prior [Member] | Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Reinsured risk	63.00%
Minimum | Fixed indexed annuities
Ceded Credit Risk [Line Items]
Reinsured risk	80.00%
Maximum | Fixed indexed annuities
Ceded Credit Risk [Line Items]
Reinsured risk	90.00%

XML

Related Party Transactions - Narrative (Details) - USD ($) shares in Thousands				3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018	Dec. 17, 2018	Mar. 31, 2019	Sep. 30, 2018	Mar. 31, 2018
Related Party Transaction [Line Items]
Related Party Transactions, Gain (Loss)				$ 0		$ 0
Management Fee Payable	$ 25,000,000	$ 20,000,000		25,000,000
Reimbursement Revenue				2,000,000
Related Party Transaction, Asset Carrying Value	1,549,000,000	1,461,000,000		1,549,000,000
Unrealized Loss on Foreign Currency Derivatives, before Tax	(4,000,000)	(2,000,000)
Subsidiary of Common Parent [Member]
Related Party Transaction [Line Items]
Benefits and other changes in policy reserves				0
Commitment to Invest
Related Party Transaction [Line Items]
Unfunded investment commitment	1,158,000,000			1,158,000,000
Commitment to Invest | Affiliated Entity
Related Party Transaction [Line Items]
Unfunded investment commitment	$ 971,000,000	$ 990,000,000		971,000,000
Preferred Stock | Affiliated Entity
Related Party Transaction [Line Items]
Total shares paid in kind (in thousands)					6
Residential Portfolio Segment [Member]
Related Party Transaction [Line Items]
Residential Mortgage Loans Purchased			$ 185,000,000	$ 12,000,000

XML

Earnings Per Share - Summary of Basic and Diluted EPS (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2019	Sep. 30, 2018	Mar. 31, 2018	Dec. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income (loss)	$ 171		$ 65
Less Preferred stock dividend	8		$ 7
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic	$ 163
Weighted-average common shares outstanding - basic (in shares)	219,645,679
Dilutive effect of unvested restricted stock and unvested performance restricted stock (in shares)	36,000
Weighted-average shares outstanding - diluted (in shares)	219,681,528
Net income (loss) per common share:
Basic (in USD per share)	$ 0.74
Diluted (in USD per share)	$ 0.74
Common Stock Warrants Outstanding	6,000,000	70,000,000
Preferred Stock, shares outstanding (in shares)	406,510		377,000	399,033
Preferred Stock
Net income (loss) per common share:
Antidilutive securities excluded from computation of EPS, less than, amount (shares)	406,000
Stock Option Awards
Net income (loss) per common share:
Antidilutive securities excluded from computation of EPS, less than, amount (shares)	1,737,000
Predecessor
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income (loss)			$ 65
Less Preferred stock dividend			7
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic			$ 58
Weighted-average common shares outstanding - basic (in shares)			214,370,000
Dilutive effect of unvested restricted stock and unvested performance restricted stock (in shares)			0
Weighted-average shares outstanding - diluted (in shares)			214,370,000
Net income (loss) per common share:
Basic (in USD per share)			$ 0.27
Diluted (in USD per share)			$ 0.27

XML

Insurance Subsidiary Financial Information and Regulatory Matters - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus	$ 100	$ 110
Non-permitted statutory accounting practices	(4)	(16)
Statutory capital and surplus	97	94
Increase (decrease) in statutory capital surplus	48	30
IOWA
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus	$ 1	$ 0

XML

Label	Element	Value
Treasury Stock [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	$ 0